Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
GRCh38/hg38 5q32-35.3(chr5:149714592-181272151)x3	ATOX1-AS1|ATP10B|C5orf52|C5orf58|CAMK2A|CLMAT3|CREBRF|CSF1R|CTC-338M12.4|ERGIC1|F12|FAM153B|G3BP1|GFPT2|GPX3|GRIA1|HAVCR2|HMMR|HMMR-AS1|HNRNPAB|IRGM|ITK|LARP1|LCP2|LINC01470|LINC01484|LINC01485|LINC01933|LINC01938|LINC01942|LINC02143|LINC02159|LINC01947|LINC01951|LINC01962|LINC02202|LINC02222|LINC02227|LOC129995237|LOC129995238|LOC129995239|LOC129995242|LOC129995243|LOC129995233|LOC129995234|LOC129995235|LOC129995236|KCNIP1|KCNIP1-AS1|KCNIP1-OT1|KIAA1191|KIF4B|KCNMB1|LOC129995244|LOC129995245|LOC129995246|LINC00847|LINC01187|LINC01202|LINC01366|LINC01411|LOC129995240|LOC129995241|LINC01574|LINC01845|LINC01847|GRK6|HAVCR1|GMCL2|GPRIN1|GRM6|HAND1|LINC01861|LINC01932|HEIH|HIGD2A|HK3|HMGXB3|HNRNPH1|FAM193B|FAM200C|FAM153A|FAT2|FAXDC2|FBLL1|HRH2|IL12B|GABRP|GALNT10|GARIN3|GEMIN5|IL12B-AS1|INSYN2B|GLRA1|CLTB|CPEB4|CPLX2|LINC01944|CANX|CBY3|CDX1|CLINT1|CLK4|CYFIP2|DBN1|CNOT6|CNOT8|COL23A1|DCTN4|EFCAB9|EIF4E1B|GM2A|FABP6|FABP6-AS1|FAF2|ARL10|ARSI|ATOX1|FAM114A2|ATP6V0E1|B4GALT7|BTNL3|BTNL8|BTNL9|C1QTNF2|C5orf47|ANXA6|BNIP1|BOD1|CCDC69|CCNG1|CCNJL|CD74|CDHR2|ADAM19|ADAMTS2|ADRA1B|DDX41|DOCK2|DOK3|DRD1|DUSP1|EBF1|FBXW11|FGF18|FGFR4|FLT4|FNDC9|FOXI1|GABRA1|GABRA6|GABRA6-AS1|GABRB2|GABRG2|LOC129995247|LOC129995248|LOC129995249|LOC129995250|LOC129995251|LOC129995252|LOC129995253|LOC129995254|LOC129995255|LOC129995256|LOC129995257|LOC129995258|LOC129995259|LOC129995260|LOC129995261|LOC129995262|LOC129995263|LOC129995264|LOC129995265|LOC129995266|LOC129995267|LOC129995268|LOC129995269|LOC129995270|LOC129995271|LOC129995272|LOC129995273|LOC129995274|LOC129995275|LOC129995276|LOC129995277|LOC129995278|LOC129995279|LOC129995280|LOC129995281|LOC129995282|LOC129995283|LOC129995284|LOC129995285|LOC129995286|LOC129995287|LOC129995288|LOC129995289|LOC129995290|LOC129995291|LOC129995292|LOC129995293|LOC129995294|LOC129995295|LOC129995296|LOC129995297|LOC129995298|LOC129995299|LOC129995300|LOC129995301|LOC129995302|LOC129995303|LOC129995304|LOC129995305|LOC129995306|LOC129995307|LOC129995308|LOC129995309|LOC129995310|LOC129995311|LOC129995312|LOC129995313|LOC129995314|LOC129995315|LOC129995316|LOC129995317|LOC129995318|LOC129995319|LOC129995320|LOC129995321|LOC129995322|LOC129995323|LOC129995324|LOC129995325|LOC129995326|LOC129995327|LOC129995328|LOC129995329|LOC129995330|LOC129995331|LOC129995332|LOC129995333|LOC129995334|LOC129995335|LOC129995336|LOC129995337|LOC129995338|LOC129995339|LOC129995340|LOC129995341|LOC129995342|LOC129995343|LOC129995344|LOC129995345|LOC129995346|LOC129995347|LOC129995348|LOC129995349|LOC129995350|LOC129995351|LOC129995352|LOC129995353|LOC129995354|LOC129995355|LOC129995356|LOC129995357|LOC129995358|LOC129995359|LOC129995360|LOC129995361|LOC129995362|LOC129995363|LOC129995364|LOC129995365|LOC129995366|LOC129995367|LOC129995368|LOC129995369|LOC129995370|LOC129995371|LOC129995372|LOC129995373|LOC129995374|LOC129995375|LOC129995376|LOC129995377|LOC129995378|LOC129995379|LOC129995380|LOC129995381|LOC129995382|LOC129995383|LOC129995384|LOC129995385|LOC129995386|LOC129995387|LOC129995388|LOC129995389|LOC129995390|LOC129995391|LOC129995392|LOC129995393|LOC129995394|LOC129995395|LOC129995396|LOC129995397|LOC129995398|LOC129995399|LOC129995400|LOC129995401|LOC129995402|LOC129995403|LOC129995404|LOC129995405|LOC129995406|LOC129995407|LOC129995408|LOC129995409|LOC129995410|LOC129995411|LOC129995412|LOC129995413|LOC129995414|LOC129995415|LOC129995416|LOC129995417|LOC129995418|LOC129995419|LOC129995420|LOC129995421|LOC129995422|LOC129995423|LOC129995424|LOC129995425|LOC129995426|LOC129995427|LOC129995428|LOC129995429|LOC129995430|LOC129995431|LOC129995432|LOC129995433|LOC129995434|LOC129995435|LOC129995436|LOC129995437|LOC129995438|LOC129995439|LOC129995440|LOC129995441|LOC129995442|LOC129995443|LOC129995444|LOC129995445|LOC129995446|LOC129995447|LOC129995448|LOC129995449|LOC129995450|LOC129995451|LOC129995452|LOC129995453|LOC129995454|LOC129995455|LOC129995456|LOC129995457|LOC129995458|LOC129995459|LOC129995460|LOC129995461|LOC129995462|LOC129995463|LOC129995464|LOC129995465|LOC129995466|LOC129995467|LOC129995468|LOC129995469|LOC129995470|LOC129995471|LOC129995472|LOC129995473|LOC129995474|LOC129995475|LOC129995476|LOC129995477|LOC129995478|LOC129995479|LOC129995480|LOC129995481|LOC129995482|LOC129995483|LOC129995484|LOC129995485|LOC129995486|LOC129995487|LOC129995488|LOC129995489|LOC129995490|LOC129995491|LOC129995492|LOC129995493|LOC129995494|LOC129995495|LOC129995496|LOC129995497|LOC129995498|LOC129995499|LOC129995500|LOC129995501|LOC129995502|LOC129995503|LOC129995504|LOC129995505|LOC129995506|LOC129995507|LOC129995508|LOC129995509|LOC129995510|LOC129995511|LOC129995512|LOC129995513|LOC129995514|LOC129995515|LOC129995516|LOC132089189|LOC132089190|LOC132089191|LOC132089192|LOC132089193|LOC132089194|LOC132089195|LOC132089196|LOC132089197|LOC132089198|LOC132089199|LOC132089200|LOC132089201|LOC132089202|LOC132089203|LOC132089204|LOC132089205|LOC132089206|LOC132089207|LOC132089208|LOC132089209|LOC132089210|LOC132089211|LOC132089212|LOC132089213|LOC132089214|LOC132089215|LOC132089216|LOC132089217|LOC132089218|LOC132089219|LOC132089220|LOC132089221|LOC132089222|LOC132089223|LOC132089224|LOC132089225|LOC132089226|LOC132089227|LOC132089228|LOC132089230|LOC132090739|LOC132090740|LOC132090741|LOC132090742|LOC132090743|LOC132090744|LOC132090745|LOC132090746|LOC132090747|LOC132090748|LOC132205961|LOC132205962|LSM11|LTC4S|MAML1|MAPK9|MAT2B|MED7|MFAP3|MGAT1|MGAT4B|MIR103A1|MIR103B1|MIR10523|MIR12118|MIR12125|MIR1229|MIR1271|MIR1294|MIR1303|MIR146A|MIR218-2|MIR3141|MIR3142|MIR3142HG|MIR340|MIR378A|MIR378E|MIR378H|MIR3912|MIR4281|MIR4634|MIR4638|MIR5003|MIR585|MIR6499|MIR8056|MIR8089|MRNIP|MRNIP-DT|MRPL22|MSANTD5|MSX2|MXD3|MYOZ3|MYOZ3-AS1|N4BP3|NDST1|NDST1-AS1|NEURL1B|NHP2|NIPAL4|NIPAL4-DT|NKX2-5|NMUR2|NOP16|NPM1|NSD1|NSG2|NUDCD2|OR2V1|OR2V2|OR2Y1|PANK3|PDE6A|PDGFRB|PDLIM7|PFN3|PHYKPL|PPARGC1B|PPP1R2B|PRELID1|PROP1|PRR7|PRR7-AS1|PTTG1|PWWP2A|RAB24|RACK1|RANBP17|RARS1|RASGEF1C|RBM22|RGS14|RMND5B|RNF130|RNF145|RNF44|RPL26L1|RPL26L1-AS1|RPS14|RUFY1|RUFY1-AS1|SAP30L|SAP30L-AS1|SCGB3A1|SFXN1|SGCD|SH3PXD2B|SIMC1|SLC26A2|SLC34A1|SLC36A1|SLC36A2|SLC36A3|SLC6A7|SLIT3|SLIT3-AS1|SLIT3-AS2|SLU7|SMIM23|SMIM3|SNCB|SNORA70J|SNORA74B|SNORD95|SNORD96A|SOX30|SPARC|SPATA31J1|SPDL1|SQSTM1|STC2|STK10|SYNPO|TBC1D9B|TCOF1|TENM2|TENM2-AS1|TENM2-AS3|THG1L|THOC3|THOC3-AS1|TIGD6|TIMD4|TLX3|TMED9|TNIP1|TRA-TGC3-1|TRIM41|TRIM52|TRIM52-AS1|TRIM7|TRIM7-AS2|TRK-CTT2-2|TRK-CTT2-3|TRL-AAG1-1|TRL-AAG1-2|TRL-AAG1-3|TRL-AAG2-1|TRP-TGG3-1|TRT-TGT6-1|TRV-AAC1-2|TRV-AAC1-3|TRV-AAC1-4|TRV-AAC2-1|TRV-CAC1-2|TRV-CAC1-3|TRV-CAC1-4|TRV-CAC1-5|TSPAN17|TTC1|UBLCP1|UBTD2|UIMC1|UNC5A|WWC1|ZFP2|ZFP62|ZNF300|ZNF346|ZNF354A|ZNF354B|ZNF354C|ZNF454|ZNF454-DT|ZNF879|LINC02995|LINC03000|LMAN2|LOC100128059|LOC100128340|LOC100288254|LOC100289470|LOC100502572|LOC100652758|LOC100996385|LOC101927908|LOC101928093|LOC102546299|LOC102724551|LOC105377730|LOC105377753|LOC105377763|LOC105378230|LOC105980006|LOC105980008|LOC108004526|LOC108228201|LOC109279841|LOC110120620|LOC110120643|LOC110120714|LOC110120747|LOC110120777|LOC110120965|LOC110120995|LOC110120998|LOC110121000|LOC110121027|LOC110121041|LOC110121211|LOC110121241|LOC110121272|LOC110121284|LOC111188152|LOC111188153|LOC111188154|LOC111188156|LOC111429606|LOC111500319|LOC111556140|LOC111828524|LOC112997568|LOC112997569|LOC112997570|LOC112997571|LOC112997572|LOC112997574|LOC112997575|LOC112997576|LOC112997577|LOC112997578|LOC112997579|LOC112997580|LOC112997581|LOC112997582|LOC112997583|LOC112997584|LOC114004391|LOC116158526|LOC116158527|LOC116158528|LOC116158530|LOC116158531|LOC116158532|LOC116158533|LOC116158534|LOC116158535|LOC116158536|LOC121099710|LOC121099711|LOC121099712|LOC121099713|LOC121099714|LOC121099715|LOC121099716|LOC121099717|LOC121099718|LOC121740630|LOC121740631|LOC121740632|LOC121740633|LOC121740634|LOC121740635|LOC123575590|LOC123575592|LOC123575593|LOC123575594|LOC123575595|LOC123575596|LOC123575597|LOC123575598|LOC123575599|LOC123575600|LOC123575601|LOC123575602|LOC123575603|LOC123575604|LOC123575605|LOC123575606|LOC123575607|LOC123575608|LOC123575609|LOC123575610|LOC123575611|LOC123575612|LOC123575614|LOC123575615|LOC123575616|LOC123575617|LOC123575618|LOC123575619|LOC123575620|LOC123575621|LOC123575622|LOC123575623|LOC123575624|LOC123575625|LOC123575626|LOC123575627|LOC123575628|LOC123575629|LOC123575630|LOC123575631|LOC123575632|LOC123575633|LOC123575634|LOC123575635|LOC123575636|LOC123575637|LOC123575638|LOC123575639|LOC123575640|LOC123575641|LOC126807551|LOC126807552|LOC126807553|LOC126807554|LOC126807555|LOC126807556|LOC126807557|LOC126807558|LOC126807559|LOC126807560|LOC126807561|LOC126807562|LOC126807563|LOC126807564|LOC126807565|LOC126807566|LOC126807567|LOC126807568|LOC126807569|LOC126807570|LOC126807571|LOC126807572|LOC126807573|LOC126807574|LOC126807575|LOC126807576|LOC126807577|LOC126807578|LOC126807579|LOC126807580|LOC126807581|LOC126807582|LOC126807583|LOC126807584|LOC126807585|LOC126807586|LOC126807587|LOC126807588|LOC126807589|LOC126807590|LOC126807591|LOC126807592|LOC126807593|LOC126807594|LOC126807595|LOC126807596|LOC126807597|LOC126807598|LOC126807599|LOC126807600|LOC126807601|LOC126807602|LOC126807603|LOC126807604|LOC126807605|LOC126807606|LOC126807607|LOC126807608|LOC126807609|LOC126807610|LOC126807611|LOC126807612|LOC126807613|LOC126807614|LOC126807615|LOC126807616|LOC126807617|LOC126807618|LOC126807619|LOC126807620|LOC126807621|LOC126807622|LOC126807623|LOC126807624|LOC126807625|LOC126807626|LOC126807627|LOC126807628|LOC126807629|LOC126807630|LOC126807631|LOC126807632|LOC126807633|LOC128772274|LOC128966623|LOC129389395|LOC129389396|LOC129389397|LOC129389398|LOC129389399|LOC129389400|LOC129389401|LOC129389402|LOC129389403|LOC129389404|LOC129389405|LOC129389406|LOC129389407|LOC129389408|LOC129389409|LOC129389410|LOC129389411|LOC129389412|LOC129389413|LOC129389414|LOC129389415|LOC129389416|LOC129389417|LOC129389418|LOC129389419|LOC129389420|LOC129389421|LOC129389422|LOC129994966|LOC129994967|LOC129994968|LOC129994969|LOC129994970|LOC129994971|LOC129994972|LOC129994973|LOC129994974|LOC129994975|LOC129994976|LOC129994977|LOC129994978|LOC129994979|LOC129994980|LOC129994981|LOC129994982|LOC129994983|LOC129994984|LOC129994985|LOC129994986|LOC129994987|LOC129994988|LOC129994989|LOC129994990|LOC129994991|LOC129994992|LOC129994993|LOC129994994|LOC129994995|LOC129994996|LOC129994997|LOC129994998|LOC129994999|LOC129995000|LOC129995001|LOC129995002|LOC129995003|LOC129995004|LOC129995005|LOC129995006|LOC129995007|LOC129995008|LOC129995009|LOC129995010|LOC129995011|LOC129995012|LOC129995013|LOC129995014|LOC129995015|LOC129995016|LOC129995017|LOC129995018|LOC129995019|LOC129995020|LOC129995021|LOC129995022|LOC129995023|LOC129995024|LOC129995025|LOC129995026|LOC129995027|LOC129995028|LOC129995029|LOC129995030|LOC129995031|LOC129995032|LOC129995033|LOC129995034|LOC129995035|LOC129995036|LOC129995037|LOC129995038|LOC129995039|LOC129995040|LOC129995041|LOC129995042|LOC129995043|LOC129995044|LOC129995045|LOC129995046|LOC129995047|LOC129995048|LOC129995049|LOC129995050|LOC129995051|LOC129995052|LOC129995053|LOC129995054|LOC129995055|LOC129995056|LOC129995057|LOC129995058|LOC129995059|LOC129995060|LOC129995061|LOC129995062|LOC129995063|LOC129995064|LOC129995065|LOC129995066|LOC129995067|LOC129995068|LOC129995069|LOC129995070|LOC129995071|LOC129995072|LOC129995073|LOC129995074|LOC129995075|LOC129995076|LOC129995077|LOC129995078|LOC129995079|LOC129995080|LOC129995081|LOC129995082|LOC129995083|LOC129995084|LOC129995085|LOC129995086|LOC129995087|LOC129995088|LOC129995089|LOC129995090|LOC129995091|LOC129995092|LOC129995093|LOC129995094|LOC129995095|LOC129995096|LOC129995097|LOC129995098|LOC129995099|LOC129995100|LOC129995101|LOC129995102|LOC129995103|LOC129995104|LOC129995105|LOC129995106|LOC129995107|LOC129995108|LOC129995109|LOC129995110|LOC129995111|LOC129995112|LOC129995113|LOC129995114|LOC129995115|LOC129995116|LOC129995117|LOC129995118|LOC129995119|LOC129995120|LOC129995121|LOC129995122|LOC129995123|LOC129995124|LOC129995125|LOC129995126|LOC129995127|LOC129995128|LOC129995129|LOC129995130|LOC129995131|LOC129995132|LOC129995133|LOC129995134|LOC129995135|LOC129995136|LOC129995137|LOC129995138|LOC129995139|LOC129995140|LOC129995141|LOC129995142|LOC129995143|LOC129995144|LOC129995145|LOC129995146|LOC129995147|LOC129995148|LOC129995149|LOC129995150|LOC129995151|LOC129995152|LOC129995153|LOC129995154|LOC129995155|LOC129995156|LOC129995157|LOC129995158|LOC129995159|LOC129995160|LOC129995161|LOC129995162|LOC129995163|LOC129995164|LOC129995165|LOC129995166|LOC129995167|LOC129995168|LOC129995169|LOC129995170|LOC129995171|LOC129995172|LOC129995173|LOC129995174|LOC129995175|LOC129995176|LOC129995177|LOC129995178|LOC129995179|LOC129995180|LOC129995181|LOC129995182|LOC129995183|LOC129995184|LOC129995185|LOC129995186|LOC129995187|LOC129995188|LOC129995189|LOC129995190|LOC129995191|LOC129995192|LOC129995193|LOC129995194|LOC129995195|LOC129995196|LOC129995197|LOC129995198|LOC129995199|LOC129995200|LOC129995201|LOC129995202|LOC129995203|LOC129995204|LOC129995205|LOC129995206|LOC129995207|LOC129995208|LOC129995209|LOC129995210|LOC129995211|LOC129995212|LOC129995213|LOC129995214|LOC129995215|LOC129995216|LOC129995217|LOC129995218|LOC129995219|LOC129995220|LOC129995221|LOC129995222|LOC129995223|LOC129995224|LOC129995225|LOC129995226|LOC129995227|LOC129995228|LOC129995229|LOC129995230|LOC129995231|LOC129995232		See cases	VCV000058118	5	149094155 - 180699152	5	149714592 - 181272151	58118	72713			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 5q33.1-34(chr5:152443869-166104392)x1	ADAM19|ADRA1B|ATP10B|C1QTNF2|C5orf52|CCNG1|CCNJL|CLINT1|CNOT8|CYFIP2|EBF1|FABP6|FABP6-AS1|FAM114A2|FAM200C|FAXDC2|FNDC9|GABRA1|GABRA6|GABRA6-AS1|GABRB2|GABRG2|GALNT10|GARIN3|GEMIN5|GRIA1|HAND1|HAVCR1|HAVCR2|HMMR|HMMR-AS1|IL12B|ITK|KIF4B|LARP1|LINC01202|LINC01470|LINC01845|LINC01847|LINC01861|LINC01932|LINC01938|LINC02143|LINC02159|LINC02202|LINC02227|LINC03000|LOC102546299|LOC108228201|LOC110120620|LOC110120777|LOC110120965|LOC110120995|LOC110120998|LOC110121000|LOC110121027|LOC112997570|LOC112997571|LOC112997572|LOC112997574|LOC116158526|LOC121099711|LOC121099712|LOC121740631|LOC123575603|LOC123575604|LOC123575605|LOC123575606|LOC123575607|LOC123575608|LOC126807559|LOC126807560|LOC126807561|LOC126807562|LOC126807563|LOC126807564|LOC126807565|LOC126807566|LOC126807567|LOC126807568|LOC126807569|LOC126807570|LOC126807571|LOC126807572|LOC126807573|LOC126807574|LOC126807575|LOC126807576|LOC126807577|LOC126807578|LOC129389402|LOC129389403|LOC129389404|LOC129389405|LOC129389406|LOC129389407|LOC129389408|LOC129389409|LOC129389410|LOC129389411|LOC129995063|LOC129995064|LOC129995065|LOC129995066|LOC129995067|LOC129995068|LOC129995069|LOC129995070|LOC129995071|LOC129995072|LOC129995073|LOC129995074|LOC129995075|LOC129995076|LOC129995077|LOC129995078|LOC129995079|LOC129995080|LOC129995081|LOC129995082|LOC129995083|LOC129995084|LOC129995085|LOC129995086|LOC129995087|LOC129995088|LOC129995089|LOC129995090|LOC129995091|LOC129995092|LOC129995093|LOC129995094|LOC129995095|LOC129995096|LOC129995097|LOC129995098|LOC129995099|LOC129995100|LOC129995101|LOC129995102|LOC129995103|LOC129995104|LOC129995105|LOC129995106|LOC129995107|LOC129995108|LOC129995109|LOC129995110|LOC129995111|LOC129995112|LOC129995113|LOC129995114|LOC129995115|LOC129995116|LOC129995117|LOC129995118|LOC129995119|LOC129995120|LOC129995121|LOC129995122|LOC129995123|LOC129995124|LOC129995125|LOC129995126|LOC129995127|LOC129995128|LOC129995129|LOC129995130|LOC129995131|LOC129995132|LOC129995133|LOC129995134|LOC129995135|LOC129995136|LOC129995137|LOC129995138|LOC129995139|LOC129995140|LOC129995141|LOC129995142|LOC129995143|LOC129995144|LOC129995145|LOC129995146|LOC129995147|LOC129995148|LOC129995149|LOC129995150|LOC129995151|LOC129995152|LOC129995153|LOC129995154|LOC129995155|LOC129995156|LOC129995157|LOC129995158|LOC129995159|LOC129995160|LOC129995161|LOC129995162|LOC129995163|LOC129995164|LOC129995165|LOC129995166|LOC129995167|LOC129995168|LOC129995169|LOC129995170|LOC129995171|LOC129995172|LOC129995173|LOC129995174|LOC129995175|LOC129995176|LOC129995177|LOC129995178|LOC129995179|LOC129995180|LOC129995181|LOC129995182|LOC129995183|LOC129995184|LOC129995185|LOC129995186|LOC129995187|LOC129995188|LOC129995189|LOC129995190|LOC129995191|LOC129995192|LOC129995193|LOC129995194|LOC129995195|LOC129995196|LOC129995197|LOC129995198|LOC129995199|LOC129995200|LOC129995201|LOC129995202|LOC129995203|LOC129995204|LOC132089203|LOC132089204|LOC132089205|LOC132089206|LOC132089207|LOC132089208|LOC132089209|LOC132089210|LOC132089211|LOC132089212|LOC132089213|LOC132089214|LOC132089215|LOC132089216|LOC132089217|LOC132089218|LOC132089219|LOC132089220|LOC132089221|LOC132089222|LOC132089223|LOC132090745|LOC132090746|LOC132090747|LOC132205961|LOC132205962|LOC285626|LSM11|MAT2B|MED7|MFAP3|MIR1294|MIR1303|MIR146A|MIR3141|MIR3142|MIR3142HG|MIR378H|MRPL22|NIPAL4|NIPAL4-DT|NUDCD2|PPP1R2B|PTTG1|PWWP2A|RNF145|SAP30L|SAP30L-AS1|SGCD|SLU7|SOX30|THG1L|TIMD4|TTC1|UBLCP1		See cases	VCV000149231	5	151823430 - 165531397	5	152443869 - 166104392	149231	158982			copy number loss		Pathogenic	Apr 2, 2012	no assertion criteria provided							
GRCh38/hg38 5q33.1-34(chr5:152761187-167248053)x1	ADAM19|ADRA1B|ATP10B|C1QTNF2|C5orf52|CCNG1|CCNJL|CLINT1|CNOT8|CYFIP2|EBF1|FABP6|FABP6-AS1|FAM114A2|FAM200C|FAXDC2|FNDC9|GABRA1|GABRA6|GABRA6-AS1|GABRB2|GABRG2|GALNT10|GARIN3|GEMIN5|GRIA1|HAND1|HAVCR1|HAVCR2|HMMR|HMMR-AS1|IL12B|ITK|KIF4B|LARP1|LINC01202|LINC01470|LINC01845|LINC01847|LINC01861|LINC01932|LINC01938|LINC01947|LINC02143|LINC02159|LINC02202|LINC02227|LINC03000|LOC101927908|LOC102546299|LOC108228201|LOC110120620|LOC110120777|LOC110120965|LOC110120995|LOC110120998|LOC110121000|LOC110121027|LOC112997570|LOC112997571|LOC112997572|LOC112997574|LOC116158526|LOC121099711|LOC121099712|LOC121740631|LOC123575603|LOC123575604|LOC123575605|LOC123575606|LOC123575607|LOC123575608|LOC126807559|LOC126807560|LOC126807561|LOC126807562|LOC126807563|LOC126807564|LOC126807565|LOC126807566|LOC126807567|LOC126807568|LOC126807569|LOC126807570|LOC126807571|LOC126807572|LOC126807573|LOC126807574|LOC126807575|LOC126807576|LOC126807577|LOC126807578|LOC126807579|LOC129389402|LOC129389403|LOC129389404|LOC129389405|LOC129389406|LOC129389407|LOC129389408|LOC129389409|LOC129389410|LOC129389411|LOC129995064|LOC129995065|LOC129995066|LOC129995067|LOC129995068|LOC129995069|LOC129995070|LOC129995071|LOC129995072|LOC129995073|LOC129995074|LOC129995075|LOC129995076|LOC129995077|LOC129995078|LOC129995079|LOC129995080|LOC129995081|LOC129995082|LOC129995083|LOC129995084|LOC129995085|LOC129995086|LOC129995087|LOC129995088|LOC129995089|LOC129995090|LOC129995091|LOC129995092|LOC129995093|LOC129995094|LOC129995095|LOC129995096|LOC129995097|LOC129995098|LOC129995099|LOC129995100|LOC129995101|LOC129995102|LOC129995103|LOC129995104|LOC129995105|LOC129995106|LOC129995107|LOC129995108|LOC129995109|LOC129995110|LOC129995111|LOC129995112|LOC129995113|LOC129995114|LOC129995115|LOC129995116|LOC129995117|LOC129995118|LOC129995119|LOC129995120|LOC129995121|LOC129995122|LOC129995123|LOC129995124|LOC129995125|LOC129995126|LOC129995127|LOC129995128|LOC129995129|LOC129995130|LOC129995131|LOC129995132|LOC129995133|LOC129995134|LOC129995135|LOC129995136|LOC129995137|LOC129995138|LOC129995139|LOC129995140|LOC129995141|LOC129995142|LOC129995143|LOC129995144|LOC129995145|LOC129995146|LOC129995147|LOC129995148|LOC129995149|LOC129995150|LOC129995151|LOC129995152|LOC129995153|LOC129995154|LOC129995155|LOC129995156|LOC129995157|LOC129995158|LOC129995159|LOC129995160|LOC129995161|LOC129995162|LOC129995163|LOC129995164|LOC129995165|LOC129995166|LOC129995167|LOC129995168|LOC129995169|LOC129995170|LOC129995171|LOC129995172|LOC129995173|LOC129995174|LOC129995175|LOC129995176|LOC129995177|LOC129995178|LOC129995179|LOC129995180|LOC129995181|LOC129995182|LOC129995183|LOC129995184|LOC129995185|LOC129995186|LOC129995187|LOC129995188|LOC129995189|LOC129995190|LOC129995191|LOC129995192|LOC129995193|LOC129995194|LOC129995195|LOC129995196|LOC129995197|LOC129995198|LOC129995199|LOC129995200|LOC129995201|LOC129995202|LOC129995203|LOC129995204|LOC132089219|LOC132089220|LOC132089221|LOC132089222|LOC132089223|LOC132089224|LOC132090746|LOC132090747|LOC285626|LSM11|MAT2B|MED7|MFAP3|MIR1294|MIR1303|MIR146A|MIR3141|MIR3142|MIR3142HG|MIR378H|MRPL22|NIPAL4|NIPAL4-DT|NUDCD2|PPP1R2B|PTTG1|PWWP2A|RNF145|SAP30L|SAP30L-AS1|SGCD|SLU7|SOX30|TENM2|THG1L|TIMD4|TTC1|UBLCP1		See cases	VCV000058390	5	152140747 - 166675058	5	152761187 - 167248053	58390	72985			copy number loss		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 5q33.3-35.3(chr5:156825512-181269805)x3	LOC129995152|LOC129995170|LOC129995184|LOC129995185|LOC129995198|LOC129995199|LOC129995200|LOC129995214|LOC129995215|LOC129995216|LOC129995234|LOC129995235|LOC129995236|LOC129995247|LOC129995262|LOC129995263|LOC129995264|LOC129995278|LOC129995279|LOC129995280|LOC129995295|LOC129995296|LOC129995297|LOC129995314|LOC129995315|LOC129995332|LOC129995333|LOC129995334|LOC129995347|LOC129995348|LOC129995359|LOC129995360|LOC129995375|LOC129995376|LOC129995393|LOC129995394|LOC129995395|LOC129995407|LOC129995408|LOC129995422|LOC129995423|LOC129995435|LOC129995436|LOC129995445|LOC129995456|LOC129995457|LOC129995470|LOC129995481|LOC129995482|LOC129995494|LOC129995505|LOC132089227|LOC132089228|LOC132089230|MIR103A1|MIR5003|MIR585|PANK3|RACK1|RANBP17|RUFY1-AS1|SCGB3A1|SNORD96A|THG1L|TRL-AAG1-2|TRL-AAG1-3|TSPAN17|ZNF354A|ZNF354B|ZNF354C|BTNL9|CLINT1|CYFIP2|FAM153B|HAVCR1|HAVCR2|HEIH|INSYN2B|LINC01366|LINC01411|LINC01484|LCP2|LINC00847|LINC01187|LINC01202|LINC01845|LINC01847|LINC01942|FAM193B|LINC01485|LINC01574|HIGD2A|GPRIN1|GRK6|GRM6|HNRNPAB|HNRNPH1|IL12B-AS1|HRH2|IL12B|LINC01932|LINC01938|C1QTNF2|C5orf47|ITK|KCNIP1|CLK4|KIAA1191|DBN1|EFCAB9|TTC1|UBLCP1|ZNF454|SFXN1|SH3PXD2B|SOX30|SPATA31J1|F12|MIR103B1|MIR10523|THOC3|THOC3-AS1|MIR8056|MIR8089|MRNIP|LOC129995483|LOC129995484|LOC129995485|PDLIM7|PFN3|LOC129995495|LOC129995496|TRL-AAG2-1|LOC129995437|LOC129995506|LOC129995507|LOC129995508|LOC129995509|LOC129995446|LOC129995447|RARS1|LOC129995377|LOC129995378|LOC129995458|LOC129995396|LOC129995397|LOC132090748|LSM11|LOC129995316|LOC129995317|LOC129995409|LOC129995410|LOC129995335|LOC129995336|LOC129995471|LOC129995472|LOC129995473|LOC129995474|LOC129995248|LOC129995249|LOC129995349|LOC129995350|LOC129995351|LOC129995265|LOC129995266|LOC129995424|LOC129995425|LOC129995426|LOC129995186|LOC129995187|LOC129995281|LOC129995282|LOC129995201|LOC129995202|LOC129995203|LOC129995361|LOC129995217|LOC129995218|LOC129995219|LOC129995298|LOC129995299|LOC129995153|LOC129995154|LOC129995155|LOC129995237|LOC129995238|LOC129995171|LOC129995172|LOC129995156|LOC129995157|LOC129995158|LOC129995173|LOC129995174|LOC129995188|LOC129995189|LOC129995204|LOC129995205|LOC129995206|LOC129995220|LOC129995221|LOC129995239|LOC129995250|LOC129995251|LOC129995267|LOC129995268|LOC129995269|LOC129995283|LOC129995284|LOC129995285|LOC129995300|LOC129995301|LOC129995302|LOC129995318|LOC129995319|LOC129995320|LOC129995337|LOC129995352|LOC129995362|LOC129995363|LOC129995379|LOC129995380|LOC129995381|LOC129995398|LOC129995399|LOC129995411|LOC129995412|LOC129995427|LOC129995428|LOC129995438|LOC129995439|LOC129995448|LOC129995449|LOC129995450|LOC129995459|LOC129995460|LOC129995475|LOC129995476|LOC129995486|LOC129995487|LOC129995497|LOC129995498|LOC129995510|LTC4S|MIR12118|MIR12125|MRNIP-DT|MSANTD5|PHYKPL|PPP1R2B|RASGEF1C|RGS14|SIMC1|SPDL1|TIMD4|TRP-TGG3-1|TRT-TGT6-1|UBTD2|ZNF454-DT|ZNF879|ATP10B|C5orf52|CLTB|CNOT6|EIF4E1B|ERGIC1|FABP6|FABP6-AS1|FAF2|FAM153A|FAM200C|FBLL1|CANX|CBY3|CCNG1|CCNJL|CDHR2|HK3|HMMR|HMMR-AS1|ATP6V0E1|B4GALT7|GABRP|GARIN3|C5orf58|GFPT2|GMCL2|BNIP1|BOD1|COL23A1|CPEB4|BTNL8|BTNL3|CPLX2|CREBRF|CTC-338M12.4|KCNIP1-AS1|KCNIP1-OT1|KCNMB1|UNC5A|WWC1|ZFP2|ZFP62|TRV-AAC1-2|TRV-AAC1-3|TRV-AAC1-4|TRV-AAC2-1|TRV-CAC1-2|TRV-CAC1-3|TRV-CAC1-4|TRV-CAC1-5|TRL-AAG1-1|TRK-CTT2-2|TRIM7|TRIM7-AS2|TRK-CTT2-3|UIMC1|STC2|STK10|TBC1D9B|TENM2|TENM2-AS1|TENM2-AS3|SLC34A1|SLIT3|SMIM23|SNCB|SNORA70J|SNORA74B|SNORD95|SLIT3-AS1|SLIT3-AS2|SLU7|SQSTM1|ZNF346|PTTG1|PWWP2A|RAB24|RMND5B|RNF130|RPL26L1-AS1|RUFY1|RNF145|NUDCD2|OR2V1|OR2V2|RNF44|RPL26L1|NIPAL4-DT|MIR146A|MIR218-2|MIR3142|MIR3142HG|MIR340|MIR378E|MIR3912|MIR4281|MIR4634|MIR4638|PRR7-AS1|PROP1|PRR7|MAML1|MAPK9|MAT2B|MED7|MGAT1|MGAT4B|PRELID1|LOC129995514|LOC129995515|LOC129995516|LOC132089224|LOC132089225|LOC129995511|LOC129995512|LOC129995513|LOC132089226|MIR1229|MIR1271|LOC129995502|LOC129995503|LOC129995504|LOC129995500|LOC129995501|LOC129995488|OR2Y1|LOC129995480|LOC129995489|LOC129995490|LOC129995491|LOC129995492|LOC129995493|LOC129995461|LOC129995462|LOC129995463|LOC129995468|LOC129995469|LOC129995499|LOC129995477|LOC129995454|LOC129995455|LOC129995479|LOC129995451|LOC129995441|LOC129995442|LOC129995443|LOC129995444|LOC129995478|LOC129995464|LOC129995465|LOC129995429|LOC129995430|LOC129995431|LOC129995432|LOC129995433|LOC129995434|LOC129995466|LOC129995467|LOC129995416|LOC129995417|LOC129995418|LOC129995419|LOC129995413|LOC129995414|LOC129995415|LOC129995420|LOC129995421|LOC129995440|LOC129995402|LOC129995403|LOC129995404|LOC129995405|LOC129995406|LOC129995382|LOC129995383|LOC129995452|LOC129995453|LOC129995372|LOC129995373|LOC129995374|LOC129995384|LOC129995385|LOC129995386|LOC129995391|LOC129995392|LOC129995387|LOC129995388|LOC129995389|LOC129995390|LOC129995353|LOC129995354|LOC129995355|LOC129995356|LOC129995400|LOC129995401|LOC129995364|LOC129995365|LOC129995366|LOC129995340|LOC129995341|LOC129995342|LOC129995345|LOC129995346|LOC129995367|LOC129995368|LOC129995369|LOC129995338|LOC129995339|LOC129995324|LOC129995325|LOC129995326|LOC129995327|LOC129995328|LOC129995329|LOC129995330|LOC129995331|LOC129995370|LOC129995371|LOC129995357|LOC129995303|LOC129995304|LOC129995308|LOC129995309|LOC129995310|LOC129995311|LOC129995312|LOC129995313|LOC129995305|LOC129995306|LOC129995307|LOC129995358|LOC129995287|LOC129995288|LOC129995292|LOC129995293|LOC129995294|LOC129995286|LOC129995289|LOC129995290|LOC129995291|LOC129995321|LOC129995322|LOC129995323|LOC129995271|LOC129995272|LOC129995273|LOC129995275|LOC129995276|LOC129995277|LOC129995274|LOC129995252|LOC129995253|LOC129995254|LOC129995343|LOC129995344|LOC129995245|LOC129995246|LOC129995258|LOC129995259|LOC129995260|LOC129995261|LOC129995255|LOC129995256|LOC129995257|LOC129995222|LOC129995223|LOC129995224|LOC129995232|LOC129995233|LOC129995270|LOC129995240|LOC129995241|LOC129995210|LOC129995211|LOC129995212|LOC129995213|LOC129995242|LOC129995207|LOC129995208|LOC129995194|LOC129995195|LOC129995196|LOC129995197|LOC129995192|LOC129995193|LOC129995243|LOC129995244|LOC129995229|LOC129995230|LOC129995231|LOC129995175|LOC129995176|LOC129995180|LOC129995181|LOC129995182|LOC129995183|LOC129995177|LOC129995178|LOC129995179|LOC129995165|LOC129995166|LOC129995167|LOC129995162|LOC129995163|LOC129995164|LOC129995225|LOC129995226|LOC129995227|LOC129995228|LOC129995159|LOC129995160|LOC129995161|LOC129995190|LOC129995191|LOC129995209|LOC129995168|LOC129995169|LOC129995148|LOC129995149|LOC129995150|LOC129995151|MSX2|MXD3|N4BP3|NEURL1B|NHP2|NIPAL4|NKX2-5|NOP16|NPM1|NSD1|NSG2|TLX3|TMED9|TRA-TGC3-1|TRIM41|TRIM52|TRIM52-AS1|ADAM19|ADAMTS2|ADRA1B|ARL10|DDX41|DOCK2|DOK3|DRD1|DUSP1|EBF1|FBXW11|FGF18|FGFR4|FLT4|FNDC9|FOXI1|GABRA1|GABRA6|GABRA6-AS1|GABRB2|GABRG2|LINC01944|LINC01947|LINC01951|LINC01962|LINC02143|LINC02159|LINC02202|LINC02222|LINC02227|LINC02995|LINC03000|LMAN2|LOC100128059|LOC100128340|LOC100288254|LOC100289470|LOC100502572|LOC100996385|LOC101927908|LOC101928093|LOC102546299|LOC102724551|LOC105377730|LOC105377753|LOC105377763|LOC105980006|LOC105980008|LOC108004526|LOC109279841|LOC110120620|LOC110120643|LOC110120714|LOC110120747|LOC110120777|LOC110120965|LOC110120995|LOC110120998|LOC110121000|LOC110121027|LOC110121041|LOC110121211|LOC110121241|LOC110121272|LOC110121284|LOC111500319|LOC111556140|LOC112997571|LOC112997572|LOC112997574|LOC112997575|LOC112997576|LOC112997577|LOC112997578|LOC112997579|LOC112997580|LOC112997581|LOC112997582|LOC112997583|LOC112997584|LOC114004391|LOC116158527|LOC116158528|LOC116158530|LOC116158531|LOC116158532|LOC116158533|LOC116158534|LOC116158535|LOC116158536|LOC121099711|LOC121099712|LOC121099713|LOC121099714|LOC121099715|LOC121099716|LOC121099717|LOC121099718|LOC121740632|LOC121740633|LOC121740634|LOC121740635|LOC123575606|LOC123575607|LOC123575608|LOC123575609|LOC123575610|LOC123575611|LOC123575612|LOC123575614|LOC123575615|LOC123575616|LOC123575617|LOC123575618|LOC123575619|LOC123575620|LOC123575621|LOC123575622|LOC123575623|LOC123575624|LOC123575625|LOC123575626|LOC123575627|LOC123575628|LOC123575629|LOC123575630|LOC123575631|LOC123575632|LOC123575633|LOC123575634|LOC123575635|LOC123575636|LOC123575637|LOC123575638|LOC123575639|LOC123575640|LOC123575641|LOC126807567|LOC126807568|LOC126807569|LOC126807570|LOC126807571|LOC126807572|LOC126807573|LOC126807574|LOC126807575|LOC126807576|LOC126807577|LOC126807578|LOC126807579|LOC126807580|LOC126807581|LOC126807582|LOC126807583|LOC126807584|LOC126807585|LOC126807586|LOC126807587|LOC126807588|LOC126807589|LOC126807590|LOC126807591|LOC126807592|LOC126807593|LOC126807594|LOC126807595|LOC126807596|LOC126807597|LOC126807598|LOC126807599|LOC126807600|LOC126807601|LOC126807602|LOC126807603|LOC126807604|LOC126807605|LOC126807606|LOC126807607|LOC126807608|LOC126807609|LOC126807610|LOC126807611|LOC126807612|LOC126807613|LOC126807614|LOC126807615|LOC126807616|LOC126807617|LOC126807618|LOC126807619|LOC126807620|LOC126807621|LOC126807622|LOC126807623|LOC126807624|LOC126807625|LOC126807626|LOC126807627|LOC126807628|LOC126807629|LOC126807630|LOC126807631|LOC126807632|LOC126807633|LOC128966623|LOC129389403|LOC129389404|LOC129389405|LOC129389406|LOC129389407|LOC129389408|LOC129389409|LOC129389410|LOC129389411|LOC129389412|LOC129389413|LOC129389414|LOC129389415|LOC129389416|LOC129389417|LOC129389418|LOC129389419|LOC129389420|LOC129389421|LOC129389422|LOC129995104|LOC129995105|LOC129995106|LOC129995107|LOC129995108|LOC129995109|LOC129995110|LOC129995111|LOC129995112|LOC129995113|LOC129995114|LOC129995115|LOC129995116|LOC129995117|LOC129995118|LOC129995119|LOC129995120|LOC129995121|LOC129995122|LOC129995123|LOC129995124|LOC129995125|LOC129995126|LOC129995127|LOC129995128|LOC129995129|LOC129995130|LOC129995131|LOC129995132|LOC129995133|LOC129995134|LOC129995135|LOC129995136|LOC129995137|LOC129995138|LOC129995139|LOC129995140|LOC129995141|LOC129995142|LOC129995143|LOC129995144|LOC129995145|LOC129995146|LOC129995147		See cases	VCV000144365	5	156252523 - 180696806	5	156825512 - 181269805	144365	154116			copy number gain		Pathogenic	Dec 30, 2009	no assertion criteria provided							
GRCh38/hg38 5q33.3(chr5:156991620-157210423)x3	GARIN3|HAVCR1|HAVCR2|ITK|LOC126807568|LOC129995106|LOC129995107|LOC129995108|LOC129995109|LOC129995110|LOC129995111|MED7		See cases	VCV000059473	5	156418631 - 156637434	5	156991620 - 157210423	59473	74068			copy number gain		Uncertain significance	Aug 12, 2011	criteria provided, single submitter							
NC_000005.10:g.157180782C>T	ITK		Lymphoproliferative syndrome 1	VCV001170558	5	156607793	5	157180782	1170558	1154968	rs146866105	NC_000005.10:157180781:C:T	single nucleotide variant		Benign	Oct 28, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.-95A>G	ITK		Lymphoproliferative syndrome 1	VCV000905614	5	156607894	5	157180883	905614	896068	rs117806853	NC_000005.10:157180882:A:G	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.-32C>A	ITK		Lymphoproliferative syndrome 1	VCV000352455	5	156607957	5	157180946	352455	298492	rs148134638	NC_000005.10:157180945:C:A	single nucleotide variant	5 prime UTR variant	Benign	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.6C>T (p.Asn2=)	ITK		Lymphoproliferative syndrome 1	VCV001078747	5	156607994	5	157180983	1078747	1072563	rs764145653	NC_000005.10:157180982:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.10T>C (p.Phe4Leu)	ITK	F4L	Lymphoproliferative syndrome 1	VCV001386742	5	156607998	5	157180987	1386742	1357869	rs1393178996	NC_000005.10:157180986:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.15C>T (p.Ile5=)	ITK		Lymphoproliferative syndrome 1	VCV001658927	5	156608003	5	157180992	1658927	1640472	rs750096142	NC_000005.10:157180991:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 23, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.24A>G (p.Glu8=)	ITK		Lymphoproliferative syndrome 1	VCV001140512	5	156608012	5	157181001	1140512	1115684	rs2113732596	NC_000005.10:157181000:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 11, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.26A>G (p.Glu9Gly)	ITK	E9G	Lymphoproliferative syndrome 1	VCV001403911	5	156608014	5	157181003	1403911	1467277	rs2113732600	NC_000005.10:157181002:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.33C>A (p.Leu11=)	ITK		Autoinflammatory syndrome|Lymphoproliferative syndrome 1	VCV001084872	5	156608021	5	157181010	1084872	1072564	rs765948222	NC_000005.10:157181009:C:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 14, 2021	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.49C>A (p.Gln17Lys)	ITK	Q17K	Lymphoproliferative syndrome 1	VCV002780898	5	156608037	5	157181026	2780898	2940751		NC_000005.10:157181025:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.49C>T (p.Gln17Ter)	ITK	Q17*	Lymphoproliferative syndrome 1	VCV001456681	5	156608037	5	157181026	1456681	1454783	rs781686293	NC_000005.10:157181025:C:T	single nucleotide variant	nonsense	Pathogenic	Aug 10, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.72G>A (p.Ser24=)	ITK		Lymphoproliferative syndrome 1	VCV002067965	5	156608060	5	157181049	2067965	2129354		NC_000005.10:157181048:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 14, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.82G>T (p.Val28Phe)	ITK	V28F	Lymphoproliferative syndrome 1	VCV000638898	5	156608070	5	157181059	638898	633673	rs1580869283	NC_000005.10:157181058:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.85C>T (p.Arg29Cys)	ITK	R29C	Lymphoproliferative syndrome 1	VCV002417920	5	156608073	5	157181062	2417920	1947868		NC_000005.10:157181061:C:T	single nucleotide variant	missense variant	Uncertain significance	May 8, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.86G>A (p.Arg29His)	ITK	R29H	Lymphoproliferative syndrome 1	VCV000064372	5	156608074	5	157181063	64372	75337	rs397514261	NC_000005.10:157181062:G:A	single nucleotide variant	missense variant	Pathogenic	May 1, 2012	no assertion criteria provided							
NM_005546.4(ITK):c.87C>T (p.Arg29=)	ITK		Lymphoproliferative syndrome 1	VCV002159315	5	156608075	5	157181064	2159315	1890324		NC_000005.10:157181063:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 20, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.87C>A (p.Arg29=)	ITK		Lymphoproliferative syndrome 1	VCV001114001	5	156608075	5	157181064	1114001	1094150	rs146496148	NC_000005.10:157181063:C:A	single nucleotide variant	synonymous variant	Likely benign	May 20, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.91T>C (p.Phe31Leu)	ITK	F31L	Lymphoproliferative syndrome 1	VCV001042777	5	156608079	5	157181068	1042777	1026491	rs1753503357	NC_000005.10:157181067:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.99A>G (p.Leu33=)	ITK		Lymphoproliferative syndrome 1	VCV002185450	5	156608087	5	157181076	2185450	1914152		NC_000005.10:157181075:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.112C>T (p.Leu38=)	ITK		Lymphoproliferative syndrome 1	VCV002878677	5	156608100	5	157181089	2878677	3033478		NC_000005.10:157181088:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 30, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.129del (p.Arg44fs)	ITK	R44fs	Lymphoproliferative syndrome 1	VCV003064392	5	156608117	5	157181106	3064392	3224597		NC_000005.10:157181105:T:	Deletion	frameshift variant	Likely pathogenic	Mar 25, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.131G>A (p.Arg44His)	ITK	R44H	Lymphoproliferative syndrome 1	VCV001500819	5	156608119	5	157181108	1500819	1501742	rs201892355	NC_000005.10:157181107:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.134A>T (p.His45Leu)	ITK	H45L	Lymphoproliferative syndrome 1	VCV000846918	5	156608122	5	157181111	846918	830565	rs1753504528	NC_000005.10:157181110:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2019	criteria provided, single submitter							
NM_005546.4(ITK):c.137G>A (p.Gly46Glu)	ITK	G46E	Inborn genetic diseases	VCV003530782	5	156608125	5	157181114	3530782	3687202		NC_000005.10:157181113:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.138+4T>C	ITK		Lymphoproliferative syndrome 1	VCV001928280	5	156608130	5	157181119	1928280	1981130		NC_000005.10:157181118:T:C	single nucleotide variant	intron variant	Uncertain significance	Dec 27, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.138+13T>C	ITK		Lymphoproliferative syndrome 1	VCV000905615	5	156608139	5	157181128	905615	896069	rs200603754	NC_000005.10:157181127:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 31, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.138+19_138+20dup	ITK		Lymphoproliferative syndrome 1	VCV001588599	5	156608143 - 156608144	5	157181132 - 157181133	1588599	1640926	rs766419332	NC_000005.10:157181132:TTT:TTTTT	Duplication	intron variant	Likely benign	Jan 6, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.138+158T>A	ITK		not provided	VCV001233008	5	156608284	5	157181273	1233008	1223421	rs409602	NC_000005.10:157181272:T:A	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.139-20A>T	ITK		Lymphoproliferative syndrome 1	VCV002797477	5	156635880	5	157208869	2797477	2962051		NC_000005.10:157208868:A:T	single nucleotide variant	intron variant	Likely benign	Feb 10, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.139-6C>T	ITK		Autoinflammatory syndrome|Lymphoproliferative syndrome 1	VCV000352456	5	156635894	5	157208883	352456	298493	rs780173849	NC_000005.10:157208882:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 28, 2023	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.139-3C>T	ITK		Lymphoproliferative syndrome 1	VCV001360487	5	156635897	5	157208886	1360487	1363929	rs746991589	NC_000005.10:157208885:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 11, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.139-2A>G	ITK		Lymphoproliferative syndrome 1	VCV002860481	5	156635898	5	157208887	2860481	3025409		NC_000005.10:157208886:A:G	single nucleotide variant	splice acceptor variant	Likely pathogenic	Oct 13, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.141G>C (p.Lys47Asn)	ITK	K47N	Lymphoproliferative syndrome 1	VCV000855763	5	156635902	5	157208891	855763	830566	rs772972728	NC_000005.10:157208890:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2019	criteria provided, single submitter							
NM_005546.4(ITK):c.146G>A (p.Arg49His)	ITK	R49H	Lymphoproliferative syndrome 1	VCV000906130	5	156635907	5	157208896	906130	893710	rs762768477	NC_000005.10:157208895:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.149C>T (p.Thr50Met)	ITK	T50M	Lymphoproliferative syndrome 1	VCV000861656	5	156635910	5	157208899	861656	830567	rs774040719	NC_000005.10:157208898:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.150G>T (p.Thr50=)	ITK		Lymphoproliferative syndrome 1	VCV001665299	5	156635911	5	157208900	1665299	1621167	rs61743239	NC_000005.10:157208899:G:T	single nucleotide variant	synonymous variant	Likely benign	Jul 17, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.150G>A (p.Thr50=)	ITK		Lymphoproliferative syndrome 1	VCV000352457	5	156635911	5	157208900	352457	302919	rs61743239	NC_000005.10:157208899:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 15, 2023	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.159G>T (p.Gly53=)	ITK		Lymphoproliferative syndrome 1	VCV002049588	5	156635920	5	157208909	2049588	2107475		NC_000005.10:157208908:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 19, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.160T>A (p.Ser54Thr)	ITK	S54T	Lymphoproliferative syndrome 1	VCV001974754	5	156635921	5	157208910	1974754	2033890		NC_000005.10:157208909:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.164T>C (p.Ile55Thr)	ITK	I55T	Lymphoproliferative syndrome 1	VCV000950030	5	156635925	5	157208914	950030	923963	rs200593448	NC_000005.10:157208913:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.165T>C (p.Ile55=)	ITK		Lymphoproliferative syndrome 1	VCV001152954	5	156635926	5	157208915	1152954	1136692	rs1489407579	NC_000005.10:157208914:T:C	single nucleotide variant	synonymous variant	Likely benign	May 30, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.168G>A (p.Glu56=)	ITK		Lymphoproliferative syndrome 1	VCV002819448	5	156635929	5	157208918	2819448	2987803		NC_000005.10:157208917:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 8, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.171C>T (p.Leu57=)	ITK		Lymphoproliferative syndrome 1	VCV002910754	5	156635932	5	157208921	2910754	3070180		NC_000005.10:157208920:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 6, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.171C>G (p.Leu57=)	ITK		not provided	VCV002655991	5	156635932	5	157208921	2655991	2825484		NC_000005.10:157208920:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.174C>T (p.Ser58=)	ITK		Lymphoproliferative syndrome 1	VCV001102779	5	156635935	5	157208924	1102779	1094151	rs2113752364	NC_000005.10:157208923:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 27, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.176G>A (p.Arg59Gln)	ITK	R59Q	Lymphoproliferative syndrome 1	VCV001059196	5	156635937	5	157208926	1059196	1043465	rs757740059	NC_000005.10:157208925:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.189T>G (p.Val63=)	ITK		Lymphoproliferative syndrome 1	VCV002803811	5	156635950	5	157208939	2803811	2963635		NC_000005.10:157208938:T:G	single nucleotide variant	synonymous variant	Likely benign	May 11, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.194T>C (p.Ile65Thr)	ITK	I65T	Lymphoproliferative syndrome 1	VCV001047133	5	156635955	5	157208944	1047133	1026492	rs1286793954	NC_000005.10:157208943:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.198G>A (p.Val66=)	ITK		Lymphoproliferative syndrome 1	VCV001081040	5	156635959	5	157208948	1081040	1072565	rs1487057304	NC_000005.10:157208947:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 24, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.212G>A (p.Ser71Asn)	ITK	S71N	Lymphoproliferative syndrome 1	VCV001008736	5	156635973	5	157208962	1008736	990823	rs1386860362	NC_000005.10:157208961:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.212G>C (p.Ser71Thr)	ITK	S71T	Lymphoproliferative syndrome 1	VCV000942255	5	156635973	5	157208962	942255	932807	rs1386860362	NC_000005.10:157208961:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.219A>G (p.Pro73=)	ITK		Lymphoproliferative syndrome 1	VCV001908342	5	156635980	5	157208969	1908342	1962526		NC_000005.10:157208968:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 4, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.226T>C (p.Tyr76His)	ITK	Y76H	Lymphoproliferative syndrome 1	VCV003622532	5	156635987	5	157208976	3622532	3760430		NC_000005.10:157208975:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.228T>A (p.Tyr76Ter)	ITK	Y76*	Lymphoproliferative syndrome 1	VCV002004689	5	156635989	5	157208978	2004689	2058755		NC_000005.10:157208977:T:A	single nucleotide variant	nonsense	Pathogenic	Jul 24, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.228T>C (p.Tyr76=)	ITK		Lymphoproliferative syndrome 1	VCV000729272	5	156635989	5	157208978	729272	734985	rs140451238	NC_000005.10:157208977:T:C	single nucleotide variant	synonymous variant	Benign	Jan 7, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.237G>A (p.Pro79=)	ITK		Lymphoproliferative syndrome 1	VCV000352458	5	156635998	5	157208987	352458	296627	rs201403794	NC_000005.10:157208986:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.243+5G>A	ITK		Lymphoproliferative syndrome 1	VCV000861388	5	156636009	5	157208998	861388	851272	rs140464697	NC_000005.10:157208997:G:A	single nucleotide variant	intron variant	Uncertain significance	Oct 28, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.243+9A>C	ITK		Lymphoproliferative syndrome 1	VCV001113892	5	156636013	5	157209002	1113892	1094152	rs757220870	NC_000005.10:157209001:A:C	single nucleotide variant	intron variant	Likely benign	Feb 21, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.243+14del	ITK		Lymphoproliferative syndrome 1	VCV003015962	5	156636017	5	157209006	3015962	3171086		NC_000005.10:157209005:GG:G	Deletion	intron variant	Likely benign	Oct 24, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.243+16G>T	ITK		Lymphoproliferative syndrome 1	VCV002890086	5	156636020	5	157209009	2890086	3051530		NC_000005.10:157209008:G:T	single nucleotide variant	intron variant	Likely benign	Jan 21, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.243+316C>T	ITK		not provided	VCV001258100	5	156636320	5	157209309	1258100	1248870	rs12659723	NC_000005.10:157209308:C:T	single nucleotide variant	intron variant	Benign	Jun 19, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.244-17TG[4]	ITK		Lymphoproliferative syndrome 1	VCV001668556	5	156638281 - 156638282	5	157211270 - 157211271	1668556	1633930	rs1053873443	NC_000005.10:157211269:TGTGTGTGTGT:TGTGTGTGT	Microsatellite	intron variant	Likely benign	Dec 23, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.244-8G>C	ITK		Lymphoproliferative syndrome 1	VCV002701614	5	156638290	5	157211279	2701614	2859197		NC_000005.10:157211278:G:C	single nucleotide variant	intron variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.244-8G>A	ITK		Lymphoproliferative syndrome 1|Autoinflammatory syndrome	VCV000352459	5	156638290	5	157211279	352459	296628	rs199759038	NC_000005.10:157211278:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.244-7T>C	ITK		Lymphoproliferative syndrome 1	VCV003627932	5	156638291	5	157211280	3627932	3761918		NC_000005.10:157211279:T:C	single nucleotide variant	intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.249G>A (p.Val83=)	ITK		Lymphoproliferative syndrome 1	VCV002902679	5	156638303	5	157211292	2902679	3058274		NC_000005.10:157211291:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 19, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.267A>G (p.Leu89=)	ITK		Lymphoproliferative syndrome 1	VCV002198936	5	156638321	5	157211310	2198936	1930684		NC_000005.10:157211309:A:G	single nucleotide variant	synonymous variant	Likely benign	May 31, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.276T>C (p.Phe92=)	ITK		Lymphoproliferative syndrome 1	VCV002726520	5	156638330	5	157211319	2726520	2889154		NC_000005.10:157211318:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 4, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.279T>C (p.Ala93=)	ITK		Lymphoproliferative syndrome 1	VCV002803669	5	156638333	5	157211322	2803669	2963493		NC_000005.10:157211321:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 27, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.282A>G (p.Pro94=)	ITK		Lymphoproliferative syndrome 1	VCV001553415	5	156638336	5	157211325	1553415	1553199	rs1189784154	NC_000005.10:157211324:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.286C>A (p.Arg96Ser)	ITK	R96S	Inborn genetic diseases	VCV002533552	5	156638340	5	157211329	2533552	2689293		NC_000005.10:157211328:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.286C>G (p.Arg96Gly)	ITK	R96G	Lymphoproliferative syndrome 1	VCV001509448	5	156638340	5	157211329	1509448	1365069	rs372181411	NC_000005.10:157211328:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.286C>T (p.Arg96Cys)	ITK	R96C	Lymphoproliferative syndrome 1	VCV000840048	5	156638340	5	157211329	840048	830568	rs372181411	NC_000005.10:157211328:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.287G>A (p.Arg96His)	ITK	R96H	not specified|ITK-related disorder|Lymphoproliferative syndrome 1	VCV000934494	5	156638341	5	157211330	934494	932808	rs751865122	NC_000005.10:157211329:G:A	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.287G>C (p.Arg96Pro)	ITK	R96P	Lymphoproliferative syndrome 1|Autoinflammatory syndrome	VCV000352460	5	156638341	5	157211330	352460	302920	rs751865122	NC_000005.10:157211329:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.295C>T (p.Arg99Trp)	ITK	R99W	Lymphoproliferative syndrome 1	VCV000998373	5	156638349	5	157211338	998373	985958	rs1754188575	NC_000005.10:157211337:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.296G>A (p.Arg99Gln)	ITK	R99Q	Lymphoproliferative syndrome 1	VCV001428561	5	156638350	5	157211339	1428561	1379851	rs1293136647	NC_000005.10:157211338:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.302G>A (p.Arg101His)	ITK	R101H	Lymphoproliferative syndrome 1	VCV001382169	5	156638356	5	157211345	1382169	1434598	rs752789103	NC_000005.10:157211344:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.303C>G (p.Arg101=)	ITK		Lymphoproliferative syndrome 1	VCV001438184	5	156638357	5	157211346	1438184	1355037	rs756139529	NC_000005.10:157211345:C:G	single nucleotide variant	synonymous variant	Uncertain significance	Aug 22, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.307G>A (p.Val103Met)	ITK	V103M	Lymphoproliferative syndrome 1|not provided	VCV001404585	5	156638361	5	157211350	1404585	1405346	rs778856924	NC_000005.10:157211349:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.315C>T (p.Ala105=)	ITK		Lymphoproliferative syndrome 1	VCV001134463	5	156638369	5	157211358	1134463	1115685	rs1360242669	NC_000005.10:157211357:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 14, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.323A>G (p.Glu108Gly)	ITK	E108G	Lymphoproliferative syndrome 1	VCV001044513	5	156638377	5	157211366	1044513	1026493	rs150470437	NC_000005.10:157211365:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.325+10C>T	ITK		Lymphoproliferative syndrome 1	VCV001092924	5	156638389	5	157211378	1092924	1072566	rs746749131	NC_000005.10:157211377:C:T	single nucleotide variant	intron variant	Likely benign	May 15, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.326-630dup	ITK		not specified	VCV002628137	5	156640563 - 156640564	5	157213552 - 157213553	2628137	2795644		NC_000005.10:157213552:TTTTTTTTT:TTTTTTTTTT	Duplication	intron variant	Benign	Nov 12, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.326-157G>A	ITK		not provided	VCV001267673	5	156641045	5	157214034	1267673	1258009	rs30139	NC_000005.10:157214033:G:A	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.326-17G>A	ITK		Lymphoproliferative syndrome 1	VCV001577802	5	156641185	5	157214174	1577802	1522230	rs751331298	NC_000005.10:157214173:G:A	single nucleotide variant	intron variant	Likely benign	Nov 15, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.326-9C>T	ITK		Lymphoproliferative syndrome 1	VCV001634346	5	156641193	5	157214182	1634346	1632433	rs372285130	NC_000005.10:157214181:C:T	single nucleotide variant	intron variant	Likely benign	Jul 27, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.329C>T (p.Thr110Met)	ITK	T110M	Lymphoproliferative syndrome 1	VCV000942730	5	156641205	5	157214194	942730	932809	rs778357395	NC_000005.10:157214193:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.330G>A (p.Thr110=)	ITK		Lymphoproliferative syndrome 1	VCV001123249	5	156641206	5	157214195	1123249	1115686	rs1754250689	NC_000005.10:157214194:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 11, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.339T>C (p.Asn113=)	ITK		Lymphoproliferative syndrome 1	VCV001104149	5	156641215	5	157214204	1104149	1094153	rs2113755827	NC_000005.10:157214203:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 24, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.340A>C (p.Asn114His)	ITK	N114H	Lymphoproliferative syndrome 1	VCV002176588	5	156641216	5	157214205	2176588	1901435		NC_000005.10:157214204:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.344G>A (p.Ser115Asn)	ITK	S115N	Lymphoproliferative syndrome 1	VCV001362779	5	156641220	5	157214209	1362779	1396099	rs759851827	NC_000005.10:157214208:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.356A>G (p.Lys119Arg)	ITK	K119R	not specified|Lymphoproliferative syndrome 1	VCV000934760	5	156641232	5	157214221	934760	932810	rs577305220	NC_000005.10:157214220:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 1, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.364C>A (p.Pro122Thr)	ITK	P122T	Lymphoproliferative syndrome 1	VCV000934848	5	156641240	5	157214229	934848	932811	rs1362373639	NC_000005.10:157214228:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.370T>C (p.Phe124Leu)	ITK	F124L	Lymphoproliferative syndrome 1	VCV002004774	5	156641246	5	157214235	2004774	2058840		NC_000005.10:157214234:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.378G>A (p.Met126Ile)	ITK	M126I	not provided|Lymphoproliferative syndrome 1	VCV001010930	5	156641254	5	157214243	1010930	990824	rs775741366	NC_000005.10:157214242:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.380del (p.Asp127fs)	ITK	D127fs	Lymphoproliferative syndrome 1	VCV002088804	5	156641256	5	157214245	2088804	2137570		NC_000005.10:157214244:A:	Deletion	frameshift variant	Pathogenic	Jan 21, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.386A>G (p.Lys129Arg)	ITK	K129R	Lymphoproliferative syndrome 1	VCV001001038	5	156641262	5	157214251	1001038	990825	rs201959697	NC_000005.10:157214250:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.389G>A (p.Trp130Ter)	ITK	W130*	Lymphoproliferative syndrome 1	VCV002750136	5	156641265	5	157214254	2750136	2919094		NC_000005.10:157214253:G:A	single nucleotide variant	nonsense	Pathogenic	Aug 4, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.396C>T (p.Cys132=)	ITK		Lymphoproliferative syndrome 1	VCV000906131	5	156641272	5	157214261	906131	893711	rs1459993484	NC_000005.10:157214260:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Sep 9, 2023	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.399T>C (p.Cys133=)	ITK		Lymphoproliferative syndrome 1	VCV002727526	5	156641275	5	157214264	2727526	2892732		NC_000005.10:157214263:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 7, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.402T>C (p.Ser134=)	ITK		Lymphoproliferative syndrome 1	VCV001112906	5	156641278	5	157214267	1112906	1094154	rs764229263	NC_000005.10:157214266:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 21, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.407T>C (p.Leu136Pro)	ITK	L136P	Inborn genetic diseases|Lymphoproliferative syndrome 1	VCV000940441	5	156641283	5	157214272	940441	932812	rs540238373	NC_000005.10:157214271:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.408G>A (p.Leu136=)	ITK		Lymphoproliferative syndrome 1	VCV001102502	5	156641284	5	157214273	1102502	1094155	rs2113755882	NC_000005.10:157214272:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 11, 2019	criteria provided, single submitter							
NM_005546.4(ITK):c.410A>T (p.Glu137Val)	ITK	E137V	Lymphoproliferative syndrome 1	VCV000854839	5	156641286	5	157214275	854839	830569	rs75593900	NC_000005.10:157214274:A:T	single nucleotide variant	missense variant	Uncertain significance	May 15, 2019	criteria provided, single submitter							
NM_005546.4(ITK):c.414G>A (p.Lys138=)	ITK		Lymphoproliferative syndrome 1	VCV002974750	5	156641290	5	157214279	2974750	3133402		NC_000005.10:157214278:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.423A>G (p.Thr141=)	ITK		Lymphoproliferative syndrome 1	VCV002801757	5	156641299	5	157214288	2801757	2956398		NC_000005.10:157214287:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.434A>G (p.Gln145Arg)	ITK	Q145R	Lymphoproliferative syndrome 1	VCV001356648	5	156641310	5	157214299	1356648	1447397	rs372432770	NC_000005.10:157214298:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.439G>C (p.Asp147His)	ITK	D147H	Lymphoproliferative syndrome 1	VCV002045322	5	156641315	5	157214304	2045322	2103214		NC_000005.10:157214303:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.439G>A (p.Asp147Asn)	ITK	D147N	Autoinflammatory syndrome	VCV001694289	5	156641315	5	157214304	1694289	1686724	rs1463419892	NC_000005.10:157214303:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2016	criteria provided, single submitter							
NM_005546.4(ITK):c.450G>C (p.Lys150Asn)	ITK	K150N	Lymphoproliferative syndrome 1	VCV001039448	5	156641326	5	157214315	1039448	1026494	rs755833813	NC_000005.10:157214314:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.454+19C>T	ITK		Lymphoproliferative syndrome 1	VCV002751764	5	156641349	5	157214338	2751764	2919426		NC_000005.10:157214337:C:T	single nucleotide variant	intron variant	Likely benign	Aug 11, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.455-254C>T	ITK		not provided	VCV001267227	5	156644624	5	157217613	1267227	1254550	rs152112	NC_000005.10:157217612:C:T	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.455-229G>A	ITK		not provided	VCV001247232	5	156644649	5	157217638	1247232	1235895	rs2288504	NC_000005.10:157217637:G:A	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.455-17T>C	ITK		Lymphoproliferative syndrome 1	VCV001544694	5	156644860	5	157217850	1544694	1524971	rs1754330526	NC_000005.10:157217849:T:C	single nucleotide variant	intron variant	Likely benign	Dec 6, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.455-16G>T	ITK		Lymphoproliferative syndrome 1	VCV003623549	5	156644861	5	157217851	3623549	3754804		NC_000005.10:157217850:G:T	single nucleotide variant	intron variant	Likely benign	Mar 28, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.455-14T>C	ITK		Lymphoproliferative syndrome 1	VCV001573064	5	156644863	5	157217853	1573064	1573430	rs964299428	NC_000005.10:157217852:T:C	single nucleotide variant	intron variant	Likely benign	Jun 12, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.474T>G (p.Pro158=)	ITK		Lymphoproliferative syndrome 1	VCV000753896	5	156644896	5	157217886	753896	764990	rs755924629	NC_000005.10:157217885:T:G	single nucleotide variant	synonymous variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.487G>C (p.Asp163His)	ITK	D163H	Lymphoproliferative syndrome 1	VCV002123917	5	156644909	5	157217899	2123917	2174045		NC_000005.10:157217898:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.491A>C (p.Asn164Thr)	ITK	N164T	Lymphoproliferative syndrome 1	VCV001938576	5	156644913	5	157217903	1938576	1994006		NC_000005.10:157217902:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.495G>T (p.Arg165Ser)	ITK	R165S	Lymphoproliferative syndrome 1	VCV000654225	5	156644917	5	157217907	654225	633674	rs533252659	NC_000005.10:157217906:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.495+9G>C	ITK		not provided|Lymphoproliferative syndrome 1	VCV001665150	5	156644926	5	157217916	1665150	1621019	rs1206380007	NC_000005.10:157217915:G:C	single nucleotide variant	intron variant	Likely benign	Dec 23, 2020	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.495+12C>T	ITK		Lymphoproliferative syndrome 1	VCV000352461	5	156644929	5	157217919	352461	296629	rs376728021	NC_000005.10:157217918:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 31, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.495+13G>A	ITK		Lymphoproliferative syndrome 1	VCV003015991	5	156644930	5	157217920	3015991	3171115		NC_000005.10:157217919:G:A	single nucleotide variant	intron variant	Likely benign	May 31, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.495+16A>G	ITK		Lymphoproliferative syndrome 1	VCV001616153	5	156644933	5	157217923	1616153	1613873	rs2113757973	NC_000005.10:157217922:A:G	single nucleotide variant	intron variant	Likely benign	Nov 22, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.495+17G>C	ITK		Lymphoproliferative syndrome 1	VCV002415848	5	156644934	5	157217924	2415848	1937191		NC_000005.10:157217923:G:C	single nucleotide variant	intron variant	Likely benign	Jul 8, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.495+20C>T	ITK		Lymphoproliferative syndrome 1	VCV002711258	5	156644937	5	157217927	2711258	2878710		NC_000005.10:157217926:C:T	single nucleotide variant	intron variant	Likely benign	Jan 25, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.495+22G>A	ITK		not specified|not provided	VCV001265355	5	156644939	5	157217929	1265355	1254822	rs246747	NC_000005.10:157217928:G:A	single nucleotide variant	intron variant	Benign	Nov 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.496-18G>C	ITK		Lymphoproliferative syndrome 1	VCV001588390	5	156649855	5	157222845	1588390	1574933	rs201770355	NC_000005.10:157222844:G:C	single nucleotide variant	intron variant	Likely benign	Jan 29, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.496-4C>G	ITK		Lymphoproliferative syndrome 1	VCV000352462	5	156649869	5	157222859	352462	298494	rs749411240	NC_000005.10:157222858:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 22, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.496C>G (p.Arg166Gly)	ITK	R166G	Lymphoproliferative syndrome 1	VCV003611471	5	156649873	5	157222863	3611471	3745037		NC_000005.10:157222862:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.501A>C (p.Pro167=)	ITK		Lymphoproliferative syndrome 1	VCV001530272	5	156649878	5	157222868	1530272	1582057	rs768405946	NC_000005.10:157222867:A:C	single nucleotide variant	synonymous variant	Likely benign	Jul 25, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.501A>G (p.Pro167=)	ITK		Lymphoproliferative syndrome 1	VCV001102776	5	156649878	5	157222868	1102776	1094156	rs768405946	NC_000005.10:157222867:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.512C>T (p.Pro171Leu)	ITK	P171L	Lymphoproliferative syndrome 1|Inborn genetic diseases	VCV001457163	5	156649889	5	157222879	1457163	1477900	rs776493663	NC_000005.10:157222878:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 8, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.525G>A (p.Val175=)	ITK		Lymphoproliferative syndrome 1	VCV001652752	5	156649902	5	157222892	1652752	1579252	rs2113760967	NC_000005.10:157222891:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.526G>A (p.Val176Ile)	ITK	V176I	Lymphoproliferative syndrome 1	VCV000665307	5	156649903	5	157222893	665307	633675	rs1452423111	NC_000005.10:157222892:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.529A>G (p.Ile177Val)	ITK	I177V	Lymphoproliferative syndrome 1	VCV000907123	5	156649906	5	157222896	907123	893712	rs1754451258	NC_000005.10:157222895:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.530T>C (p.Ile177Thr)	ITK	I177T	not provided	VCV003337185	5	156649907	5	157222897	3337185	3495847		NC_000005.10:157222896:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.537A>G (p.Leu179=)	ITK		Lymphoproliferative syndrome 1	VCV001920254	5	156649914	5	157222904	1920254	1975282		NC_000005.10:157222903:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 21, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.539A>G (p.Tyr180Cys)	ITK	Y180C	Lymphoproliferative syndrome 1	VCV000579957	5	156649916	5	157222906	579957	564978	rs1561657402	NC_000005.10:157222905:A:G	single nucleotide variant	missense variant	Uncertain significance	May 13, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.559C>T (p.Pro187Ser)	ITK	P187S	Autoinflammatory syndrome	VCV001694290	5	156649936	5	157222926	1694290	1686725	rs1156578676	NC_000005.10:157222925:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2017	criteria provided, single submitter							
NM_005546.4(ITK):c.570C>T (p.Leu190=)	ITK		Lymphoproliferative syndrome 1	VCV002185549	5	156649947	5	157222937	2185549	1914250		NC_000005.10:157222936:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 19, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.571G>A (p.Ala191Thr)	ITK	A191T	Lymphoproliferative syndrome 1	VCV000352463	5	156649948	5	157222938	352463	296636	rs534229766	NC_000005.10:157222937:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.577C>A (p.Arg193=)	ITK		Lymphoproliferative syndrome 1	VCV001534013	5	156649954	5	157222944	1534013	1584503	rs765859749	NC_000005.10:157222943:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 7, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.578G>A (p.Arg193Gln)	ITK	R193Q	Lymphoproliferative syndrome 1|Autoinflammatory syndrome	VCV000352464	5	156649955	5	157222945	352464	298495	rs17054374	NC_000005.10:157222944:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.580C>T (p.Arg194Cys)	ITK	R194C	Lymphoproliferative syndrome 1	VCV001364548	5	156649957	5	157222947	1364548	1409029	rs146738280	NC_000005.10:157222946:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.581G>A (p.Arg194His)	ITK	R194H	Lymphoproliferative syndrome 1	VCV000836277	5	156649958	5	157222948	836277	830570	rs755761978	NC_000005.10:157222947:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.583A>C (p.Asn195His)	ITK	N195H	Lymphoproliferative syndrome 1	VCV002113047	5	156649960	5	157222950	2113047	2164335		NC_000005.10:157222949:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.585C>T (p.Asn195=)	ITK		Lymphoproliferative syndrome 1	VCV001104460	5	156649962	5	157222952	1104460	1094157	rs988688399	NC_000005.10:157222951:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.586G>C (p.Glu196Gln)	ITK	E196Q	Lymphoproliferative syndrome 1|Inborn genetic diseases	VCV001499869	5	156649963	5	157222953	1499869	1385689	rs777670016	NC_000005.10:157222952:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.586G>A (p.Glu196Lys)	ITK	E196K	Lymphoproliferative syndrome 1	VCV001002737	5	156649963	5	157222953	1002737	990826	rs777670016	NC_000005.10:157222952:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.601C>T (p.Leu201=)	ITK		Lymphoproliferative syndrome 1	VCV002851840	5	156649978	5	157222968	2851840	3016168		NC_000005.10:157222967:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 5, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.609T>C (p.Ser203=)	ITK		Lymphoproliferative syndrome 1	VCV002858801	5	156649986	5	157222976	2858801	3025016		NC_000005.10:157222975:T:C	single nucleotide variant	synonymous variant	Likely benign	May 31, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.622TGG[1] (p.Trp209del)	ITK	W209del	Lymphoproliferative syndrome 1|Lymphoproliferative disorder	VCV000352465	5	156649999 - 156650001	5	157222989 - 157222991	352465	296638	rs757871566	NC_000005.10:157222988:TGGTGG:TGG	Microsatellite	inframe_deletion	Uncertain significance	Aug 4, 2021	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.630A>G (p.Arg210=)	ITK		Lymphoproliferative syndrome 1	VCV001537673	5	156650007	5	157222997	1537673	1649952	rs2113761067	NC_000005.10:157222996:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 15, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.631G>A (p.Val211Ile)	ITK	V211I	Lymphoproliferative syndrome 1	VCV002134098	5	156650008	5	157222998	2134098	2186817		NC_000005.10:157222997:G:A	single nucleotide variant	missense variant	Uncertain significance	May 20, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.631G>C (p.Val211Leu)	ITK	V211L	not provided|Lymphoproliferative syndrome 1|Inborn genetic diseases	VCV000540358	5	156650008	5	157222998	540358	521452	rs142038079	NC_000005.10:157222997:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 26, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.633C>A (p.Val211=)	ITK		Lymphoproliferative syndrome 1	VCV002782427	5	156650010	5	157223000	2782427	2940984		NC_000005.10:157222999:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 15, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.640A>G (p.Arg214Gly)	ITK	R214G	Lymphoproliferative syndrome 1	VCV001362842	5	156650017	5	157223007	1362842	1396162	rs369919319	NC_000005.10:157223006:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.647+10C>A	ITK		Lymphoproliferative syndrome 1	VCV002179503	5	156650034	5	157223024	2179503	1919900		NC_000005.10:157223023:C:A	single nucleotide variant	intron variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.647+16G>A	ITK		Lymphoproliferative syndrome 1	VCV001400530	5	156650040	5	157223030	1400530	1440757	rs1754455192	NC_000005.10:157223029:G:A	single nucleotide variant	intron variant	Likely benign	Jan 10, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.647+18C>G	ITK		Lymphoproliferative syndrome 1	VCV002035816	5	156650042	5	157223032	2035816	2093733		NC_000005.10:157223031:C:G	single nucleotide variant	intron variant	Likely benign	Sep 5, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.647+19T>G	ITK		Lymphoproliferative syndrome 1	VCV003629032	5	156650043	5	157223033	3629032	3752906		NC_000005.10:157223032:T:G	single nucleotide variant	intron variant	Likely benign	Mar 20, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.647+20G>A	ITK		Lymphoproliferative syndrome 1	VCV002024038	5	156650044	5	157223034	2024038	2080664		NC_000005.10:157223033:G:A	single nucleotide variant	intron variant	Likely benign	Aug 13, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.647+28C>T	ITK		not provided|not specified	VCV001227498	5	156650052	5	157223042	1227498	1216182	rs2288502	NC_000005.10:157223041:C:T	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.648-291G>T	ITK		not provided	VCV001266871	5	156655015	5	157228005	1266871	1255906	rs450067	NC_000005.10:157228004:G:T	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.648-9T>C	ITK		Lymphoproliferative syndrome 1	VCV001535456	5	156655297	5	157228287	1535456	1595911	rs2113764460	NC_000005.10:157228286:T:C	single nucleotide variant	intron variant	Likely benign	Jun 3, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.648-8T>C	ITK		Lymphoproliferative syndrome 1	VCV001159871	5	156655298	5	157228288	1159871	1136693	rs1754577712	NC_000005.10:157228287:T:C	single nucleotide variant	intron variant	Likely benign	Oct 23, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.651T>C (p.His217=)	ITK		Lymphoproliferative syndrome 1	VCV001956450	5	156655309	5	157228299	1956450	2015296		NC_000005.10:157228298:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 20, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.656G>C (p.Gly219Ala)	ITK	G219A	Lymphoproliferative syndrome 1	VCV001995756	5	156655314	5	157228304	1995756	2060128		NC_000005.10:157228303:G:C	single nucleotide variant	missense variant	Uncertain significance	May 23, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.657A>G (p.Gly219=)	ITK		Lymphoproliferative syndrome 1	VCV002128140	5	156655315	5	157228305	2128140	2182143		NC_000005.10:157228304:A:G	single nucleotide variant	synonymous variant	Likely benign	May 27, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.659A>G (p.Tyr220Cys)	ITK	Y220C	Lymphoproliferative syndrome 1	VCV002105641	5	156655317	5	157228307	2105641	2166102		NC_000005.10:157228306:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.667A>G (p.Ser223Gly)	ITK	S223G	Lymphoproliferative syndrome 1|Inborn genetic diseases	VCV000658392	5	156655325	5	157228315	658392	633676	rs200825710	NC_000005.10:157228314:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.674A>G (p.Tyr225Cys)	ITK	Y225C	Lymphoproliferative syndrome 1	VCV000642717	5	156655332	5	157228322	642717	633677	rs201567966	NC_000005.10:157228321:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.675T>C (p.Tyr225=)	ITK		Lymphoproliferative syndrome 1	VCV001097683	5	156655333	5	157228323	1097683	1072567	rs767930063	NC_000005.10:157228322:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.676C>G (p.Leu226Val)	ITK	L226V	Lymphoproliferative syndrome 1	VCV001447648	5	156655334	5	157228324	1447648	1403535	rs1754578642	NC_000005.10:157228323:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.678G>T (p.Leu226=)	ITK		Lymphoproliferative syndrome 1	VCV000765310	5	156655336	5	157228326	765310	764991	rs775005554	NC_000005.10:157228325:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 7, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.681G>A (p.Val227=)	ITK		Lymphoproliferative syndrome 1	VCV002726271	5	156655339	5	157228329	2726271	2888907		NC_000005.10:157228328:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.695A>G (p.Asn232Ser)	ITK	N232S	Inborn genetic diseases	VCV002619351	5	156655353	5	157228343	2619351	2792389		NC_000005.10:157228342:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.699T>C (p.Asn233=)	ITK		Lymphoproliferative syndrome 1	VCV001563142	5	156655357	5	157228347	1563142	1556140	rs2113764510	NC_000005.10:157228346:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 21, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.702G>A (p.Leu234=)	ITK		Lymphoproliferative syndrome 1	VCV002004498	5	156655360	5	157228350	2004498	2058564		NC_000005.10:157228349:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Nov 27, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.713A>C (p.Glu238Ala)	ITK	E238A	Lymphoproliferative syndrome 1	VCV002129928	5	156655371	5	157228361	2129928	2189205		NC_000005.10:157228360:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.713+6A>T	ITK		Lymphoproliferative syndrome 1	VCV001405967	5	156655377	5	157228367	1405967	1493229	rs765046607	NC_000005.10:157228366:A:T	single nucleotide variant	intron variant	Uncertain significance	Oct 16, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.714-13T>C	ITK		Lymphoproliferative syndrome 1	VCV002835722	5	156659337	5	157232327	2835722	2995554		NC_000005.10:157232326:T:C	single nucleotide variant	intron variant	Likely benign	Feb 16, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.714-12C>T	ITK		Lymphoproliferative syndrome 1	VCV001982367	5	156659338	5	157232328	1982367	2038927		NC_000005.10:157232327:C:T	single nucleotide variant	intron variant	Likely benign	Jun 23, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.714-11C>T	ITK		Lymphoproliferative syndrome 1	VCV001565593	5	156659339	5	157232329	1565593	1590183	rs2113766902	NC_000005.10:157232328:C:T	single nucleotide variant	intron variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.714-9T>C	ITK		ITK-related disorder	VCV003029882	5	156659341	5	157232331	3029882	3201022		NC_000005.10:157232330:T:C	single nucleotide variant	intron variant	Likely benign	Jan 27, 2023	no assertion criteria provided							
NM_005546.4(ITK):c.714-5T>C	ITK		Lymphoproliferative syndrome 1	VCV002704549	5	156659345	5	157232335	2704549	2866819		NC_000005.10:157232334:T:C	single nucleotide variant	intron variant	Likely benign	Dec 21, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.719A>G (p.Tyr240Cys)	ITK	Y240C	Lymphoproliferative syndrome 1	VCV000973643	5	156659355	5	157232345	973643	961945	rs1754673755	NC_000005.10:157232344:A:G	single nucleotide variant	missense variant	Uncertain significance	May 21, 2020	no assertion criteria provided							
NM_005546.4(ITK):c.725A>G (p.Lys242Arg)	ITK	K242R	Lymphoproliferative syndrome 1	VCV000540356	5	156659361	5	157232351	540356	521465	rs761513530	NC_000005.10:157232350:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2017	criteria provided, single submitter							
NM_005546.4(ITK):c.727A>T (p.Ser243Cys)	ITK	S243C	Inborn genetic diseases	VCV003111652	5	156659363	5	157232353	3111652	3268327		NC_000005.10:157232352:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.737G>A (p.Arg246Gln)	ITK	R246Q	Lymphoproliferative syndrome 1	VCV001417177	5	156659373	5	157232363	1417177	1377544	rs1230916806	NC_000005.10:157232362:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.741C>A (p.Asp247Glu)	ITK	D247E	Lymphoproliferative syndrome 1	VCV000947235	5	156659377	5	157232367	947235	923964	rs1294640313	NC_000005.10:157232366:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.742A>T (p.Lys248Ter)	ITK	K248*	Lymphoproliferative syndrome 1	VCV002148272	5	156659378	5	157232368	2148272	1871060		NC_000005.10:157232367:A:T	single nucleotide variant	nonsense	Pathogenic	Feb 16, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.758T>C (p.Leu253Pro)	ITK	L253P	Lymphoproliferative syndrome 1	VCV001011286	5	156659394	5	157232384	1011286	990827	rs1754675255	NC_000005.10:157232383:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.759T>G (p.Leu253=)	ITK		Lymphoproliferative syndrome 1	VCV000747524	5	156659395	5	157232385	747524	749393	rs1580900008	NC_000005.10:157232384:T:G	single nucleotide variant	synonymous variant	Likely benign	Nov 28, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.764A>T (p.Asp255Val)	ITK	D255V	Lymphoproliferative syndrome 1	VCV003616660	5	156659400	5	157232390	3616660	3742885		NC_000005.10:157232389:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.767C>T (p.Thr256Ile)	ITK	T256I	Lymphoproliferative syndrome 1	VCV000540357	5	156659403	5	157232393	540357	520959	rs115751349	NC_000005.10:157232392:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.768+3A>G	ITK		not specified|Autoinflammatory syndrome|Lymphoproliferative syndrome 1	VCV000858563	5	156659407	5	157232397	858563	852194	rs374214545	NC_000005.10:157232396:A:G	single nucleotide variant	intron variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.768+17T>C	ITK		Lymphoproliferative syndrome 1	VCV001630799	5	156659421	5	157232411	1630799	1618951	rs757441899	NC_000005.10:157232410:T:C	single nucleotide variant	intron variant	Likely benign	Sep 1, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.768+202AGGG[2]	ITK		not provided	VCV001257655	5	156659606 - 156659617	5	157232596 - 157232607	1257655	1249704	rs35417315	NC_000005.10:157232595:AGGGAGGGAGGGAGGGAGGGA:AGGGAGGGA	Microsatellite	intron variant	Benign	May 13, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.769-297T>C	ITK		not provided	VCV001266289	5	156664822	5	157237812	1266289	1256620	rs13355489	NC_000005.10:157237811:T:C	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.769-220G>T	ITK		not provided	VCV001264489	5	156664899	5	157237889	1264489	1256110	rs13357051	NC_000005.10:157237888:G:T	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.769-164C>T	ITK		not provided	VCV001257541	5	156664955	5	157237945	1257541	1249590	rs13361568	NC_000005.10:157237944:C:T	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.769-141C>T	ITK		not provided	VCV001264492	5	156664978	5	157237968	1264492	1256113	rs30117	NC_000005.10:157237967:C:T	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.769-20A>G	ITK		Lymphoproliferative syndrome 1	VCV002147405	5	156665099	5	157238089	2147405	1880595		NC_000005.10:157238088:A:G	single nucleotide variant	intron variant	Likely benign	Jul 8, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.769-19T>C	ITK		Lymphoproliferative syndrome 1	VCV002991628	5	156665100	5	157238090	2991628	3148061		NC_000005.10:157238089:T:C	single nucleotide variant	intron variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.769-13C>T	ITK		Lymphoproliferative syndrome 1	VCV000352466	5	156665106	5	157238096	352466	296639	rs56100638	NC_000005.10:157238095:C:T	single nucleotide variant	intron variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.769-10A>T	ITK		Lymphoproliferative syndrome 1|Autoinflammatory syndrome	VCV000352467	5	156665109	5	157238099	352467	298496	rs55646940	NC_000005.10:157238098:A:T	single nucleotide variant	intron variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.780A>T (p.Gly260=)	ITK		Lymphoproliferative syndrome 1	VCV002070581	5	156665130	5	157238120	2070581	2119814		NC_000005.10:157238119:A:T	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.781G>A (p.Ala261Thr)	ITK	A261T	Inborn genetic diseases	VCV002246859	5	156665131	5	157238121	2246859	2237574		NC_000005.10:157238120:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.782C>A (p.Ala261Asp)	ITK	A261D	Lymphoproliferative syndrome 1	VCV001964620	5	156665132	5	157238122	1964620	2031082		NC_000005.10:157238121:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.782C>G (p.Ala261Gly)	ITK	A261G	Lymphoproliferative syndrome 1	VCV001435124	5	156665132	5	157238122	1435124	1422099	rs767455537	NC_000005.10:157238121:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.790G>A (p.Val264Ile)	ITK	V264I	Lymphoproliferative syndrome 1	VCV000861874	5	156665140	5	157238130	861874	830571	rs753847568	NC_000005.10:157238129:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2019	criteria provided, single submitter							
NM_005546.4(ITK):c.792A>G (p.Val264=)	ITK		Lymphoproliferative syndrome 1	VCV001644207	5	156665142	5	157238132	1644207	1564248	rs757278824	NC_000005.10:157238131:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 6, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.810A>G (p.Ala270=)	ITK		Autoinflammatory syndrome|Lymphoproliferative syndrome 1	VCV001694291	5	156665160	5	157238150	1694291	1686726	rs750585884	NC_000005.10:157238149:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.822C>T (p.Thr274=)	ITK		Lymphoproliferative syndrome 1	VCV000736640	5	156665172	5	157238162	736640	749394	rs200351890	NC_000005.10:157238161:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 16, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.823G>A (p.Val275Met)	ITK	V275M	Lymphoproliferative syndrome 1	VCV000960571	5	156665173	5	157238163	960571	944506	rs780522355	NC_000005.10:157238162:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.840G>A (p.Lys280=)	ITK		Lymphoproliferative syndrome 1	VCV003610966	5	156665190	5	157238180	3610966	3748255		NC_000005.10:157238179:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 26, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.841G>T (p.Ala281Ser)	ITK	A281S	Inborn genetic diseases	VCV003530784	5	156665191	5	157238181	3530784	3687204		NC_000005.10:157238180:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.844G>C (p.Val282Leu)	ITK	V282L	Lymphoproliferative syndrome 1	VCV002736044	5	156665194	5	157238184	2736044	2899036		NC_000005.10:157238183:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.844G>A (p.Val282Ile)	ITK	V282I	Lymphoproliferative syndrome 1	VCV000352468	5	156665194	5	157238184	352468	302921	rs202191474	NC_000005.10:157238183:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.851+5G>A	ITK		Lymphoproliferative syndrome 1	VCV000907124	5	156665206	5	157238196	907124	896070	rs769166363	NC_000005.10:157238195:G:A	single nucleotide variant	intron variant	Uncertain significance	Aug 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.851+14T>C	ITK		Lymphoproliferative syndrome 1	VCV002768069	5	156665215	5	157238205	2768069	2932681		NC_000005.10:157238204:T:C	single nucleotide variant	intron variant	Likely benign	Jun 4, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.851+20C>A	ITK		Lymphoproliferative syndrome 1	VCV001666996	5	156665221	5	157238211	1666996	1622421	rs1482377891	NC_000005.10:157238210:C:A	single nucleotide variant	intron variant	Likely benign	Dec 28, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.852-273T>G	ITK		not provided	VCV001285670	5	156666799	5	157239789	1285670	1275509	rs30118	NC_000005.10:157239788:T:G	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.852-7_852-4del	ITK		Lymphoproliferative syndrome 1	VCV001654273	5	156667062 - 156667065	5	157240052 - 157240055	1654273	1527091	rs2113772194	NC_000005.10:157240051:TTTGTTT:TTT	Deletion	intron variant	Likely benign	Nov 27, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.852-6T>C	ITK		Lymphoproliferative syndrome 1	VCV003607454	5	156667066	5	157240056	3607454	3747337		NC_000005.10:157240055:T:C	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_005546.4(ITK):c.857A>C (p.Asn286Thr)	ITK	N286T	Lymphoproliferative syndrome 1	VCV001716804	5	156667077	5	157240067	1716804	1778485		NC_000005.10:157240066:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.858C>T (p.Asn286=)	ITK		Lymphoproliferative syndrome 1	VCV002726651	5	156667078	5	157240068	2726651	2885842		NC_000005.10:157240067:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 3, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.858C>A (p.Asn286Lys)	ITK	N286K	Inborn genetic diseases	VCV002230468	5	156667078	5	157240068	2230468	2219922		NC_000005.10:157240067:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.859A>G (p.Asn287Asp)	ITK	N287D	Lymphoproliferative syndrome 1	VCV001368474	5	156667079	5	157240069	1368474	1340067	rs748573843	NC_000005.10:157240068:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.868A>G (p.Ile290Val)	ITK	I290V	Lymphoproliferative syndrome 1	VCV002166181	5	156667088	5	157240078	2166181	1898794		NC_000005.10:157240077:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.868A>T (p.Ile290Leu)	ITK	I290L	not provided|Lymphoproliferative syndrome 1	VCV001417228	5	156667088	5	157240078	1417228	1377595	rs150729024	NC_000005.10:157240077:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.873G>A (p.Lys291=)	ITK		Lymphoproliferative syndrome 1	VCV001131004	5	156667093	5	157240083	1131004	1115687	rs1580905431	NC_000005.10:157240082:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 3, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.873G>T (p.Lys291Asn)	ITK	K291N	Lymphoproliferative syndrome 1	VCV000657763	5	156667093	5	157240083	657763	633678	rs1580905431	NC_000005.10:157240082:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.909G>T (p.Lys303Asn)	ITK	K303N	Lymphoproliferative syndrome 1	VCV001449027	5	156667129	5	157240119	1449027	1338782	rs1380849049	NC_000005.10:157240118:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.910C>A (p.Arg304=)	ITK		Lymphoproliferative syndrome 1	VCV001155011	5	156667130	5	157240120	1155011	1136694	rs1333663722	NC_000005.10:157240119:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 10, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.911G>A (p.Arg304Gln)	ITK	R304Q	Lymphoproliferative syndrome 1	VCV003628997	5	156667131	5	157240121	3628997	3752871		NC_000005.10:157240120:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, single submitter							
NM_005546.4(ITK):c.913del (p.Tyr305fs)	ITK	Y305fs	Inborn genetic diseases	VCV000521210	5	156667133	5	157240123	521210	511581	rs1554102738	NC_000005.10:157240122:T:	Deletion	frameshift variant	Pathogenic	Jul 28, 2016	criteria provided, single submitter							
NM_005546.4(ITK):c.915C>T (p.Tyr305=)	ITK		Lymphoproliferative syndrome 1	VCV001581373	5	156667135	5	157240125	1581373	1534473	rs773986316	NC_000005.10:157240124:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 21, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.922G>T (p.Ala308Ser)	ITK	A308S	Inborn genetic diseases	VCV003530785	5	156667142	5	157240132	3530785	3687205		NC_000005.10:157240131:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.929del (p.Lys310fs)	ITK	K310fs	not provided	VCV003251232	5	156667146	5	157240136	3251232	3410031		NC_000005.10:157240135:AAAA:AAA	Deletion	frameshift variant	Pathogenic	Jun 1, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.927A>G (p.Glu309=)	ITK		Lymphoproliferative syndrome 1	VCV001628916	5	156667147	5	157240137	1628916	1617507	rs372201861	NC_000005.10:157240136:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 24, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.929_930delinsT (p.Lys310fs)	ITK	K310fs	not provided	VCV003257570	5	156667149 - 156667150	5	157240139 - 157240140	3257570	3416324		NC_000005.10:157240138:AG:T	Indel	frameshift variant	Pathogenic	Jul 1, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.935T>C (p.Val312Ala)	ITK	V312A	Lymphoproliferative syndrome 1	VCV001377843	5	156667155	5	157240145	1377843	1469648	rs764110831	NC_000005.10:157240144:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.940G>A (p.Asp314Asn)	ITK	D314N	Lymphoproliferative syndrome 1	VCV001425153	5	156667160	5	157240150	1425153	1353660	rs138078237	NC_000005.10:157240149:G:A	single nucleotide variant	missense variant	Uncertain significance	May 5, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.940G>C (p.Asp314His)	ITK	D314H	Lymphoproliferative syndrome 1|ITK-related disorder	VCV000956536	5	156667160	5	157240150	956536	944507	rs138078237	NC_000005.10:157240149:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.978T>C (p.Asn326=)	ITK		Lymphoproliferative syndrome 1	VCV001976825	5	156667198	5	157240188	1976825	2030811		NC_000005.10:157240187:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 2, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.985+10A>G	ITK		Lymphoproliferative syndrome 1	VCV001645123	5	156667215	5	157240205	1645123	1599021	rs2113772313	NC_000005.10:157240204:A:G	single nucleotide variant	intron variant	Likely benign	Feb 5, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.985+19G>T	ITK		Lymphoproliferative syndrome 1	VCV002801804	5	156667224	5	157240214	2801804	2956445		NC_000005.10:157240213:G:T	single nucleotide variant	intron variant	Likely benign	Jul 6, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.985+20T>C	ITK		Lymphoproliferative syndrome 1	VCV003603869	5	156667225	5	157240215	3603869	3746343		NC_000005.10:157240214:T:C	single nucleotide variant	intron variant	Likely benign	Aug 5, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.985+75G>A	ITK		not specified|not provided	VCV001221812	5	156667280	5	157240270	1221812	1210922	rs6860090	NC_000005.10:157240269:G:A	single nucleotide variant	intron variant	Benign	Nov 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.985+241C>A	ITK		not provided	VCV001222921	5	156667446	5	157240436	1222921	1212030	rs30119	NC_000005.10:157240435:C:A	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.986-188T>C	ITK		not provided	VCV001295389	5	156668468	5	157241458	1295389	1285184	rs3734024	NC_000005.10:157241457:T:C	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.986-10A>G	ITK		Lymphoproliferative syndrome 1	VCV000907125	5	156668646	5	157241636	907125	896071	rs757798734	NC_000005.10:157241635:A:G	single nucleotide variant	intron variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.986-5_986-2del	ITK		Lymphoproliferative syndrome 1	VCV002071551	5	156668650 - 156668653	5	157241640 - 157241643	2071551	2122928		NC_000005.10:157241639:ACCCA:A	Deletion	splice acceptor variant	Uncertain significance	Jul 3, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.986-4C>T	ITK		Lymphoproliferative syndrome 1	VCV001563577	5	156668652	5	157241642	1563577	1620081	rs757984727	NC_000005.10:157241641:C:T	single nucleotide variant	intron variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.987C>A (p.Gly329=)	ITK		Lymphoproliferative syndrome 1	VCV001546281	5	156668657	5	157241647	1546281	1526131	rs1754909834	NC_000005.10:157241646:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 3, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.993G>T (p.Val331=)	ITK		Lymphoproliferative syndrome 1	VCV001671167	5	156668663	5	157241653	1671167	1530057	rs2113773254	NC_000005.10:157241652:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.999A>T (p.Arg333=)	ITK		Lymphoproliferative syndrome 1	VCV001540016	5	156668669	5	157241659	1540016	1630333	rs1227714166	NC_000005.10:157241658:A:T	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1003C>T (p.Arg335Trp)	ITK	R335W	Lymphoproliferative syndrome 1	VCV000012741	5	156668673	5	157241663	12741	27780	rs121908191	NC_000005.10:157241662:C:T	single nucleotide variant	missense variant	Pathogenic	May 1, 2012	no assertion criteria provided							
NM_005546.4(ITK):c.1004G>A (p.Arg335Gln)	ITK	R335Q	Lymphoproliferative syndrome 1	VCV000941330	5	156668674	5	157241664	941330	932813	rs546493307	NC_000005.10:157241663:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1019T>C (p.Phe340Ser)	ITK	F340S	Inborn genetic diseases	VCV002469289	5	156668689	5	157241679	2469289	2437959		NC_000005.10:157241678:T:C	single nucleotide variant	missense variant	Likely benign	Feb 1, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1026G>A (p.Arg342=)	ITK		not provided	VCV003388877	5	156668696	5	157241686	3388877	3548003		NC_000005.10:157241685:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1033G>T (p.Ala345Ser)	ITK	A345S	Lymphoproliferative syndrome 1	VCV001475882	5	156668703	5	157241693	1475882	1423602	rs1202690965	NC_000005.10:157241692:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1034C>T (p.Ala345Val)	ITK	A345V	not specified|Lymphoproliferative syndrome 1	VCV000647566	5	156668704	5	157241694	647566	633679	rs1421908099	NC_000005.10:157241693:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1039G>A (p.Val347Ile)	ITK	V347I	Lymphoproliferative syndrome 1	VCV000352469	5	156668709	5	157241699	352469	298498	rs886060326	NC_000005.10:157241698:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.1043C>T (p.Thr348Ile)	ITK	T348I	Lymphoproliferative syndrome 1|Inborn genetic diseases	VCV002278452	5	156668713	5	157241703	2278452	2263087		NC_000005.10:157241702:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1043C>G (p.Thr348Arg)	ITK	T348R	Lymphoproliferative syndrome 1	VCV001423059	5	156668713	5	157241703	1423059	1425338	rs1358243764	NC_000005.10:157241702:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1044A>C (p.Thr348=)	ITK		Lymphoproliferative syndrome 1	VCV002013775	5	156668714	5	157241704	2013775	2067858		NC_000005.10:157241703:A:C	single nucleotide variant	synonymous variant	Likely benign	Sep 7, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1048G>A (p.Gly350Arg)	ITK	G350R	Lymphoproliferative syndrome 1	VCV002826319	5	156668718	5	157241708	2826319	2989540		NC_000005.10:157241707:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1052T>G (p.Leu351Arg)	ITK	L351R	Lymphoproliferative syndrome 1	VCV002008430	5	156668722	5	157241712	2008430	2066380		NC_000005.10:157241711:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1053G>A (p.Leu351=)	ITK		Lymphoproliferative syndrome 1	VCV001119399	5	156668723	5	157241713	1119399	1094158	rs769875966	NC_000005.10:157241712:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 29, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1059C>T (p.Tyr353=)	ITK		Lymphoproliferative syndrome 1	VCV002139272	5	156668729	5	157241719	2139272	1875066		NC_000005.10:157241718:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Sep 27, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1060G>A (p.Gly354Arg)	ITK	G354R	Lymphoproliferative syndrome 1	VCV000352470	5	156668730	5	157241720	352470	296640	rs886060327	NC_000005.10:157241719:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1060+11C>A	ITK		Lymphoproliferative syndrome 1	VCV002021860	5	156668741	5	157241731	2021860	2083621		NC_000005.10:157241730:C:A	single nucleotide variant	intron variant	Likely benign	Aug 5, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1060+12A>C	ITK		Lymphoproliferative syndrome 1	VCV000352471	5	156668742	5	157241732	352471	296650	rs765303299	NC_000005.10:157241731:A:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 13, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.1061-19CT[8]	ITK		Lymphoproliferative syndrome 1	VCV002899419	5	156670613 - 156670614	5	157243603 - 157243604	2899419	3057600		NC_000005.10:157243603:CTCTCTCTCTCTCT:CTCTCTCTCTCTCTCT	Microsatellite	intron variant	Benign	Jul 11, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1061-20A>G	ITK		Lymphoproliferative syndrome 1	VCV001651510	5	156670613	5	157243603	1651510	1546959	rs1754957807	NC_000005.10:157243602:A:G	single nucleotide variant	intron variant	Likely benign	Feb 25, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1061-19CT[6]	ITK		ITK-related disorder	VCV003039689	5	156670614 - 156670615	5	157243604 - 157243605	3039689	3207331		NC_000005.10:157243603:CTCTCTCTCTCTCT:CTCTCTCTCTCT	Microsatellite	intron variant	Likely benign	May 17, 2022	no assertion criteria provided							
NM_005546.4(ITK):c.1061-7C>T	ITK		Lymphoproliferative syndrome 1	VCV003619448	5	156670626	5	157243616	3619448	3756471		NC_000005.10:157243615:C:T	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1061-1G>A	ITK		ITK-related disorder	VCV002631535	5	156670632	5	157243622	2631535	2801069		NC_000005.10:157243621:G:A	single nucleotide variant	splice acceptor variant	Uncertain significance	Aug 20, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1061G>A (p.Gly354Glu)	ITK	G354E	ITK-related disorder	VCV002634589	5	156670633	5	157243623	2634589	2804113		NC_000005.10:157243622:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1063A>G (p.Lys355Glu)	ITK	K355E	Lymphoproliferative syndrome 1	VCV001412476	5	156670635	5	157243625	1412476	1344457	rs1580907931	NC_000005.10:157243624:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1065A>G (p.Lys355=)	ITK		Lymphoproliferative syndrome 1	VCV001440962	5	156670637	5	157243627	1440962	1362109	rs749296136	NC_000005.10:157243626:A:G	single nucleotide variant	synonymous variant	Uncertain significance	Jan 26, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1069G>A (p.Val357Met)	ITK	V357M	Lymphoproliferative syndrome 1|not provided	VCV001366907	5	156670641	5	157243631	1366907	1338072	rs772167595	NC_000005.10:157243630:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1070T>G (p.Val357Gly)	ITK	V357G	Inborn genetic diseases	VCV003111650	5	156670642	5	157243632	3111650	3268325		NC_000005.10:157243631:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1074C>G (p.Ile358Met)	ITK	I358M	Lymphoproliferative syndrome 1	VCV000841026	5	156670646	5	157243636	841026	830572	rs142689933	NC_000005.10:157243635:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2019	criteria provided, single submitter							
NM_005546.4(ITK):c.1074C>T (p.Ile358=)	ITK		Lymphoproliferative syndrome 1	VCV000759081	5	156670646	5	157243636	759081	764992	rs142689933	NC_000005.10:157243635:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 26, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1075G>C (p.Asp359His)	ITK	D359H	Lymphoproliferative syndrome 1|Inborn genetic diseases	VCV001024741	5	156670647	5	157243637	1024741	1006002	rs760908622	NC_000005.10:157243636:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2023	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.1082C>T (p.Ser361Leu)	ITK	S361L	Lymphoproliferative syndrome 1	VCV000944136	5	156670654	5	157243644	944136	923965	rs1031236089	NC_000005.10:157243643:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1089C>T (p.Leu363=)	ITK		Lymphoproliferative syndrome 1	VCV001139840	5	156670661	5	157243651	1139840	1115688	rs776918875	NC_000005.10:157243650:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 6, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.1090A>G (p.Thr364Ala)	ITK	T364A	Lymphoproliferative syndrome 1	VCV000903773	5	156670662	5	157243652	903773	893713	rs1754959182	NC_000005.10:157243651:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.1119A>G (p.Gln373=)	ITK		Lymphoproliferative syndrome 1	VCV000352472	5	156670691	5	157243681	352472	296652	rs189091977	NC_000005.10:157243680:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Oct 19, 2022	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.1124G>T (p.Gly375Val)	ITK	G375V	Lymphoproliferative syndrome 1	VCV001014617	5	156670696	5	157243686	1014617	1006003	rs773691716	NC_000005.10:157243685:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.1125G>T (p.Gly375=)	ITK		not provided|Lymphoproliferative syndrome 1	VCV000624116	5	156670697	5	157243687	624116	612705	rs373555923	NC_000005.10:157243686:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1131G>A (p.Val377=)	ITK		Lymphoproliferative syndrome 1	VCV002716650	5	156670703	5	157243693	2716650	2876348		NC_000005.10:157243692:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 13, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1133A>G (p.His378Arg)	ITK	H378R	Inborn genetic diseases|Lymphoproliferative syndrome 1	VCV003016758	5	156670705	5	157243695	3016758	3182239		NC_000005.10:157243694:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1135C>T (p.Leu379=)	ITK		Lymphoproliferative syndrome 1	VCV001908338	5	156670707	5	157243697	1908338	1962522		NC_000005.10:157243696:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1149C>T (p.Leu383=)	ITK		Lymphoproliferative syndrome 1	VCV001116685	5	156670721	5	157243711	1116685	1094159	rs2113774536	NC_000005.10:157243710:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 5, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1152C>T (p.Asn384=)	ITK		Lymphoproliferative syndrome 1	VCV001135148	5	156670724	5	157243714	1135148	1115689	rs754601013	NC_000005.10:157243713:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 20, 2019	criteria provided, single submitter							
NM_005546.4(ITK):c.1153A>G (p.Lys385Glu)	ITK	K385E	Lymphoproliferative syndrome 1	VCV000579298	5	156670725	5	157243715	579298	560350	rs767083015	NC_000005.10:157243714:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1162G>A (p.Val388Met)	ITK	V388M	Inborn genetic diseases	VCV003286943	5	156670734	5	157243724	3286943	3451814		NC_000005.10:157243723:G:A	single nucleotide variant	missense variant	Uncertain significance	May 10, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1177A>G (p.Ile393Val)	ITK	I393V	Lymphoproliferative syndrome 1	VCV000903774	5	156670749	5	157243739	903774	893714	rs1754961162	NC_000005.10:157243738:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.1181G>A (p.Arg394Gln)	ITK	R394Q	Inborn genetic diseases|Lymphoproliferative syndrome 1	VCV000940469	5	156670753	5	157243743	940469	932814	rs777757937	NC_000005.10:157243742:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 17, 2022	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.1188G>T (p.Gly396=)	ITK		Lymphoproliferative syndrome 1	VCV002195496	5	156670760	5	157243750	2195496	1929862		NC_000005.10:157243749:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 16, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1201G>T (p.Glu401Ter)	ITK	E401*	Lymphoproliferative syndrome 1	VCV002109594	5	156670773	5	157243763	2109594	2163469		NC_000005.10:157243762:G:T	single nucleotide variant	nonsense	Pathogenic	Mar 14, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1210A>G (p.Ile404Val)	ITK	I404V	Lymphoproliferative syndrome 1	VCV001523247	5	156670782	5	157243772	1523247	1350416	rs1266552256	NC_000005.10:157243771:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1211T>C (p.Ile404Thr)	ITK	I404T	Inborn genetic diseases	VCV003530780	5	156670783	5	157243773	3530780	3687200		NC_000005.10:157243772:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1219G>T (p.Ala407Ser)	ITK	A407S	Lymphoproliferative syndrome 1	VCV002879834	5	156670791	5	157243781	2879834	3036494		NC_000005.10:157243780:G:T	single nucleotide variant	missense variant	Uncertain significance	May 8, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1229T>C (p.Met410Thr)	ITK	M410T	Lymphoproliferative syndrome 1	VCV001417815	5	156670801	5	157243791	1417815	1374301	rs776824188	NC_000005.10:157243790:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1232+19G>C	ITK		Lymphoproliferative syndrome 1	VCV001574519	5	156670823	5	157243813	1574519	1659704	rs17595865	NC_000005.10:157243812:G:C	single nucleotide variant	intron variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1232+19G>A	ITK		not provided|Lymphoproliferative syndrome 1	VCV001170314	5	156670823	5	157243813	1170314	1154969	rs17595865	NC_000005.10:157243812:G:A	single nucleotide variant	intron variant	Benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1232+112C>T	ITK		not specified|not provided	VCV001263333	5	156670916	5	157243906	1263333	1251951	rs66943334	NC_000005.10:157243905:C:T	single nucleotide variant	intron variant	Benign	Nov 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1232+196C>T	ITK		not provided	VCV001269396	5	156671000	5	157243990	1269396	1260537	rs34099004	NC_000005.10:157243989:C:T	single nucleotide variant	intron variant	Benign	May 12, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1233-16T>C	ITK		Lymphoproliferative syndrome 1	VCV002881009	5	156671256	5	157244246	2881009	3042607		NC_000005.10:157244245:T:C	single nucleotide variant	intron variant	Likely benign	Dec 1, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1233-8T>C	ITK		Lymphoproliferative syndrome 1	VCV002026868	5	156671264	5	157244254	2026868	2084788		NC_000005.10:157244253:T:C	single nucleotide variant	intron variant	Likely benign	Dec 2, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1233-6C>T	ITK		Lymphoproliferative syndrome 1	VCV001113258	5	156671266	5	157244256	1113258	1094160	rs2113774921	NC_000005.10:157244255:C:T	single nucleotide variant	intron variant	Likely benign	Dec 1, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1235A>G (p.Lys412Arg)	ITK	K412R	Lymphoproliferative syndrome 1	VCV000944137	5	156671274	5	157244264	944137	923966	rs953401521	NC_000005.10:157244263:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1250A>C (p.Lys417Thr)	ITK	K417T	Lymphoproliferative syndrome 1	VCV001922213	5	156671289	5	157244279	1922213	1975941		NC_000005.10:157244278:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1255G>A (p.Val419Met)	ITK	V419M	Lymphoproliferative syndrome 1	VCV001389577	5	156671294	5	157244284	1389577	1377057	rs1754974716	NC_000005.10:157244283:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1263G>C (p.Leu421=)	ITK		Lymphoproliferative syndrome 1	VCV001575953	5	156671302	5	157244292	1575953	1520815	rs778053976	NC_000005.10:157244291:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 4, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1276C>T (p.Leu426=)	ITK		Autoinflammatory syndrome|Lymphoproliferative syndrome 1	VCV000352473	5	156671315	5	157244305	352473	296653	rs145991142	NC_000005.10:157244304:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 2, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.1281G>A (p.Glu427=)	ITK		Lymphoproliferative syndrome 1	VCV001900933	5	156671320	5	157244310	1900933	1963763		NC_000005.10:157244309:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1282C>A (p.Gln428Lys)	ITK	Q428K	Lymphoproliferative syndrome 1|not specified	VCV000641419	5	156671321	5	157244311	641419	633680	rs150270557	NC_000005.10:157244310:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1283A>G (p.Gln428Arg)	ITK	Q428R	Lymphoproliferative syndrome 1	VCV001041708	5	156671322	5	157244312	1041708	1026495	rs1754976541	NC_000005.10:157244311:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.1302G>A (p.Val434=)	ITK		Lymphoproliferative syndrome 1	VCV001994788	5	156671341	5	157244331	1994788	2053154		NC_000005.10:157244330:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 27, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1312A>T (p.Met438Leu)	ITK	M438L	Lymphoproliferative syndrome 1	VCV002191669	5	156671351	5	157244341	2191669	1928640		NC_000005.10:157244340:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1321G>A (p.Gly441Ser)	ITK	G441S	Lymphoproliferative syndrome 1	VCV002095031	5	156671360	5	157244350	2095031	2156815		NC_000005.10:157244349:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1332A>G (p.Ser444=)	ITK		Lymphoproliferative syndrome 1	VCV001605622	5	156671371	5	157244361	1605622	1646674	rs758367076	NC_000005.10:157244360:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1335T>G (p.Asp445Glu)	ITK	D445E	Lymphoproliferative syndrome 1	VCV001472180	5	156671374	5	157244364	1472180	1385328	rs752788773	NC_000005.10:157244363:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1337A>T (p.Tyr446Phe)	ITK	Y446F	Lymphoproliferative syndrome 1	VCV001350051	5	156671376	5	157244366	1350051	1472874	rs2113775023	NC_000005.10:157244365:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1342C>G (p.Arg448Gly)	ITK	R448G	Lymphoproliferative syndrome 1	VCV002013805	5	156671381	5	157244371	2013805	2067888		NC_000005.10:157244370:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1342C>T (p.Arg448Cys)	ITK	R448C	Lymphoproliferative syndrome 1	VCV001035963	5	156671381	5	157244371	1035963	1026496	rs143652027	NC_000005.10:157244370:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1343G>C (p.Arg448Pro)	ITK	R448P	Lymphoproliferative syndrome 1	VCV001371168	5	156671382	5	157244372	1371168	1427374	rs144735141	NC_000005.10:157244371:G:C	single nucleotide variant	missense variant	Uncertain significance	May 17, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1343G>A (p.Arg448His)	ITK	R448H	Lymphoproliferative syndrome 1|not provided	VCV000577129	5	156671382	5	157244372	577129	563007	rs144735141	NC_000005.10:157244371:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1351C>T (p.Arg451Trp)	ITK	R451W	Inborn genetic diseases|not provided|not specified|Lymphoproliferative syndrome 1	VCV000575120	5	156671390	5	157244380	575120	560239	rs200331133	NC_000005.10:157244379:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1354G>C (p.Gly452Arg)	ITK	G452R	Lymphoproliferative syndrome 1	VCV001376804	5	156671393	5	157244383	1376804	1479668	rs2113775046	NC_000005.10:157244382:G:C	single nucleotide variant	missense variant	Uncertain significance	May 18, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1361T>C (p.Phe454Ser)	ITK	F454S	Lymphoproliferative syndrome 1	VCV001493701	5	156671400	5	157244390	1493701	1449204	rs2113775055	NC_000005.10:157244389:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1363G>C (p.Ala455Pro)	ITK	A455P	Lymphoproliferative syndrome 1	VCV002768453	5	156671402	5	157244392	2768453	2929621		NC_000005.10:157244391:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1371G>T (p.Glu457Asp)	ITK	E457D	Lymphoproliferative syndrome 1	VCV001430779	5	156671410	5	157244400	1430779	1467456	rs746321007	NC_000005.10:157244399:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1389T>C (p.Cys463=)	ITK		Lymphoproliferative syndrome 1	VCV003614187	5	156671428	5	157244418	3614187	3748882		NC_000005.10:157244417:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 28, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1393G>A (p.Asp465Asn)	ITK	D465N	Lymphoproliferative syndrome 1	VCV001046045	5	156671432	5	157244422	1046045	1026497	rs1754979969	NC_000005.10:157244421:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.1394A>C (p.Asp465Ala)	ITK	D465A	Lymphoproliferative syndrome 1	VCV000840148	5	156671433	5	157244423	840148	830573	rs1754980034	NC_000005.10:157244422:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1398G>A (p.Val466=)	ITK		Lymphoproliferative syndrome 1	VCV003620487	5	156671437	5	157244427	3620487	3750871		NC_000005.10:157244426:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 26, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1398G>T (p.Val466=)	ITK		Autoinflammatory syndrome|not specified|Lymphoproliferative syndrome 1	VCV000540360	5	156671437	5	157244427	540360	521396	rs17595896	NC_000005.10:157244426:G:T	single nucleotide variant	synonymous variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1408A>G (p.Met470Val)	ITK	M470V	Lymphoproliferative syndrome 1	VCV001997765	5	156671447	5	157244437	1997765	2056985		NC_000005.10:157244436:A:G	single nucleotide variant	missense variant	Uncertain significance	May 21, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1411G>A (p.Ala471Thr)	ITK	A471T	Lymphoproliferative syndrome 1|not provided	VCV000646233	5	156671450	5	157244440	646233	633681	rs368438364	NC_000005.10:157244439:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1412C>T (p.Ala471Val)	ITK	A471V	Lymphoproliferative syndrome 1	VCV002120680	5	156671451	5	157244441	2120680	2173400		NC_000005.10:157244440:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1414T>C (p.Tyr472His)	ITK	Y472H	Lymphoproliferative syndrome 1	VCV001473469	5	156671453	5	157244443	1473469	1391348	rs2113775104	NC_000005.10:157244442:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1428A>G (p.Ala476=)	ITK		Lymphoproliferative syndrome 1	VCV002115907	5	156671467	5	157244457	2115907	2182846		NC_000005.10:157244456:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 26, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1437C>A (p.Ile479=)	ITK		Lymphoproliferative syndrome 1	VCV000712809	5	156671476	5	157244466	712809	721351	rs756176085	NC_000005.10:157244465:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 7, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1446C>T (p.Asp482=)	ITK		Lymphoproliferative syndrome 1	VCV000765942	5	156671485	5	157244475	765942	764993	rs1270596383	NC_000005.10:157244474:C:T	single nucleotide variant	synonymous variant	Likely benign	May 27, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.1447T>A (p.Leu483Met)	ITK	L483M	Lymphoproliferative syndrome 1	VCV002181322	5	156671486	5	157244476	2181322	1916550		NC_000005.10:157244475:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1449+4T>C	ITK		Autoimmune lymphoproliferative syndrome type 1	VCV003367065	5	156671492	5	157244482	3367065	3526266		NC_000005.10:157244481:T:C	single nucleotide variant	intron variant	Uncertain significance	May 20, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1449+7G>T	ITK		Lymphoproliferative syndrome 1	VCV001093836	5	156671495	5	157244485	1093836	1072568	rs779098639	NC_000005.10:157244484:G:T	single nucleotide variant	intron variant	Likely benign	Jul 8, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1449+7G>C	ITK		not provided|Lymphoproliferative syndrome 1	VCV000707927	5	156671495	5	157244485	707927	730349	rs779098639	NC_000005.10:157244484:G:C	single nucleotide variant	intron variant	Likely benign	Mar 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1449+10T>C	ITK		Lymphoproliferative syndrome 1	VCV000765227	5	156671498	5	157244488	765227	774995	rs1580908781	NC_000005.10:157244487:T:C	single nucleotide variant	intron variant	Likely benign	Aug 21, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1449+14G>A	ITK		Lymphoproliferative syndrome 1	VCV002169067	5	156671502	5	157244492	2169067	1906891		NC_000005.10:157244491:G:A	single nucleotide variant	intron variant	Uncertain significance	Jul 8, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1449+16G>C	ITK		Lymphoproliferative syndrome 1	VCV002969279	5	156671504	5	157244494	2969279	3131821		NC_000005.10:157244493:G:C	single nucleotide variant	intron variant	Likely benign	Feb 16, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1450-20T>C	ITK		Lymphoproliferative syndrome 1	VCV003627663	5	156672716	5	157245706	3627663	3761649		NC_000005.10:157245705:T:C	single nucleotide variant	intron variant	Likely benign	Jan 13, 2025	criteria provided, single submitter							
NM_005546.4(ITK):c.1450-17G>A	ITK		Lymphoproliferative syndrome 1	VCV001170275	5	156672719	5	157245709	1170275	1154970	rs13156643	NC_000005.10:157245708:G:A	single nucleotide variant	intron variant	Benign	Jan 31, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1450-16C>T	ITK		Lymphoproliferative syndrome 1	VCV001529286	5	156672720	5	157245710	1529286	1604001	rs1024625013	NC_000005.10:157245709:C:T	single nucleotide variant	intron variant	Likely benign	Sep 26, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1450-10T>C	ITK		Lymphoproliferative syndrome 1	VCV001575156	5	156672726	5	157245716	1575156	1638441	rs368847879	NC_000005.10:157245715:T:C	single nucleotide variant	intron variant	Likely benign	Aug 18, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1450-9C>T	ITK		Lymphoproliferative syndrome 1	VCV002882008	5	156672727	5	157245717	2882008	3034197		NC_000005.10:157245716:C:T	single nucleotide variant	intron variant	Likely benign	Jan 13, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1450-4C>T	ITK		Lymphoproliferative syndrome 1	VCV002201280	5	156672732	5	157245722	2201280	1924817		NC_000005.10:157245721:C:T	single nucleotide variant	intron variant	Likely benign	Nov 11, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1455C>T (p.Ala485=)	ITK		Autoinflammatory syndrome|not provided|Lymphoproliferative syndrome 1	VCV000352474	5	156672741	5	157245731	352474	302632	rs201568204	NC_000005.10:157245730:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Oct 1, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.1479C>T (p.Asn493=)	ITK		Lymphoproliferative syndrome 1	VCV001537558	5	156672765	5	157245755	1537558	1649837	rs199517255	NC_000005.10:157245754:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 2, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1492G>T (p.Val498Leu)	ITK	V498L	Lymphoproliferative syndrome 1	VCV000473141	5	156672778	5	157245768	473141	454785	rs758820629	NC_000005.10:157245767:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1510A>T (p.Thr504Ser)	ITK	T504S	not provided|Lymphoproliferative syndrome 1	VCV000540355	5	156672796	5	157245786	540355	521467	rs151046132	NC_000005.10:157245785:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 18, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.1514+11G>C	ITK		Lymphoproliferative syndrome 1	VCV001570073	5	156672811	5	157245801	1570073	1623389	rs755534838	NC_000005.10:157245800:G:C	single nucleotide variant	intron variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1514+13T>A	ITK		Lymphoproliferative syndrome 1	VCV002746557	5	156672813	5	157245803	2746557	2897432		NC_000005.10:157245802:T:A	single nucleotide variant	intron variant	Likely benign	Aug 23, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1514+17G>T	ITK		Lymphoproliferative syndrome 1	VCV001111229	5	156672817	5	157245807	1111229	1094161	rs537175316	NC_000005.10:157245806:G:T	single nucleotide variant	intron variant	Likely benign	Dec 2, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1515-18C>T	ITK		Lymphoproliferative syndrome 1	VCV002766067	5	156672873	5	157245863	2766067	2931973		NC_000005.10:157245862:C:T	single nucleotide variant	intron variant	Likely benign	Oct 5, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1515-11T>C	ITK		Lymphoproliferative syndrome 1	VCV001961823	5	156672880	5	157245870	1961823	2016792		NC_000005.10:157245869:T:C	single nucleotide variant	intron variant	Likely benign	Jan 24, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1515-10C>T	ITK		Lymphoproliferative syndrome 1	VCV001979045	5	156672881	5	157245871	1979045	2038222		NC_000005.10:157245870:C:T	single nucleotide variant	intron variant	Likely benign	Feb 19, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1515-8C>G	ITK		Lymphoproliferative syndrome 1	VCV001665027	5	156672883	5	157245873	1665027	1620896	rs2113775972	NC_000005.10:157245872:C:G	single nucleotide variant	intron variant	Likely benign	Jan 9, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1518C>T (p.Phe506=)	ITK		not provided|Lymphoproliferative syndrome 1	VCV001136344	5	156672894	5	157245884	1136344	1115690	rs755630347	NC_000005.10:157245883:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1518C>G (p.Phe506Leu)	ITK	F506L	Lymphoproliferative syndrome 1	VCV000840402	5	156672894	5	157245884	840402	830574	rs755630347	NC_000005.10:157245883:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2019	criteria provided, single submitter							
NM_005546.4(ITK):c.1524G>C (p.Leu508=)	ITK		Lymphoproliferative syndrome 1	VCV001574316	5	156672900	5	157245890	1574316	1659501	rs1416245185	NC_000005.10:157245889:G:C	single nucleotide variant	synonymous variant	Likely benign	Jul 27, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1529A>T (p.Asp510Val)	ITK	D510V	Lymphoproliferative syndrome 1	VCV002057893	5	156672905	5	157245895	2057893	2113180		NC_000005.10:157245894:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1530T>C (p.Asp510=)	ITK		Lymphoproliferative syndrome 1	VCV002054451	5	156672906	5	157245896	2054451	2112333		NC_000005.10:157245895:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 12, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1533G>A (p.Gln511=)	ITK		Lymphoproliferative syndrome 1	VCV001930746	5	156672909	5	157245899	1930746	1988341		NC_000005.10:157245898:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1544C>A (p.Ser515Tyr)	ITK	S515Y	Inborn genetic diseases	VCV003111651	5	156672920	5	157245910	3111651	3268326		NC_000005.10:157245909:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1548A>T (p.Thr516=)	ITK		Lymphoproliferative syndrome 1	VCV001082558	5	156672924	5	157245914	1082558	1072569	rs769884280	NC_000005.10:157245913:A:T	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1550G>A (p.Gly517Asp)	ITK	G517D	Lymphoproliferative syndrome 1	VCV001339017	5	156672926	5	157245916	1339017	1330060	rs2113776005	NC_000005.10:157245915:G:A	single nucleotide variant	missense variant	Uncertain significance		criteria provided, single submitter							
NM_005546.4(ITK):c.1554C>T (p.Thr518=)	ITK		Lymphoproliferative syndrome 1	VCV002827840	5	156672930	5	157245920	2827840	2979951		NC_000005.10:157245919:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 12, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1558T>C (p.Phe520Leu)	ITK	F520L	not specified	VCV002443151	5	156672934	5	157245924	2443151	2416871		NC_000005.10:157245923:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2022	no assertion criteria provided							
NM_005546.4(ITK):c.1562C>T (p.Pro521Leu)	ITK	P521L	Lymphoproliferative syndrome 1	VCV001481575	5	156672938	5	157245928	1481575	1367093	rs759932471	NC_000005.10:157245927:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1563G>A (p.Pro521=)	ITK		Lymphoproliferative syndrome 1	VCV000905681	5	156672939	5	157245929	905681	893715	rs767821181	NC_000005.10:157245928:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 10, 2023	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.1573G>A (p.Ala525Thr)	ITK	A525T	not provided|Lymphoproliferative syndrome 1	VCV001029978	5	156672949	5	157245939	1029978	1016526	rs753217800	NC_000005.10:157245938:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1576T>C (p.Ser526Pro)	ITK	S526P	Lymphoproliferative syndrome 1	VCV001900833	5	156672952	5	157245942	1900833	1963663		NC_000005.10:157245941:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1577C>A (p.Ser526Tyr)	ITK	S526Y	Lymphoproliferative syndrome 1	VCV000950029	5	156672953	5	157245943	950029	923967	rs756611419	NC_000005.10:157245942:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2019	criteria provided, single submitter							
NM_005546.4(ITK):c.1588T>G (p.Phe530Val)	ITK	F530V	Lymphoproliferative syndrome 1|Autoinflammatory syndrome	VCV001502856	5	156672964	5	157245954	1502856	1404449	rs2113776036	NC_000005.10:157245953:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1590C>T (p.Phe530=)	ITK		Lymphoproliferative syndrome 1	VCV001112059	5	156672966	5	157245956	1112059	1094162	rs753357815	NC_000005.10:157245955:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 19, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1596C>T (p.Phe532=)	ITK		Lymphoproliferative syndrome 1	VCV001119342	5	156672972	5	157245962	1119342	1094163	rs778532127	NC_000005.10:157245961:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1601G>A (p.Arg534His)	ITK	R534H	Lymphoproliferative syndrome 1|not specified	VCV000649542	5	156672977	5	157245967	649542	633682	rs745561238	NC_000005.10:157245966:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1617C>T (p.Ser539=)	ITK		Lymphoproliferative syndrome 1	VCV001159928	5	156672993	5	157245983	1159928	1136695	rs771875150	NC_000005.10:157245982:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 12, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1618G>A (p.Asp540Asn)	ITK	D540N	Lymphoproliferative syndrome 1	VCV001061376	5	156672994	5	157245984	1061376	1043466	rs886713435	NC_000005.10:157245983:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2020	criteria provided, single submitter							
NM_005546.4(ITK):c.1633+14T>C	ITK		Lymphoproliferative syndrome 1	VCV001656161	5	156673023	5	157246013	1656161	1529408	rs1755013722	NC_000005.10:157246012:T:C	single nucleotide variant	intron variant	Likely benign	Nov 28, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1633+216T>C	ITK		not provided	VCV001231109	5	156673225	5	157246215	1231109	1221071	rs25776	NC_000005.10:157246214:T:C	single nucleotide variant	intron variant	Benign	Nov 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.1634-20G>A	ITK		Lymphoproliferative syndrome 1	VCV001591220	5	156675840	5	157248830	1591220	1608813	rs376886440	NC_000005.10:157248829:G:A	single nucleotide variant	intron variant	Likely benign	Oct 9, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1634-17C>T	ITK		Lymphoproliferative syndrome 1	VCV001112806	5	156675843	5	157248833	1112806	1094164	rs192786276	NC_000005.10:157248832:C:T	single nucleotide variant	intron variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1634-16T>C	ITK		Lymphoproliferative syndrome 1	VCV001545783	5	156675844	5	157248834	1545783	1612455	rs199877199	NC_000005.10:157248833:T:C	single nucleotide variant	intron variant	Benign	Jan 25, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1634-5T>C	ITK		Lymphoproliferative syndrome 1	VCV001086160	5	156675855	5	157248845	1086160	1072570	rs754408834	NC_000005.10:157248844:T:C	single nucleotide variant	intron variant	Likely benign	Mar 14, 2019	criteria provided, single submitter							
NM_005546.4(ITK):c.1651G>C (p.Val551Leu)	ITK	V551L	Inborn genetic diseases	VCV003286944	5	156675877	5	157248867	3286944	3451815		NC_000005.10:157248866:G:C	single nucleotide variant	missense variant	Uncertain significance	May 26, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1658G>A (p.Ser553Asn)	ITK	S553N	Lymphoproliferative syndrome 1	VCV000576436	5	156675884	5	157248874	576436	563009	rs1561666191	NC_000005.10:157248873:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1664del (p.Gly555fs)	ITK	G555fs	Lymphoproliferative syndrome 1	VCV002109769	5	156675889	5	157248879	2109769	2163644		NC_000005.10:157248878:GG:G	Deletion	frameshift variant	Pathogenic	Mar 27, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1665C>T (p.Gly555=)	ITK		Lymphoproliferative syndrome 1|not provided	VCV001057049	5	156675891	5	157248881	1057049	1043467	rs374778457	NC_000005.10:157248880:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1673C>T (p.Pro558Leu)	ITK	P558L	Lymphoproliferative syndrome 1	VCV002101229	5	156675899	5	157248889	2101229	2151249		NC_000005.10:157248888:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1674G>A (p.Pro558=)	ITK		Inborn genetic diseases|Lymphoproliferative syndrome 1	VCV001108239	5	156675900	5	157248890	1108239	1094165	rs199593468	NC_000005.10:157248889:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1674G>C (p.Pro558=)	ITK		Lymphoproliferative syndrome 1	VCV001092293	5	156675900	5	157248890	1092293	1072571	rs199593468	NC_000005.10:157248889:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 16, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1684C>T (p.Arg562Ter)	ITK	R562*	not provided	VCV000871619	5	156675910	5	157248900	871619	859408	rs1207540324	NC_000005.10:157248899:C:T	single nucleotide variant	nonsense	Pathogenic	Apr 1, 2019	criteria provided, single submitter							
NM_005546.4(ITK):c.1685G>A (p.Arg562Gln)	ITK	R562Q	Lymphoproliferative syndrome 1	VCV000578820	5	156675911	5	157248901	578820	560352	rs142618425	NC_000005.10:157248900:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1686A>G (p.Arg562=)	ITK		Lymphoproliferative syndrome 1	VCV002069884	5	156675912	5	157248902	2069884	2126107		NC_000005.10:157248901:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 24, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1695A>C (p.Ser565=)	ITK		Lymphoproliferative syndrome 1	VCV002976837	5	156675921	5	157248911	2976837	3130737		NC_000005.10:157248910:A:C	single nucleotide variant	synonymous variant	Likely benign	Jan 18, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1704G>A (p.Val568=)	ITK		Lymphoproliferative syndrome 1	VCV001940377	5	156675930	5	157248920	1940377	1994515		NC_000005.10:157248919:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 28, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1705G>A (p.Glu569Lys)	ITK	E569K	Lymphoproliferative syndrome 1	VCV001944609	5	156675931	5	157248921	1944609	2002178		NC_000005.10:157248920:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1709A>G (p.Asp570Gly)	ITK	D570G	Lymphoproliferative syndrome 1	VCV001044993	5	156675935	5	157248925	1044993	1026498	rs962121468	NC_000005.10:157248924:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1710C>T (p.Asp570=)	ITK		Lymphoproliferative syndrome 1	VCV001634495	5	156675936	5	157248926	1634495	1546448	rs774326746	NC_000005.10:157248925:C:T	single nucleotide variant	synonymous variant	Likely benign	May 17, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1711A>G (p.Ile571Val)	ITK	I571V	Lymphoproliferative syndrome 1|Inborn genetic diseases	VCV000352475	5	156675937	5	157248927	352475	302643	rs144950783	NC_000005.10:157248926:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1713C>A (p.Ile571=)	ITK		Lymphoproliferative syndrome 1	VCV001585595	5	156675939	5	157248929	1585595	1540111	rs1245139906	NC_000005.10:157248928:C:A	single nucleotide variant	synonymous variant	Likely benign	Apr 27, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1715G>A (p.Ser572Asn)	ITK	S572N	Lymphoproliferative syndrome 1|Inborn genetic diseases	VCV000473142	5	156675941	5	157248931	473142	454786	rs140542010	NC_000005.10:157248930:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1716T>C (p.Ser572=)	ITK		Lymphoproliferative syndrome 1	VCV000799642	5	156675942	5	157248932	799642	782234	rs567958718	NC_000005.10:157248931:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1719C>T (p.Thr573=)	ITK		Lymphoproliferative syndrome 1	VCV001625691	5	156675945	5	157248935	1625691	1607251	rs764500906	NC_000005.10:157248934:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 12, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1729T>C (p.Leu577=)	ITK		Lymphoproliferative syndrome 1	VCV003001107	5	156675955	5	157248945	3001107	3167860		NC_000005.10:157248944:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1730T>G (p.Leu577Trp)	ITK	L577W	not specified	VCV002443153	5	156675956	5	157248946	2443153	2416873		NC_000005.10:157248945:T:G	single nucleotide variant	missense variant	Uncertain significance	May 23, 2022	no assertion criteria provided							
NM_005546.4(ITK):c.1732T>C (p.Tyr578His)	ITK	Y578H	Lymphoproliferative syndrome 1	VCV001481220	5	156675958	5	157248948	1481220	1451658	rs1755077462	NC_000005.10:157248947:T:C	single nucleotide variant	missense variant	Uncertain significance	May 28, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1733A>G (p.Tyr578Cys)	ITK	Y578C	Lymphoproliferative syndrome 1	VCV001944037	5	156675959	5	157248949	1944037	2005475		NC_000005.10:157248948:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1736A>G (p.Lys579Arg)	ITK	K579R	Lymphoproliferative syndrome 1	VCV001499362	5	156675962	5	157248952	1499362	1389065	rs764684422	NC_000005.10:157248951:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1738C>T (p.Pro580Ser)	ITK	P580S	Lymphoproliferative syndrome 1	VCV001500935	5	156675964	5	157248954	1500935	1501857	rs1462558122	NC_000005.10:157248953:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1741C>G (p.Arg581Gly)	ITK	R581G	Lymphoproliferative syndrome 1	VCV001922688	5	156675967	5	157248957	1922688	1972528		NC_000005.10:157248956:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1741C>A (p.Arg581=)	ITK		Lymphoproliferative syndrome 1	VCV001532451	5	156675967	5	157248957	1532451	1636062	rs34482255	NC_000005.10:157248956:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1741C>T (p.Arg581Trp)	ITK	R581W	Autoinflammatory syndrome|not provided|Lymphoproliferative syndrome 1	VCV000352476	5	156675967	5	157248957	352476	296655	rs34482255	NC_000005.10:157248956:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 16, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.1742G>A (p.Arg581Gln)	ITK	R581Q	Lymphoproliferative syndrome 1	VCV000846840	5	156675968	5	157248958	846840	830575	rs548875154	NC_000005.10:157248957:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1748C>T (p.Ala583Val)	ITK	A583V	Lymphoproliferative syndrome 1|Inborn genetic diseases	VCV001514994	5	156675974	5	157248964	1514994	1482183	rs200077959	NC_000005.10:157248963:C:T	single nucleotide variant	missense variant	Uncertain significance	May 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1758C>T (p.His586=)	ITK		Lymphoproliferative syndrome 1	VCV002083923	5	156675984	5	157248974	2083923	2136582		NC_000005.10:157248973:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1759G>A (p.Val587Ile)	ITK	V587I	not provided|Autoinflammatory syndrome|Lymphoproliferative syndrome 1|not specified	VCV000522219	5	156675985	5	157248975	522219	512816	rs56005928	NC_000005.10:157248974:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1762T>C (p.Tyr588His)	ITK	Y588H	Lymphoproliferative syndrome 1	VCV000906196	5	156675988	5	157248978	906196	893716	rs370632752	NC_000005.10:157248977:T:C	single nucleotide variant	missense variant	Uncertain significance	May 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1764C>G (p.Tyr588Ter)	ITK	Y588*	Lymphoproliferative syndrome 1	VCV000064371	5	156675990	5	157248980	64371	75336	rs397514260	NC_000005.10:157248979:C:G	single nucleotide variant	nonsense	Pathogenic	May 1, 2012	no assertion criteria provided							
NM_005546.4(ITK):c.1768A>C (p.Ile590Leu)	ITK	I590L	Lymphoproliferative syndrome 1	VCV002783262	5	156675994	5	157248984	2783262	2947861		NC_000005.10:157248983:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1770T>G (p.Ile590Met)	ITK	I590M	Lymphoproliferative syndrome 1	VCV000949954	5	156675996	5	157248986	949954	923968	rs1755079116	NC_000005.10:157248985:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2019	criteria provided, single submitter							
NM_005546.4(ITK):c.1791+5G>A	ITK		Lymphoproliferative syndrome 1	VCV000644968	5	156676022	5	157249012	644968	651405	rs1288043073	NC_000005.10:157249011:G:A	single nucleotide variant	intron variant	Uncertain significance	Dec 22, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.1791+9A>G	ITK		Lymphoproliferative syndrome 1	VCV002787023	5	156676026	5	157249016	2787023	2949027		NC_000005.10:157249015:A:G	single nucleotide variant	intron variant	Likely benign	Aug 5, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1791+11G>A	ITK		Lymphoproliferative syndrome 1	VCV002202581	5	156676028	5	157249018	2202581	1928231		NC_000005.10:157249017:G:A	single nucleotide variant	intron variant	Likely benign	Aug 12, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1791+18T>C	ITK		Lymphoproliferative syndrome 1	VCV001581750	5	156676035	5	157249025	1581750	1600309	rs772259664	NC_000005.10:157249024:T:C	single nucleotide variant	intron variant	Likely benign	Dec 10, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1792-194G>A	ITK		not provided	VCV001294789	5	156679423	5	157252413	1294789	1284585	rs12055362	NC_000005.10:157252412:G:A	single nucleotide variant	intron variant	Benign	May 12, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1792-41T>C	ITK		not specified|not provided	VCV001238669	5	156679576	5	157252566	1238669	1227797	rs27341	NC_000005.10:157252565:T:C	single nucleotide variant	intron variant	Benign	Nov 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1792-17C>T	ITK		Lymphoproliferative syndrome 1	VCV001553713	5	156679600	5	157252590	1553713	1521893	rs1580913933	NC_000005.10:157252589:C:T	single nucleotide variant	intron variant	Likely benign	Oct 9, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1792-6C>T	ITK		Lymphoproliferative syndrome 1	VCV002031526	5	156679611	5	157252601	2031526	2089431		NC_000005.10:157252600:C:T	single nucleotide variant	intron variant	Likely benign	Dec 21, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1792-4C>T	ITK		Autoinflammatory syndrome|Lymphoproliferative syndrome 1	VCV000732883	5	156679613	5	157252603	732883	744211	rs201859710	NC_000005.10:157252602:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications							
NM_005546.4(ITK):c.1792-3C>T	ITK		Lymphoproliferative syndrome 1	VCV000906197	5	156679614	5	157252604	906197	896072	rs1198022484	NC_000005.10:157252603:C:T	single nucleotide variant	intron variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.1803T>C (p.Asp601=)	ITK		Lymphoproliferative syndrome 1	VCV000786790	5	156679628	5	157252618	786790	709784	rs1324881143	NC_000005.10:157252617:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 17, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1804C>A (p.Arg602=)	ITK		Lymphoproliferative syndrome 1	VCV002000826	5	156679629	5	157252619	2000826	2061330		NC_000005.10:157252618:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 20, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1805G>T (p.Arg602Leu)	ITK	R602L	Lymphoproliferative syndrome 1	VCV002194061	5	156679630	5	157252620	2194061	1926262		NC_000005.10:157252619:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1805G>A (p.Arg602Gln)	ITK	R602Q	Lymphoproliferative syndrome 1	VCV001003141	5	156679630	5	157252620	1003141	990828	rs748509752	NC_000005.10:157252619:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.1806G>A (p.Arg602=)	ITK		Lymphoproliferative syndrome 1	VCV000756821	5	156679631	5	157252621	756821	764994	rs374724747	NC_000005.10:157252620:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1828C>T (p.Arg610Cys)	ITK	R610C	Lymphoproliferative syndrome 1|not provided	VCV000665754	5	156679653	5	157252643	665754	633683	rs763559802	NC_000005.10:157252642:C:T	single nucleotide variant	missense variant	Likely benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.1829G>A (p.Arg610His)	ITK	R610H	Lymphoproliferative syndrome 1	VCV000540359	5	156679654	5	157252644	540359	520963	rs138438785	NC_000005.10:157252643:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1830T>A (p.Arg610=)	ITK		Lymphoproliferative syndrome 1	VCV002042555	5	156679655	5	157252645	2042555	2099147		NC_000005.10:157252644:T:A	single nucleotide variant	synonymous variant	Likely benign	Nov 28, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1834C>A (p.Leu612Met)	ITK	L612M	Inborn genetic diseases	VCV003530783	5	156679659	5	157252649	3530783	3687203		NC_000005.10:157252648:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2024	criteria provided, single submitter							
NM_005546.4(ITK):c.1846G>T (p.Ala616Ser)	ITK	A616S	Lymphoproliferative syndrome 1	VCV002073773	5	156679671	5	157252661	2073773	2120423		NC_000005.10:157252660:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1850A>C (p.Glu617Ala)	ITK	E617A	Lymphoproliferative syndrome 1	VCV002849202	5	156679675	5	157252665	2849202	3012846		NC_000005.10:157252664:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2023	criteria provided, single submitter							
NM_005546.4(ITK):c.1861T>C (p.Ter621Gln)	ITK		Lymphoproliferative syndrome 1	VCV000939402	5	156679686	5	157252676	939402	932815	rs148858888	NC_000005.10:157252675:T:C	single nucleotide variant	stop lost	Uncertain significance	Sep 5, 2022	criteria provided, single submitter							
NM_005546.4(ITK):c.1863G>A (p.Ter621=)	ITK		Lymphoproliferative syndrome 1	VCV001581415	5	156679688	5	157252678	1581415	1534515	rs1293534046	NC_000005.10:157252677:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 10, 2021	criteria provided, single submitter							
NM_005546.4(ITK):c.*9G>A	ITK		Lymphoproliferative syndrome 1	VCV000352477	5	156679697	5	157252687	352477	302648	rs369078550	NC_000005.10:157252686:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*72A>G	ITK		Lymphoproliferative syndrome 1	VCV000906198	5	156679760	5	157252750	906198	893717	rs1755168498	NC_000005.10:157252749:A:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*85A>C	ITK		Lymphoproliferative syndrome 1	VCV000352478	5	156679773	5	157252763	352478	302928	rs143715615	NC_000005.10:157252762:A:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*140C>T	ITK		Lymphoproliferative syndrome 1	VCV000352479	5	156679828	5	157252818	352479	296657	rs536343015	NC_000005.10:157252817:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*153A>C	ITK		Lymphoproliferative syndrome 1	VCV000352480	5	156679841	5	157252831	352480	298499	rs2229736	NC_000005.10:157252830:A:C	single nucleotide variant	3 prime UTR variant	Benign	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*210G>A	ITK		Lymphoproliferative syndrome 1	VCV000906199	5	156679898	5	157252888	906199	893718	rs191930507	NC_000005.10:157252887:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*214A>C	ITK		Lymphoproliferative syndrome 1	VCV000907188	5	156679902	5	157252892	907188	893719	rs1755171843	NC_000005.10:157252891:A:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*232G>A	ITK		Lymphoproliferative syndrome 1	VCV000907189	5	156679920	5	157252910	907189	893720	rs1223249224	NC_000005.10:157252909:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*386G>A	ITK		Lymphoproliferative syndrome 1	VCV000352481	5	156680074	5	157253064	352481	302929	rs75760314	NC_000005.10:157253063:G:A	single nucleotide variant	3 prime UTR variant	Benign	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*486G>T	ITK		Lymphoproliferative syndrome 1	VCV000352482	5	156680174	5	157253164	352482	298500	rs116624314	NC_000005.10:157253163:G:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*492T>C	ITK		Lymphoproliferative syndrome 1	VCV000907190	5	156680180	5	157253170	907190	893721	rs140503678	NC_000005.10:157253169:T:C	single nucleotide variant	3 prime UTR variant	Likely benign	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*553C>T	ITK		Lymphoproliferative syndrome 1	VCV000907191	5	156680241	5	157253231	907191	893722	rs893121882	NC_000005.10:157253230:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*554G>A	ITK		Lymphoproliferative syndrome 1	VCV000907192	5	156680242	5	157253232	907192	893723	rs777364959	NC_000005.10:157253231:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*664G>A	ITK		Lymphoproliferative syndrome 1	VCV000352483	5	156680352	5	157253342	352483	302649	rs886060328	NC_000005.10:157253341:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*672T>C	ITK		Lymphoproliferative syndrome 1	VCV000903850	5	156680360	5	157253350	903850	893724	rs142807619	NC_000005.10:157253349:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*706G>C	ITK		Lymphoproliferative syndrome 1	VCV000352484	5	156680394	5	157253384	352484	302942	rs886060329	NC_000005.10:157253383:G:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*804T>C	ITK|LOC129995117		Lymphoproliferative syndrome 1	VCV000352485	5	156680492	5	157253482	352485	296662	rs139794260	NC_000005.10:157253481:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*873C>T	ITK		Lymphoproliferative syndrome 1	VCV000903851	5	156680561	5	157253551	903851	893725	rs1439729137	NC_000005.10:157253550:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*941C>T	ITK		Lymphoproliferative syndrome 1	VCV000903852	5	156680629	5	157253619	903852	893726	rs3892245	NC_000005.10:157253618:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Apr 27, 2017	criteria provided, single submitter							
NM_005546.4(ITK):c.*941C>A	ITK		Lymphoproliferative syndrome 1	VCV000352486	5	156680629	5	157253619	352486	302661	rs3892245	NC_000005.10:157253618:C:A	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*944C>T	ITK		Lymphoproliferative syndrome 1	VCV000903853	5	156680632	5	157253622	903853	893727	rs370820165	NC_000005.10:157253621:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*980C>T	ITK		Lymphoproliferative syndrome 1|not provided	VCV000352487	5	156680668	5	157253658	352487	298507	rs79112977	NC_000005.10:157253657:C:T	single nucleotide variant	3 prime UTR variant	Likely benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_005546.4(ITK):c.*997A>G	ITK		Lymphoproliferative syndrome 1	VCV000352488	5	156680685	5	157253675	352488	296664	rs27988	NC_000005.10:157253674:A:G	single nucleotide variant	3 prime UTR variant	Benign	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1083A>G	ITK		Lymphoproliferative syndrome 1	VCV000905744	5	156680771	5	157253761	905744	893728	rs577431641	NC_000005.10:157253760:A:G	single nucleotide variant	3 prime UTR variant	Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1132A>T	ITK		Lymphoproliferative syndrome 1	VCV000905745	5	156680820	5	157253810	905745	893729	rs771492029	NC_000005.10:157253809:A:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Apr 27, 2017	criteria provided, single submitter							
NM_005546.4(ITK):c.*1152G>T	ITK		Lymphoproliferative syndrome 1	VCV000905746	5	156680840	5	157253830	905746	893730	rs1755198244	NC_000005.10:157253829:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1154T>A	ITK		Lymphoproliferative syndrome 1	VCV000352489	5	156680842	5	157253832	352489	298515	rs886060330	NC_000005.10:157253831:T:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1171G>C	ITK		Lymphoproliferative syndrome 1	VCV000352490	5	156680859	5	157253849	352490	296669	rs886060331	NC_000005.10:157253848:G:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1177A>G	ITK		Lymphoproliferative syndrome 1	VCV000905747	5	156680865	5	157253855	905747	893731	rs777088703	NC_000005.10:157253854:A:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1188A>G	ITK		Lymphoproliferative syndrome 1	VCV000352491	5	156680876	5	157253866	352491	296672	rs17054397	NC_000005.10:157253865:A:G	single nucleotide variant	3 prime UTR variant	Benign	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1208G>T	ITK		Lymphoproliferative syndrome 1	VCV000352492	5	156680896	5	157253886	352492	298517	rs115086689	NC_000005.10:157253885:G:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1252A>G	ITK		Lymphoproliferative syndrome 1	VCV000906258	5	156680940	5	157253930	906258	893732	rs761944107	NC_000005.10:157253929:A:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1255C>T	ITK		Lymphoproliferative syndrome 1	VCV000906259	5	156680943	5	157253933	906259	893733	rs575345566	NC_000005.10:157253932:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1350G>A	ITK		Lymphoproliferative syndrome 1	VCV000352493	5	156681038	5	157254028	352493	302668	rs543185318	NC_000005.10:157254027:G:A	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1361G>A	ITK		Lymphoproliferative syndrome 1	VCV000352494	5	156681049	5	157254039	352494	298519	rs79627475	NC_000005.10:157254038:G:A	single nucleotide variant	3 prime UTR variant	Benign	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1398G>A	ITK		Lymphoproliferative syndrome 1	VCV000352495	5	156681086	5	157254076	352495	302955	rs188565647	NC_000005.10:157254075:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1490G>A	ITK		Lymphoproliferative syndrome 1	VCV000906260	5	156681178	5	157254168	906260	893734	rs145699363	NC_000005.10:157254167:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1619G>A	ITK		Lymphoproliferative syndrome 1	VCV000907256	5	156681307	5	157254297	907256	893735	rs139530015	NC_000005.10:157254296:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1682G>T	ITK		Lymphoproliferative disorder	VCV000352496	5	156681370	5	157254360	352496	298531	rs538864150	NC_000005.10:157254359:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_005546.4(ITK):c.*1755T>C	ITK		Lymphoproliferative syndrome 1	VCV000352497	5	156681443	5	157254433	352497	302964	rs886060332	NC_000005.10:157254432:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1761T>A	ITK		Lymphoproliferative syndrome 1	VCV000352498	5	156681449	5	157254439	352498	298534	rs886060333	NC_000005.10:157254438:T:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1767C>A	ITK		Lymphoproliferative syndrome 1	VCV000352499	5	156681455	5	157254445	352499	298535	rs184917807	NC_000005.10:157254444:C:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1859C>T	ITK		Lymphoproliferative syndrome 1	VCV000907257	5	156681547	5	157254537	907257	893736	rs780591680	NC_000005.10:157254536:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1866C>T	ITK		Lymphoproliferative syndrome 1	VCV000352500	5	156681554	5	157254544	352500	296679	rs111629533	NC_000005.10:157254543:C:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1928G>A	ITK		Lymphoproliferative syndrome 1	VCV000352501	5	156681616	5	157254606	352501	296680	rs886060334	NC_000005.10:157254605:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1943T>C	ITK		Lymphoproliferative syndrome 1	VCV000907258	5	156681631	5	157254621	907258	893737	rs191436930	NC_000005.10:157254620:T:C	single nucleotide variant	3 prime UTR variant	Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*1945T>C	ITK		Lymphoproliferative syndrome 1	VCV000903910	5	156681633	5	157254623	903910	893738	rs184752617	NC_000005.10:157254622:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_005546.4(ITK):c.*2191C>T	ITK		Lymphoproliferative syndrome 1	VCV000352502	5	156681879	5	157254869	352502	302671	rs886060335	NC_000005.10:157254868:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
GRCh37/hg19 5q33.2-33.3(chr5:154530177-157354086)x1	ADAM19|C5orf52|CLINT1|CYFIP2|FNDC9|GARIN3|HAVCR1|HAVCR2|ITK|LSM11|MED7|NIPAL4|SGCD|SOX30|THG1L|TIMD4		not provided	VCV003392331	5	154530177 - 157354086			3392331	3551411			copy number loss		Uncertain significance	Jan 4, 2024	criteria provided, single submitter							
NC_000005.9:g.(?_155338082)_(156899968_?)dup	CYFIP2|FNDC9|GARIN3|HAVCR1|HAVCR2|ITK|MED7|NIPAL4|SGCD|TIMD4		Lymphoproliferative syndrome 1	VCV002425365	5	155338082 - 156899968			2425365	1943090			Duplication		Uncertain significance	Jan 28, 2022	criteria provided, single submitter							
NC_000005.9:g.(?_155338082)_(156899968_?)del	CYFIP2|FNDC9|GARIN3|HAVCR1|HAVCR2|ITK|MED7|NIPAL4|SGCD|TIMD4		Lymphoproliferative syndrome 1	VCV002425364	5	155338082 - 156899968			2425364	1943089			Deletion		Pathogenic	Mar 6, 2022	criteria provided, single submitter							
GRCh37/hg19 5q33.1-35.2(chr5:150535183-172906793)x3	ADAM19|ADRA1B|ANXA6|ATOX1|ATP10B|ATP6V0E1|BNIP1|C1QTNF2|C5orf52|C5orf58|CCDC69|CCNG1|CCNJL|CLINT1|CNOT8|CREBRF|CYFIP2|DOCK2|DUSP1|EBF1|EFCAB9|ERGIC1|FABP6|FAM114A2|FAM200C|FAT2|FAXDC2|FBXW11|FGF18|FNDC9|FOXI1|G3BP1|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GALNT10|GARIN3|GEMIN5|GLRA1|GM2A|GRIA1|HAND1|HAVCR1|HAVCR2|HMMR|IL12B|INSYN2B|ITK|KCNIP1|KCNMB1|KIF4B|LARP1|LCP2|LOC100128059|LOC100288254|LSM11|MAT2B|MED7|MFAP3|MIR103A1|MIR146A|MRPL22|NEURL1B|NIPAL4|NKX2-5|NMUR2|NPM1|NUDCD2|PANK3|PTTG1|PWWP2A|RANBP17|RARS1|RNF145|RPL26L1|SAP30L|SGCD|SH3PXD2B|SLC36A1|SLC36A2|SLC36A3|SLIT3|SLU7|SMIM23|SNORA74B|SOX30|SPARC|SPDL1|STC2|STK10|TENM2|THG1L|TIMD4|TLX3|TTC1|UBLCP1|UBTD2|WWC1		not provided	VCV001808662	5	150535183 - 172906793			1808662	1865666			copy number gain		Pathogenic	May 16, 2022	criteria provided, single submitter							
GRCh37/hg19 5q33.3(chr5:156486127-156930814)x3	ADAM19|CYFIP2|FNDC9|GARIN3|HAVCR2|ITK|MED7|NIPAL4		not provided	VCV001807669	5	156486127 - 156930814			1807669	1864673			copy number gain		Uncertain significance	Jan 4, 2022	criteria provided, single submitter							
GRCh37/hg19 5q32-35.3(chr5:149010383-180719789)	LTC4S|MIR103A1|MIR146A|MGAT1|MGAT4B|MIR378A|MRNIP|MRPL22|MSX2|MAPK9|MAT2B|MED7|MFAP3|MAML1|ADAM19|ADAMTS2|ADRA1B|ANXA6|ARHGEF37|ARL10|ARSI|ATOX1|ATP10B|ATP6V0E1|B4GALT7|BNIP1|BOD1|BTNL3|BTNL8|BTNL9|C1QTNF2|C5orf47|C5orf52|C5orf58|CAMK2A|CANX|CBY3|CCDC69|CCNG1|CCNJL|CD74|CDHR2|CDX1|CLINT1|CLK4|CLTB|CNOT6|CNOT8|COL23A1|CPEB4|CPLX2|CREBRF|CSF1R|CYFIP2|DBN1|DCTN4|DDX41|DOCK2|DOK3|DRD1|DUSP1|EBF1|EFCAB9|EIF4E1B|ERGIC1|F12|FABP6|FAF2|FAM114A2|FAM153A|FAM153B|FAM193B|FAM200C|FAT2|FAXDC2|FBXW11|FGF18|FGFR4|FLT4|FNDC9|FOXI1|G3BP1|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GALNT10|GARIN3|GEMIN5|GFPT2|GLRA1|GM2A|GPRIN1|GPX3|GRIA1|GRK6|GRM6|HAND1|HAVCR1|HAVCR2|HIGD2A|HK3|HMGXB3|HMMR|HNRNPAB|HNRNPH1|HRH2|IL12B|INSYN2B|IRGM|ITK|KCNIP1|KCNMB1|KIAA1191|KIF4B|LARP1|LCP2|LMAN2|LOC100128059|LOC100288254|LSM11|MXD3|MYOZ3|N4BP3|NDST1|NEURL1B|NHP2|NIPAL4|NKX2-5|NMUR2|NOP16|NPM1|NSD1|NUDCD2|OR2V1|OR2V2|OR2Y1|PANK3|PDE6A|PDGFRB|PDLIM7|PFN3|PHYKPL|PPARGC1B|PRELID1|PROP1|PRR7|PTTG1|PWWP2A|RAB24|RACK1|RANBP17|RARS1|RASGEF1C|RBM22|RGS14|RMND5B|RNF130|RNF145|RNF44|RPL26L1|RPS14|RUFY1|SAP30L|SCGB3A1|SFXN1|SGCD|SH3PXD2B|SIMC1|SLC26A2|SLC34A1|SLC36A1|SLC36A2|SLC36A3|SLC6A7|SLIT3|SLU7|SMIM23|SMIM3|SNCB|SNORA74B|SOX30|SPARC|SPATA31J1|SPDL1|SQSTM1|STC2|STK10|SYNPO|TBC1D9B|TCOF1|TENM2|THG1L|THOC3|TIGD6|TIMD4|TLX3|TMED9|TNIP1|TRIM41|TRIM52|TRIM7|TRK-CTT2-3|TRP-TGG3-1|TRT-TGT6-1|TRV-AAC1-4|TRV-CAC1-2|TSPAN17|TTC1|UBLCP1|UBTD2|UIMC1|UNC5A|WWC1|ZFP2|ZFP62|ZNF300|ZNF346|ZNF354A|ZNF354B|ZNF354C|ZNF454|ZNF879		Hunter-McAlpine craniosynostosis	VCV001703528	5	149010383 - 180719789			1703528	1695919			copy number gain		Pathogenic		no assertion criteria provided							
NC_000005.9:g.(?_155935591)_(156899968_?)del	CYFIP2|FNDC9|GARIN3|HAVCR1|HAVCR2|ITK|MED7|NIPAL4|SGCD|TIMD4		not provided	VCV001481597	5	155935591 - 156899968			1481597	1367115			Deletion		Uncertain significance	Apr 10, 2021	criteria provided, single submitter							
NC_000005.9:g.(?_156659330)_(156667225_?)del	ITK		Lymphoproliferative syndrome 1	VCV001460222	5	156659330 - 156667225			1460222	1481578			Deletion		Pathogenic	Jun 27, 2021	criteria provided, single submitter							
GRCh37/hg19 5q33.3-34(chr5:155970607-162450579)x1	ADAM19|ADRA1B|ATP10B|C1QTNF2|C5orf52|CCNJL|CLINT1|CYFIP2|EBF1|FABP6|FAM200C|FNDC9|GABRA1|GABRA6|GABRB2|GABRG2|GARIN3|HAVCR1|HAVCR2|IL12B|ITK|LSM11|MED7|MIR146A|NIPAL4|PTTG1|PWWP2A|RNF145|SGCD|SLU7|SOX30|THG1L|TIMD4|TTC1|UBLCP1		not provided	VCV001339784	5	155970607 - 162450579			1339784	1330994			copy number loss		not provided		no classification provided							
GRCh37/hg19 5q33.3-35.1(chr5:156347980-169959880)x1	ADAM19|ADRA1B|ATP10B|C1QTNF2|C5orf52|C5orf58|CCNG1|CCNJL|CLINT1|CYFIP2|DOCK2|EBF1|FABP6|FAM200C|FNDC9|FOXI1|GABRA1|GABRA6|GABRB2|GABRG2|GARIN3|HAVCR1|HAVCR2|HMMR|IL12B|INSYN2B|ITK|KCNIP1|KCNMB1|LCP2|LOC100128059|LSM11|MAT2B|MED7|MIR103A1|MIR146A|NIPAL4|NUDCD2|PANK3|PTTG1|PWWP2A|RARS1|RNF145|SLIT3|SLU7|SOX30|SPDL1|TENM2|THG1L|TIMD4|TTC1|UBLCP1|WWC1		not provided	VCV000814756	5	156347980 - 169959880			814756	802966			copy number loss		Pathogenic	Jul 24, 2018	no assertion criteria provided							
GRCh37/hg19 5q33.3-35.1(chr5:156597181-171166353)x3	C5orf52|ADAM19|ADRA1B|ATP10B|C1QTNF2|C5orf58|CCNG1|CCNJL|CLINT1|CYFIP2|DOCK2|EBF1|FABP6|FAM200C|FGF18|FNDC9|FOXI1|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|HMMR|IL12B|INSYN2B|ITK|KCNIP1|KCNMB1|LCP2|LOC100128059|LSM11|MAT2B|MIR103A1|MIR146A|NIPAL4|NPM1|NUDCD2|PANK3|PTTG1|PWWP2A|RANBP17|RARS1|RNF145|SLIT3|SLU7|SOX30|SPDL1|TENM2|THG1L|TLX3|TTC1|UBLCP1|WWC1		not provided	VCV000684880	5	156597181 - 171166353			684880	672472			copy number gain		Pathogenic	Sep 20, 2017	no assertion criteria provided							
NC_000005.9:g.(?_156607793)_(156650044_?)dup	ITK		Lymphoproliferative syndrome 1	VCV000656285	5	156607793 - 156650044			656285	651435			Duplication		Uncertain significance	Sep 11, 2018	criteria provided, single submitter							
GRCh37/hg19 5p15.1-q35.2(chr5:17628741-176575720)x1	DHFR|DHX29|DIAPH1|DIMT1|DMGDH|DMXL1|DNAJC18|ABLIM3|ACOT12|ACSL6|ACTBL2|ADAM19|ADAMTS12|ADAMTS19|ADAMTS6|ADGRV1|ADRA1B|ADRB2|AFAP1L1|AFF4|AGGF1|AGXT2|ALDH7A1|AMACR|ANKDD1B|ANKHD1|ANKHD1-EIF4EBP3|ANKRA2|ANKRD31|ANKRD34B|ANKRD55|ANXA2R|ANXA6|AP3B1|AP3S1|APBB3|APC|ARAP3|ARB2A|ARHGAP26|ARHGEF28|ARHGEF37|ARL10|ARL14EPL|ARL15|ARRDC3|ARSB|ARSI|ARSK|ATG10|ATG12|ATOX1|ATP10B|ATP6AP1L|ATP6V0E1|BDP1|BHMT|BHMT2|BNIP1|BOD1|BRD8|BRIX1|BTF3|C1QTNF2|C1QTNF3|C5orf15|C5orf22|C5orf24|C5orf34|C5orf46|C5orf47|C5orf52|C5orf58|C5orf63|C6|C7|C9|CAMK2A|CAMK4|CAMLG|CAPSL|CARD6|CARTPT|CAST|CATSPER3|CCDC112|CCDC125|CCDC152|CCDC69|CCL28|CCNB1|CCNG1|CCNH|CCNI2|CCNJL|CCNO|CD14|CD180|CD74|CDC20B|CDC23|CDC25C|CDC42SE2|CDH10|CDH12|CDH18|CDH6|CDH9|CDHR2|CDK7|CDKL3|CDKN2AIPNL|CDO1|CDX1|CENPH|CENPK|CEP120|CERT1|CETN3|CHD1|CHSY3|CKMT2|CLINT1|CLTB|CMYA5|CNOT8|COMMD10|COX7C|CPEB4|CPLANE1|CPLX2|CREBRF|CRHBP|CSF1R|CSF2|CSNK1A1|CSNK1G3|CTNNA1|CTXN3|CWC27|CXCL14|CXXC5|CYFIP2|CYSTM1|DAB2|DCANP1|DCP2|DCTN4|DDX4|DDX46|DELE1|DEPDC1B|DNAJC21|DND1|DOCK2|DPYSL3|DRD1|DROSHA|DTWD2|DUSP1|EBF1|ECSCR|EDIL3|EFCAB9|EFNA5|EGFLAM|EGFLAM-AS2|EGFLAM-AS4|EGR1|EIF4E1B|EIF4EBP3|ELL2|ELOVL7|EMB|ENC1|EPB41L4A|ERAP1|ERAP2|ERBIN|ERCC8|ERGIC1|ESM1|ETF1|F2R|F2RL1|F2RL2|FABP6|FAF2|FAM114A2|FAM13B|FAM151B|FAM153B|FAM169A|FAM170A|FAM174A|FAM200C|FAM53C|FAM81B|FAT2|FAXDC2|FBN2|FBXL17|FBXO38|FBXO4|FBXW11|FCHO2|FCHSD1|FEM1C|FER|FGF1|FGF10|FGF18|FGFR4|FNDC9|FNIP1|FOXD1|FOXI1|FST|FSTL4|FTMT|FYB1|G3BP1|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GALNT10|GAPT|GARIN3|GCNT4|GDF9|GDNF|GDNF-AS1|GEMIN5|GFM2|GFRA3|GHR|GIN1|GLRA1|GLRX|GM2A|GNPDA1|GOLPH3|GPBP1|GPR150|GPR151|GPRIN1|GPX3|GPX8|GRAMD2B|GRIA1|GRPEL2|GRXCR2|GTF2H2|GTF2H2C|GZMA|GZMK|HAND1|HAPLN1|HARS1|HARS2|HAVCR1|HAVCR2|HBEGF|HCN1|HDAC3|HEXB|HIGD2A|HINT1|HK3|HMGCR|HMGCS1|HMGXB3|HMHB1|HMMR|HNRNPA0|HOMER1|HRH2|HSD17B4|HSPA4|HSPA9|HSPB3|HTR1A|HTR4|IGIP|IK|IL12B|IL13|IL17B|IL3|IL31RA|IL4|IL5|IL6ST|IL7R|IL9|INSYN2B|IPO11|IQGAP2|IRF1|IRGM|ISL1|ISOC1|ITGA1|ITGA2|ITK|JADE2|JAKMIP2|JMY|KCNIP1|KCNMB1|KCNN2|KCTD16|KDM3B|KGD4|KIAA0825|KIAA1191|KIF20A|KIF2A|KIF3A|KIF4B|KLHL3|LARP1|LARS1|LCP2|LEAP2|LECT2|LHFPL2|LIFR|LINC02899|LINC03122|LIX1|LMBRD2|LMNB1|LNPEP|LOC100128059|LOC100288254|LOX|LRRC70|LRRTM2|LSM11|LUCAT1|LVRN|LYRM7|LYSMD3|MACIR|MACROH2A1|MAN2A1|MAP1B|MAP3K1|MARCHF3|MARVELD2|MAST4|MAT2B|MATR3|MBLAC2|MCC|MCCC2|MCIDAS|MCTP1|MED7|MEF2C|MEGF10|MFAP3|MIER3|MINAR2|MIR103A1|MIR143|MIR145|MIR146A|MIR378A|MIR449A|MIR449B|MIR9-2|MOCS2|MROH2B|MRPL22|MRPS27|MRPS30|MSH3|MSX2|MTMR12|MTREX|MTRNR2L2|MTX3|MYOT|MYOZ3|MZB1|NADK2|NAIP|NCRUPAR|NDFIP1|NDST1|NDUFA2|NDUFAF2|NDUFS4|NEURL1B|NEUROG1|NIPAL4|NIPBL|NKX2-5|NLN|NME5|NMUR2|NNT|NOP16|NPM1|NPR3|NR2F1|NR3C1|NREP|NRG2|NSA2|NSD1|NUDCD2|NUDT12|NUP155|OCLN|OSMR|OTP|OXCT1|P4HA2|PAIP1|PAIP2|PAM|PANK3|PARP8|PART1|PCBD2|PCDH1|PCDH12|PCDHA1|PCDHA10|PCDHA11|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHB1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHB16|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB8|PCDHB9|PCDHB@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCSK1|PCYOX1L|PDE4D|PDE6A|PDE8B|PDGFRB|PDLIM4|PDZD2|PELO|PFDN1|PGGT1B|PHAX|PIK3R1|PITX1|PJA2|PKD2L2|PLAC8L1|PLCXD3|PLK2|PLPP1|POC5|POLK|POLR3G|POU4F3|POU5F2|PPARGC1B|PPIC|PPIP5K2|PPP2CA|PPP2R2B|PPWD1|PRDM6|PRDM9|PRELID2|PRKAA1|PRLR|PROB1|PRR16|PRRC1|PSD2|PTCD2|PTGER4|PTTG1|PURA|PWWP2A|RAB3C|RAD1|RAD17|RAD50|RAI14|RANBP17|RANBP3L|RAPGEF6|RARS1|RASA1|RASGRF2|RBM22|RBM27|REEP2|REEP5|RELL2|RFESD|RGMB|RGS7BP|RHOBTB3|RICTOR|RIMOC1|RIOK2|RNF14|RNF145|RNF180|RNF44|RPL26L1|RPL37|RPS14|RPS23|RXFP3|S100Z|SAP30L|SAR1B|SCAMP1|SCARNA18|SCGB3A2|SEC24A|SELENOP|SEMA6A|SEPTIN8|SERF1A|SERF1B|SERINC5|SETD9|SFXN1|SGCD|SGTB|SH3PXD2B|SH3RF2|SH3TC2|SHISAL2B|SHROOM1|SIL1|SIMC1|SKIC3|SKP1|SKP2|SLC12A2|SLC1A3|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A46|SLC25A48|SLC26A2|SLC27A6|SLC30A5|SLC35A4|SLC36A1|SLC36A2|SLC36A3|SLC38A9|SLC45A2|SLC4A9|SLC6A7|SLCO4C1|SLCO6A1|SLF1|SLIT3|SLU7|SMAD5|SMIM15|SMIM23|SMIM3|SMN1|SMN2|SNCAIP|SNCB|SNHG4|SNORA74B|SNX18|SNX2|SNX24|SOWAHA|SOX30|SPARC|SPATA24|SPATA9|SPDL1|SPEF2|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SPZ1|SRA1|SREK1|SREK1IP1|SRFBP1|SRP19|SSBP2|ST8SIA4|STARD4|STC2|STING1|STK10|STK32A|SUB1|SV2C|SYNPO|TAF7|TAF9|TARS1|TBCA|TCERG1|TCF7|TCOF1|TENM2|TENT2|TGFBI|THBS4|THG1L|THOC3|TICAM2|TIFAB|TIGD6|TIMD4|TLX3|TMCO6|TMED7|TMED7-TICAM2|TMEM161B|TMEM167A|TMEM171|TMEM174|TMEM232|TMEM267|TNFAIP8|TNIP1|TNPO1|TRAPPC13|TRIM23|TRIM36|TRPC7|TSLP|TSPAN17|TSSK1B|TTC1|TTC23L|TTC33|TXNDC15|UBE2B|UBE2D2|UBLCP1|UBTD2|UGT3A1|UGT3A2|UIMC1|UNC5A|UQCRQ|UTP15|VCAN|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR36|WDR41|WDR55|WDR70|WNT8A|WWC1|XRCC4|YIPF5|YTHDC2|ZBED3|ZCCHC10|ZCCHC9|ZFR|ZFYVE16|ZMAT2|ZNF131|ZNF300|ZNF346|ZNF366|ZNF474|ZNF608|ZSWIM6		See cases	VCV000442431	5	17628741 - 176575720			442431	436093			copy number loss		Pathogenic	Feb 1, 2016	no assertion criteria provided							
GRCh37/hg19 5p15.33-q35.3(chr5:113577-180719789)	ABLIM3|ACOT12|ACSL6|ACTBL2|ADAM19|ADAMTS12|ADAMTS16|ADAMTS19|ADAMTS2|ADAMTS6|ADCY2|ADGRV1|ADRA1B|ADRB2|AFAP1L1|AFF4|AGGF1|AGXT2|AHRR|ALDH7A1|AMACR|ANKDD1B|ANKH|ANKHD1|ANKHD1-EIF4EBP3|ANKRA2|ANKRD31|ANKRD33B|ANKRD34B|ANKRD55|ANXA2R|ANXA6|AP3B1|AP3S1|APBB3|APC|ARAP3|ARB2A|ARHGAP26|ARHGEF28|ARHGEF37|ARL10|ARL14EPL|ARL15|ARRDC3|ARSB|ARSI|ARSK|ATG10|ATG12|ATOX1|ATP10B|ATP6AP1L|ATP6V0E1|ATPSCKMT|B4GALT7|BASP1|BDP1|BHMT|BHMT2|BNIP1|BOD1|BRD8|BRD9|BRIX1|BTF3|BTNL3|BTNL8|BTNL9|C1QTNF2|C1QTNF3|C5orf15|C5orf22|C5orf24|C5orf34|C5orf46|C5orf47|C5orf52|C5orf58|C5orf60|C5orf63|C6|C7|C9|CAMK2A|CAMK4|CAMLG|CANX|CAPSL|CARD6|CARTPT|CAST|CATSPER3|CBY3|CCDC112|CCDC125|CCDC127|CCDC152|CCDC69|CCL28|CCNB1|CCNG1|CCNH|CCNI2|CCNJL|CCNO|CCT5|CD14|CD180|CD74|CDC20B|CDC23|CDC25C|CDC42SE2|CDH10|CDH12|CDH18|CDH6|CDH9|CDHR2|CDK7|CDKL3|CDKN2AIPNL|CDO1|CDX1|CENPH|CENPK|CEP120|CEP72|CERT1|CETN3|CFAP90|CHD1|CHSY3|CKMT2|CLINT1|CLK4|CLPTM1L|CLTB|CMBL|CMYA5|CNOT6|CNOT8|COL23A1|COMMD10|COX7C|CPEB4|CPLANE1|CPLX2|CREBRF|CRHBP|CSF1R|CSF2|CSNK1A1|CSNK1G3|CTNNA1|CTNND2|CTXN3|CWC27|CXCL14|CXXC5|CYFIP2|CYSTM1|DAB2|DAP|DBN1|DCANP1|DCP2|DCTN4|DDX4|DDX41|DDX46|DELE1|DEPDC1B|DHFR|DHX29|DIAPH1|DIMT1|DMGDH|DMXL1|DNAH5|DNAJC18|DNAJC21|DND1|DOCK2|DOK3|DPYSL3|DRD1|DROSHA|DTWD2|DUSP1|EBF1|ECSCR|EDIL3|EFCAB9|EFNA5|EGFLAM|EGFLAM-AS2|EGFLAM-AS4|EGR1|EIF4E1B|EIF4EBP3|ELL2|ELOVL7|EMB|ENC1|EPB41L4A|ERAP1|ERAP2|ERBIN|ERCC8|ERGIC1|ESM1|ETF1|EXOC3|EXOC3-AS1|F12|F2R|F2RL1|F2RL2|FABP6|FAF2|FAM114A2|FAM13B|FAM151B|FAM153A|FAM153B|FAM169A|FAM170A|FAM174A|FAM193B|FAM200C|FAM53C|FAM81B|FASTKD3|FAT2|FAXDC2|FBN2|FBXL17|FBXL7|FBXO38|FBXO4|FBXW11|FCHO2|FCHSD1|FEM1C|FER|FGF1|FGF10|FGF18|FGFR4|FLT4|FNDC9|FNIP1|FOXD1|FOXI1|FST|FSTL4|FTMT|FYB1|G3BP1|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GALNT10|GAPT|GARIN3|GCNT4|GDF9|GDNF|GDNF-AS1|GEMIN5|GFM2|GFPT2|GFRA3|GHR|GIN1|GLRA1|GLRX|GM2A|GNPDA1|GOLPH3|GPBP1|GPR150|GPR151|GPRIN1|GPX3|GPX8|GRAMD2B|GRIA1|GRK6|GRM6|GRPEL2|GRXCR2|GTF2H2|GTF2H2C|GZMA|GZMK|HAND1|HAPLN1|HARS1|HARS2|HAVCR1|HAVCR2|HBEGF|HCN1|HDAC3|HEXB|HIGD2A|HINT1|HK3|HMGCR|HMGCS1|HMGXB3|HMHB1|HMMR|HNRNPA0|HNRNPAB|HNRNPH1|HOMER1|HRH2|HSD17B4|HSPA4|HSPA9|HSPB3|HTR1A|HTR4|ICE1|IGIP|IK|IL12B|IL13|IL17B|IL3|IL31RA|IL4|IL5|IL6ST|IL7R|IL9|INSYN2B|IPO11|IQGAP2|IRF1|IRGM|IRX1|IRX2|IRX2-DT|IRX4|ISL1|ISOC1|ITGA1|ITGA2|ITK|JADE2|JAKMIP2|JMY|KCNIP1|KCNMB1|KCNN2|KCTD16|KDM3B|KGD4|KIAA0825|KIAA1191|KIF20A|KIF2A|KIF3A|KIF4B|KLHL3|LARP1|LARS1|LCP2|LEAP2|LECT2|LHFPL2|LIFR|LINC01194|LINC02899|LINC03122|LIX1|LMAN2|LMBRD2|LMNB1|LNPEP|LOC100128059|LOC100288254|LOX|LPCAT1|LRRC14B|LRRC70|LRRTM2|LSM11|LTC4S|LUCAT1|LVRN|LYRM7|LYSMD3|MACIR|MACROH2A1|MAML1|MAN2A1|MAP1B|MAP3K1|MAPK9|MARCHF11|MARCHF3|MARCHF6|MARVELD2|MAST4|MAT2B|MATR3|MBLAC2|MCC|MCCC2|MCIDAS|MCTP1|MED10|MED7|MEF2C|MEGF10|MFAP3|MGAT1|MGAT4B|MIER3|MINAR2|MIR103A1|MIR143|MIR145|MIR146A|MIR378A|MIR449A|MIR449B|MIR9-2|MOCS2|MRNIP|MROH2B|MRPL22|MRPL36|MRPS27|MRPS30|MSH3|MSX2|MTMR12|MTREX|MTRNR2L2|MTRR|MTX3|MXD3|MYO10|MYOT|MYOZ3|MZB1|N4BP3|NADK2|NAIP|NCRUPAR|NDFIP1|NDST1|NDUFA2|NDUFAF2|NDUFS4|NDUFS6|NEURL1B|NEUROG1|NHP2|NIPAL4|NIPBL|NKD2|NKX2-5|NLN|NME5|NMUR2|NNT|NOP16|NPM1|NPR3|NR2F1|NR3C1|NREP|NRG2|NSA2|NSD1|NSUN2|NUDCD2|NUDT12|NUP155|OCLN|OR2V1|OR2V2|OR2Y1|OSMR|OTP|OTULIN|OTULIN-DT|OTULINL|OXCT1|P4HA2|PAIP1|PAIP2|PAM|PANK3|PARP8|PART1|PCBD2|PCDH1|PCDH12|PCDHA1|PCDHA10|PCDHA11|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHB1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHB16|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB8|PCDHB9|PCDHB@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCSK1|PCYOX1L|PDCD6|PDE4D|PDE6A|PDE8B|PDGFRB|PDLIM4|PDLIM7|PDZD2|PELO|PFDN1|PFN3|PGGT1B|PHAX|PHYKPL|PIK3R1|PITX1|PJA2|PKD2L2|PLAC8L1|PLCXD3|PLEKHG4B|PLK2|PLPP1|POC5|POLK|POLR3G|POU4F3|POU5F2|PPARGC1B|PPIC|PPIP5K2|PPP2CA|PPP2R2B|PPWD1|PRDM6|PRDM9|PRELID1|PRELID2|PRKAA1|PRLR|PROB1|PROP1|PRR16|PRR7|PRRC1|PSD2|PTCD2|PTGER4|PTTG1|PURA|PWWP2A|RAB24|RAB3C|RACK1|RAD1|RAD17|RAD50|RAI14|RANBP17|RANBP3L|RAPGEF6|RARS1|RASA1|RASGEF1C|RASGRF2|RBM22|RBM27|REEP2|REEP5|RELL2|RETREG1|RFESD|RGMB|RGS14|RGS7BP|RHOBTB3|RICTOR|RIMOC1|RIOK2|RMND5B|RNF130|RNF14|RNF145|RNF180|RNF44|ROPN1L|RPL26L1|RPL37|RPS14|RPS23|RUFY1|RXFP3|S100Z|SAP30L|SAR1B|SCAMP1|SCARNA18|SCGB3A1|SCGB3A2|SDHA|SEC24A|SELENOP|SEMA5A|SEMA6A|SEPTIN8|SERF1A|SERF1B|SERINC5|SETD9|SFXN1|SGCD|SGTB|SH3PXD2B|SH3RF2|SH3TC2|SHISAL2B|SHROOM1|SIL1|SIMC1|SKIC3|SKP1|SKP2|SLC12A2|SLC12A7|SLC1A3|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A46|SLC25A48|SLC26A2|SLC27A6|SLC30A5|SLC34A1|SLC35A4|SLC36A1|SLC36A2|SLC36A3|SLC38A9|SLC45A2|SLC4A9|SLC6A18|SLC6A19|SLC6A3|SLC6A7|SLC9A3|SLCO4C1|SLCO6A1|SLF1|SLIT3|SLU7|SMAD5|SMIM15|SMIM23|SMIM3|SMN1|SMN2|SNCAIP|SNCB|SNHG4|SNORA74B|SNX18|SNX2|SNX24|SOWAHA|SOX30|SPARC|SPATA24|SPATA9|SPDL1|SPEF2|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SPZ1|SQSTM1|SRA1|SRD5A1|SREK1|SREK1IP1|SRFBP1|SRP19|SSBP2|ST8SIA4|STARD4|STC2|STING1|STK10|STK32A|SUB1|SV2C|SYNPO|TAF7|TAF9|TARS1|TAS2R1|TBC1D9B|TBCA|TCERG1|TCF7|TCOF1|TENM2|TENT2|TENT4A|TERT|TGFBI|THBS4|THG1L|THOC3|TICAM2|TIFAB|TIGD6|TIMD4|TLX3|TMCO6|TMED7|TMED7-TICAM2|TMED9|TMEM161B|TMEM167A|TMEM171|TMEM174|TMEM232|TMEM267|TNFAIP8|TNIP1|TNPO1|TPPP|TRAPPC13|TRIM23|TRIM36|TRIM41|TRIM52|TRIM7|TRIO|TRIP13|TRK-CTT2-3|TRP-TGG3-1|TRPC7|TRT-TGT6-1|TRV-AAC1-4|TRV-CAC1-2|TSLP|TSPAN17|TSSK1B|TTC1|TTC23L|TTC33|TXNDC15|UBE2B|UBE2D2|UBE2QL1|UBLCP1|UBTD2|UGT3A1|UGT3A2|UIMC1|UNC5A|UQCRQ|UTP15|VCAN|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR36|WDR41|WDR55|WDR70|WNT8A|WWC1|XRCC4|YIPF5|YTHDC2|ZBED3|ZCCHC10|ZCCHC9|ZDHHC11|ZDHHC11B|ZFP2|ZFP62|ZFR|ZFYVE16|ZMAT2|ZNF131|ZNF300|ZNF346|ZNF354A|ZNF354B|ZNF354C|ZNF366|ZNF454|ZNF474|ZNF608|ZNF622|ZNF879|ZSWIM6		See cases	VCV000441920	5	113577 - 180719789			441920	435582			copy number gain		Pathogenic	Jul 14, 2015	no assertion criteria provided							
GRCh37/hg19 5p15.33-q35.3(chr5:113577-180719789)x3	ABLIM3|ACOT12|ACSL6|ACTBL2|ADAM19|ADAMTS12|ADAMTS16|ADAMTS19|ADAMTS2|ADAMTS6|ADCY2|ADGRV1|ADRA1B|ADRB2|AFAP1L1|AFF4|AGGF1|AGXT2|AHRR|ALDH7A1|AMACR|ANKDD1B|ANKH|ANKHD1|ANKHD1-EIF4EBP3|ANKRA2|ANKRD31|ANKRD33B|ANKRD34B|ANKRD55|ANXA2R|ANXA6|AP3B1|AP3S1|APBB3|APC|ARAP3|ARB2A|ARHGAP26|ARHGEF28|ARHGEF37|ARL10|ARL14EPL|ARL15|ARRDC3|ARSB|ARSI|ARSK|ATG10|ATG12|ATOX1|ATP10B|ATP6AP1L|ATP6V0E1|ATPSCKMT|B4GALT7|BASP1|BDP1|BHMT|BHMT2|BNIP1|BOD1|BRD8|BRD9|BRIX1|BTF3|BTNL3|BTNL8|BTNL9|C1QTNF2|C1QTNF3|C5orf15|C5orf22|C5orf24|C5orf34|C5orf46|C5orf47|C5orf52|C5orf58|C5orf60|C5orf63|C6|C7|C9|CAMK2A|CAMK4|CAMLG|CANX|CAPSL|CARD6|CARTPT|CAST|CATSPER3|CBY3|CCDC112|CCDC125|CCDC127|CCDC152|CCDC69|CCL28|CCNB1|CCNG1|CCNH|CCNI2|CCNJL|CCNO|CCT5|CD14|CD180|CD74|CDC20B|CDC23|CDC25C|CDC42SE2|CDH10|CDH12|CDH18|CDH6|CDH9|CDHR2|CDK7|CDKL3|CDKN2AIPNL|CDO1|CDX1|CENPH|CENPK|CEP120|CEP72|CERT1|CETN3|CFAP90|CHD1|CHSY3|CKMT2|CLINT1|CLK4|CLPTM1L|CLTB|CMBL|CMYA5|CNOT6|CNOT8|COL23A1|COMMD10|COX7C|CPEB4|CPLANE1|CPLX2|CREBRF|CRHBP|CSF1R|CSF2|CSNK1A1|CSNK1G3|CTNNA1|CTNND2|CTXN3|CWC27|CXCL14|CXXC5|CYFIP2|CYSTM1|DAB2|DAP|DBN1|DCANP1|DCP2|DCTN4|DDX4|DDX41|DDX46|DELE1|DEPDC1B|DHFR|DHX29|DIAPH1|DIMT1|DMGDH|DMXL1|DNAH5|DNAJC18|DNAJC21|DND1|DOCK2|DOK3|DPYSL3|DRD1|DROSHA|DTWD2|DUSP1|EBF1|ECSCR|EDIL3|EFCAB9|EFNA5|EGFLAM|EGFLAM-AS2|EGFLAM-AS4|EGR1|EIF4E1B|EIF4EBP3|ELL2|ELOVL7|EMB|ENC1|EPB41L4A|ERAP1|ERAP2|ERBIN|ERCC8|ERGIC1|ESM1|ETF1|EXOC3|EXOC3-AS1|F12|F2R|F2RL1|F2RL2|FABP6|FAF2|FAM114A2|FAM13B|FAM151B|FAM153A|FAM153B|FAM169A|FAM170A|FAM174A|FAM193B|FAM200C|FAM53C|FAM81B|FASTKD3|FAT2|FAXDC2|FBN2|FBXL17|FBXL7|FBXO38|FBXO4|FBXW11|FCHO2|FCHSD1|FEM1C|FER|FGF1|FGF10|FGF18|FGFR4|FLT4|FNDC9|FNIP1|FOXD1|FOXI1|FST|FSTL4|FTMT|FYB1|G3BP1|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GALNT10|GAPT|GARIN3|GCNT4|GDF9|GDNF|GDNF-AS1|GEMIN5|GFM2|GFPT2|GFRA3|GHR|GIN1|GLRA1|GLRX|GM2A|GNPDA1|GOLPH3|GPBP1|GPR150|GPR151|GPRIN1|GPX3|GPX8|GRAMD2B|GRIA1|GRK6|GRM6|GRPEL2|GRXCR2|GTF2H2|GTF2H2C|GZMA|GZMK|HAND1|HAPLN1|HARS1|HARS2|HAVCR1|HAVCR2|HBEGF|HCN1|HDAC3|HEXB|HIGD2A|HINT1|HK3|HMGCR|HMGCS1|HMGXB3|HMHB1|HMMR|HNRNPA0|HNRNPAB|HNRNPH1|HOMER1|HRH2|HSD17B4|HSPA4|HSPA9|HSPB3|HTR1A|HTR4|ICE1|IGIP|IK|IL12B|IL13|IL17B|IL3|IL31RA|IL4|IL5|IL6ST|IL7R|IL9|INSYN2B|IPO11|IQGAP2|IRF1|IRGM|IRX1|IRX2|IRX2-DT|IRX4|ISL1|ISOC1|ITGA1|ITGA2|ITK|JADE2|JAKMIP2|JMY|KCNIP1|KCNMB1|KCNN2|KCTD16|KDM3B|KGD4|KIAA0825|KIAA1191|KIF20A|KIF2A|KIF3A|KIF4B|KLHL3|LARP1|LARS1|LCP2|LEAP2|LECT2|LHFPL2|LIFR|LINC01194|LINC02899|LINC03122|LIX1|LMAN2|LMBRD2|LMNB1|LNPEP|LOC100128059|LOC100288254|LOX|LPCAT1|LRRC14B|LRRC70|LRRTM2|LSM11|LTC4S|LUCAT1|LVRN|LYRM7|LYSMD3|MACIR|MACROH2A1|MAML1|MAN2A1|MAP1B|MAP3K1|MAPK9|MARCHF11|MARCHF3|MARCHF6|MARVELD2|MAST4|MAT2B|MATR3|MBLAC2|MCC|MCCC2|MCIDAS|MCTP1|MED10|MED7|MEF2C|MEGF10|MFAP3|MGAT1|MGAT4B|MIER3|MINAR2|MIR103A1|MIR143|MIR145|MIR146A|MIR378A|MIR449A|MIR449B|MIR9-2|MOCS2|MRNIP|MROH2B|MRPL22|MRPL36|MRPS27|MRPS30|MSH3|MSX2|MTMR12|MTREX|MTRNR2L2|MTRR|MTX3|MXD3|MYO10|MYOT|MYOZ3|MZB1|N4BP3|NADK2|NAIP|NCRUPAR|NDFIP1|NDST1|NDUFA2|NDUFAF2|NDUFS4|NDUFS6|NEURL1B|NEUROG1|NHP2|NIPAL4|NIPBL|NKD2|NKX2-5|NLN|NME5|NMUR2|NNT|NOP16|NPM1|NPR3|NR2F1|NR3C1|NREP|NRG2|NSA2|NSD1|NSUN2|NUDCD2|NUDT12|NUP155|OCLN|OR2V1|OR2V2|OR2Y1|OSMR|OTP|OTULIN|OTULIN-DT|OTULINL|OXCT1|P4HA2|PAIP1|PAIP2|PAM|PANK3|PARP8|PART1|PCBD2|PCDH1|PCDH12|PCDHA1|PCDHA10|PCDHA11|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHB1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHB16|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB8|PCDHB9|PCDHB@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCSK1|PCYOX1L|PDCD6|PDE4D|PDE6A|PDE8B|PDGFRB|PDLIM4|PDLIM7|PDZD2|PELO|PFDN1|PFN3|PGGT1B|PHAX|PHYKPL|PIK3R1|PITX1|PJA2|PKD2L2|PLAC8L1|PLCXD3|PLEKHG4B|PLK2|PLPP1|POC5|POLK|POLR3G|POU4F3|POU5F2|PPARGC1B|PPIC|PPIP5K2|PPP2CA|PPP2R2B|PPWD1|PRDM6|PRDM9|PRELID1|PRELID2|PRKAA1|PRLR|PROB1|PROP1|PRR16|PRR7|PRRC1|PSD2|PTCD2|PTGER4|PTTG1|PURA|PWWP2A|RAB24|RAB3C|RACK1|RAD1|RAD17|RAD50|RAI14|RANBP17|RANBP3L|RAPGEF6|RARS1|RASA1|RASGEF1C|RASGRF2|RBM22|RBM27|REEP2|REEP5|RELL2|RETREG1|RFESD|RGMB|RGS14|RGS7BP|RHOBTB3|RICTOR|RIMOC1|RIOK2|RMND5B|RNF130|RNF14|RNF145|RNF180|RNF44|ROPN1L|RPL26L1|RPL37|RPS14|RPS23|RUFY1|RXFP3|S100Z|SAP30L|SAR1B|SCAMP1|SCARNA18|SCGB3A1|SCGB3A2|SDHA|SEC24A|SELENOP|SEMA5A|SEMA6A|SEPTIN8|SERF1A|SERF1B|SERINC5|SETD9|SFXN1|SGCD|SGTB|SH3PXD2B|SH3RF2|SH3TC2|SHISAL2B|SHROOM1|SIL1|SIMC1|SKIC3|SKP1|SKP2|SLC12A2|SLC12A7|SLC1A3|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A46|SLC25A48|SLC26A2|SLC27A6|SLC30A5|SLC34A1|SLC35A4|SLC36A1|SLC36A2|SLC36A3|SLC38A9|SLC45A2|SLC4A9|SLC6A18|SLC6A19|SLC6A3|SLC6A7|SLC9A3|SLCO4C1|SLCO6A1|SLF1|SLIT3|SLU7|SMAD5|SMIM15|SMIM23|SMIM3|SMN1|SMN2|SNCAIP|SNCB|SNHG4|SNORA74B|SNX18|SNX2|SNX24|SOWAHA|SOX30|SPARC|SPATA24|SPATA9|SPDL1|SPEF2|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SPZ1|SQSTM1|SRA1|SRD5A1|SREK1|SREK1IP1|SRFBP1|SRP19|SSBP2|ST8SIA4|STARD4|STC2|STING1|STK10|STK32A|SUB1|SV2C|SYNPO|TAF7|TAF9|TARS1|TAS2R1|TBC1D9B|TBCA|TCERG1|TCF7|TCOF1|TENM2|TENT2|TENT4A|TERT|TGFBI|THBS4|THG1L|THOC3|TICAM2|TIFAB|TIGD6|TIMD4|TLX3|TMCO6|TMED7|TMED7-TICAM2|TMED9|TMEM161B|TMEM167A|TMEM171|TMEM174|TMEM232|TMEM267|TNFAIP8|TNIP1|TNPO1|TPPP|TRAPPC13|TRIM23|TRIM36|TRIM41|TRIM52|TRIM7|TRIO|TRIP13|TRK-CTT2-3|TRP-TGG3-1|TRPC7|TRT-TGT6-1|TRV-AAC1-4|TRV-CAC1-2|TSLP|TSPAN17|TSSK1B|TTC1|TTC23L|TTC33|TXNDC15|UBE2B|UBE2D2|UBE2QL1|UBLCP1|UBTD2|UGT3A1|UGT3A2|UIMC1|UNC5A|UQCRQ|UTP15|VCAN|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR36|WDR41|WDR55|WDR70|WNT8A|WWC1|XRCC4|YIPF5|YTHDC2|ZBED3|ZCCHC10|ZCCHC9|ZDHHC11|ZDHHC11B|ZFP2|ZFP62|ZFR|ZFYVE16|ZMAT2|ZNF131|ZNF300|ZNF346|ZNF354A|ZNF354B|ZNF354C|ZNF366|ZNF454|ZNF474|ZNF608|ZNF622|ZNF879|ZSWIM6		See cases	VCV000441919	5	113577 - 180719789			441919	435581			copy number gain		Pathogenic	Dec 2, 2014	no assertion criteria provided							
GRCh37/hg19 5q15-35.3(chr5:94844077-178830410)x3	ARL10|ARL14EPL|ARSI|ARSK|CSF1R|CSF2|CSNK1A1|FAM200C|ATG12|CSNK1G3|CTNNA1|FAM53C|HINT1|HK3|LARP1|LARS1|NMUR2|NOP16|PCDHB16|PDLIM4|PDLIM7|PFDN1|RELL2|SLC36A1|SLC36A2|SLC36A3|SYNPO|TAF7|ZNF346|ZNF354A|ZNF454|ZNF474|ZNF354B|ZNF354C|TCF7|TNFAIP8|TNIP1|TRIM36|TRPC7|TSLP|TSPAN17|TSSK1B|TIFAB|TMED7-TICAM2|ZNF608|ZNF879|SLC4A9|SLC6A7|SLCO4C1|SLCO6A1|SLIT3|SLU7|SMIM3|SNCAIP|SNX24|SOWAHA|SMAD5|SMIM23|SNCB|SNHG4|SNORA74B|SNX2|TCERG1|TMED9|TMEM232|RFESD|RHOBTB3|RIOK2|RMND5B|RNF14|RNF145|RNF44|RPL26L1|RPS14|SAP30L|SAR1B|SCGB3A2|PITX1|PJA2|PKD2L2|PPARGC1B|PPIC|PHAX|PHYKPL|PCDHB5|PCDHB6|PLAC8L1|POU4F3|PFN3|PGGT1B|RGMB|RGS14|PCDHB2|PCDHB7|PCDHB8|PCDHB@|PCDHGA1|NREP|NRG2|PCDH1|PCDH12|PCDHA1|PCDHGA10|PCDHB9|PCDHB3|PCDHB4|NPM1|NR3C1|PANK3|MACROH2A1|MAN2A1|MARCHF3|MCC|MED7|MAT2B|MATR3|LECT2|LIX1|LMAN2|LSM11|LVRN|PCBD2|PCDHA10|PCDHA11|HNRNPAB|HRH2|HSD17B4|HTR4|IGIP|IK|HMHB1|HMMR|HSPA4|HSPA9|HNRNPA0|LCP2|LEAP2|LYRM7|FAT2|FAXDC2|FBN2|FTMT|G3BP1|GALNT10|GARIN3|GDF9|GEMIN5|FBXL17|FBXO38|FOXI1|FSTL4|FGFR4|FNDC9|FNIP1|MACIR|CXCL14|CXXC5|CYFIP2|CTXN3|CYSTM1|DBN1|DCANP1|DTWD2|DCP2|DCTN4|DND1|DOCK2|DOK3|ATP6V0E1|B4GALT7|ATOX1|ATP10B|DPYSL3|DRD1|BNIP1|BOD1|BRD8|C1QTNF2|C5orf15|C5orf24|C5orf46|C5orf47|C5orf52|C5orf58|C5orf63|CCDC69|CCNG1|HMGXB3|ABLIM3|ACSL6|ADAM19|ADAMTS19|ADAMTS2|ADRA1B|ADRB2|AFAP1L1|AFF4|ALDH7A1|ANKHD1|ANKHD1-EIF4EBP3|ANXA6|AP3S1|APBB3|APC|ARAP3|ARHGAP26|ARHGEF37|CAMK2A|CAMK4|CAMLG|CAST|CATSPER3|CCDC112|CCNI2|CCNJL|CD14|CD74|CDC23|CDC25C|CDC42SE2|CDHR2|CDKL3|CDKN2AIPNL|CDO1|CDX1|CEP120|CHD1|CHSY3|CLINT1|CLK4|CLTB|CNOT8|COL23A1|COMMD10|CPEB4|CPLX2|CREBRF|DDX41|DDX46|DELE1|DIAPH1|DMXL1|DNAJC18|DUSP1|EBF1|ECSCR|EFCAB9|EFNA5|EGR1|EIF4E1B|EIF4EBP3|ELL2|EPB41L4A|ERAP1|ERAP2|ERGIC1|ETF1|F12|FABP6|FAF2|FAM114A2|FAM13B|FAM153A|FAM153B|FAM170A|FAM174A|FAM193B|FBXW11|FCHSD1|FEM1C|FER|FGF1|FGF18|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GFRA3|GIN1|GLRA1|GLRX|GM2A|GNPDA1|GPR150|GPR151|GPRIN1|GPX3|GRAMD2B|GRIA1|GRK6|GRM6|GRPEL2|GRXCR2|HAND1|HARS1|HARS2|HAVCR1|HAVCR2|HBEGF|HDAC3|HIGD2A|IL12B|IL13|IL17B|IL3|IL4|IL5|IL9|INSYN2B|IRF1|IRGM|ISOC1|ITK|JADE2|JAKMIP2|KCNIP1|KCNMB1|KCNN2|KCTD16|KDM3B|KIAA1191|KIF20A|KIF3A|KIF4B|KLHL3|LMNB1|LNPEP|LOC100128059|LOC100288254|LOX|LRRTM2|MEGF10|MFAP3|MINAR2|MIR103A1|MIR143|MIR145|MIR146A|MIR378A|MRPL22|MSX2|MXD3|MYOT|MYOZ3|MZB1|N4BP3|NDFIP1|NDST1|NDUFA2|NEURL1B|NEUROG1|NHP2|NIPAL4|NKX2-5|NME5|NSD1|NUDCD2|NUDT12|P4HA2|PAIP2|PAM|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHB1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCSK1|PCYOX1L|PDE6A|PDGFRB|PPIP5K2|PPP2CA|PPP2R2B|PRDM6|PRELID1|PRELID2|PROB1|PROP1|PRR16|PRR7|PRRC1|PSD2|PTTG1|PURA|PWWP2A|RAB24|RAD50|RANBP17|RAPGEF6|RARS1|RBM22|RBM27|REEP2|REEP5|SEC24A|SEMA6A|SEPTIN8|SFXN1|SGCD|SH3PXD2B|SH3RF2|SH3TC2|SHROOM1|SIL1|SIMC1|SKIC3|SKP1|SLC12A2|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A46|SLC25A48|SLC26A2|SLC27A6|SLC34A1|SLC35A4|SOX30|SPARC|SPATA24|SPATA9|SPDL1|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SRA1|SRFBP1|SRP19|ST8SIA4|STARD4|STC2|STING1|STK10|STK32A|TCOF1|TENM2|TGFBI|THG1L|THOC3|TICAM2|TIGD6|TIMD4|TLX3|TMCO6|TMED7|TTC1|TXNDC15|UBE2B|UBE2D2|UBLCP1|UBTD2|UIMC1|UNC5A|UQCRQ|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR36|WDR55|WNT8A|WWC1|YIPF5|YTHDC2|ZCCHC10|ZFP2|ZMAT2|ZNF300		not provided	VCV000425542	5	94844077 - 178830410			425542	413876			copy number gain		Likely benign	Jan 31, 2017	criteria provided, single submitter							
GRCh37/hg19 5q21.3-35.3(chr5:106716357-180687338)x3	HRH2|HSD17B4|HSPA4|HSPA9|RNF145|RNF44|RPL26L1|RPS14|HTR4|IGIP|IK|RUFY1|SAR1B|SCGB3A1|SCGB3A2|SEC24A|SGCD|SAP30L|SH3PXD2B|SH3RF2|SH3TC2|IL13|IL17B|INSYN2B|IRF1|IRGM|IL3|IL4|JADE2|JAKMIP2|IL5|IL9|ISOC1|ITK|SEMA6A|SEPTIN8|SFXN1|IL12B|SHROOM1|SIL1|SIMC1|ABLIM3|ACSL6|ADAM19|ADAMTS19|ADAMTS2|ADRA1B|ADRB2|AFAP1L1|AFF4|ALDH7A1|ANKHD1|ANKHD1-EIF4EBP3|ANXA6|AP3S1|APBB3|APC|ARAP3|ARHGAP26|ARHGEF37|ARL10|ARL14EPL|ARSI|ATG12|ATOX1|ATP10B|ATP6V0E1|B4GALT7|BNIP1|BOD1|BRD8|BTNL3|BTNL8|BTNL9|C1QTNF2|C5orf15|C5orf24|C5orf46|C5orf47|C5orf52|C5orf58|C5orf60|C5orf63|CAMK2A|CAMK4|CAMLG|CANX|CATSPER3|CBY3|CCDC112|CCDC69|CCNG1|CCNI2|CCNJL|CD14|CD74|CDC23|CDC25C|CDC42SE2|CDHR2|CDKL3|CDKN2AIPNL|CDO1|CDX1|CEP120|CHSY3|CLINT1|CLK4|CLTB|CNOT6|CNOT8|COL23A1|COMMD10|CPEB4|CPLX2|CREBRF|CSF1R|CSF2|CSNK1A1|CSNK1G3|CTNNA1|CTXN3|CXCL14|CXXC5|CYFIP2|CYSTM1|DBN1|DCANP1|DCP2|DCTN4|DDX41|DDX46|DELE1|DIAPH1|DMXL1|DNAJC18|DND1|DOCK2|DOK3|DPYSL3|DRD1|DTWD2|DUSP1|EBF1|ECSCR|EFCAB9|EFNA5|EGR1|EIF4E1B|EIF4EBP3|EPB41L4A|ERGIC1|ETF1|F12|FABP6|FAF2|FAM114A2|FAM13B|FAM153A|FAM153B|FAM170A|FAM193B|FAM200C|FAM53C|FAT2|FAXDC2|FBN2|FBXL17|FBXO38|FBXW11|FCHSD1|FEM1C|FER|FGF1|FGF18|FGFR4|FLT4|FNDC9|FNIP1|FOXI1|FSTL4|FTMT|G3BP1|GABRA1|GABRA6|GABRB2|GABRG2|GABRP|GALNT10|GARIN3|GDF9|GEMIN5|GFPT2|GFRA3|GLRA1|GM2A|GNPDA1|GPR151|GPRIN1|GPX3|GRAMD2B|GRIA1|GRK6|GRM6|GRPEL2|GRXCR2|HAND1|HARS1|HARS2|HAVCR1|HAVCR2|HBEGF|HDAC3|HIGD2A|HINT1|HK3|HMGXB3|HMHB1|HMMR|HNRNPA0|HNRNPAB|HNRNPH1|KCNIP1|KCNMB1|KCNN2|KCTD16|KDM3B|KIAA1191|KIF20A|KIF3A|KIF4B|KLHL3|LARP1|LARS1|LCP2|LEAP2|LECT2|LMAN2|LMNB1|LOC100128059|LOC100288254|LOX|LRRTM2|LSM11|LTC4S|LVRN|LYRM7|MACROH2A1|MAML1|MAN2A1|MAPK9|MARCHF3|MAT2B|MATR3|MCC|MED7|MEGF10|MFAP3|MGAT1|MGAT4B|MINAR2|MIR103A1|MIR143|MIR145|MIR146A|MIR378A|MRNIP|MRPL22|MSX2|MXD3|MYOT|MYOZ3|MZB1|N4BP3|NDFIP1|NDST1|NDUFA2|NEURL1B|NEUROG1|NHP2|NIPAL4|NKX2-5|NME5|NMUR2|NOP16|NPM1|NR3C1|NREP|NRG2|NSD1|NUDCD2|OR2V1|OR2V2|OR2Y1|P4HA2|PAIP2|PANK3|PCBD2|PCDH1|PCDH12|PCDHA1|PCDHA10|PCDHA11|PCDHA12|PCDHA13|PCDHA2|PCDHA3|PCDHA4|PCDHA5|PCDHA6|PCDHA7|PCDHA8|PCDHA9|PCDHA@|PCDHAC1|PCDHAC2|PCDHB1|PCDHB10|PCDHB11|PCDHB12|PCDHB13|PCDHB14|PCDHB15|PCDHB16|PCDHB2|PCDHB3|PCDHB4|PCDHB5|PCDHB6|PCDHB7|PCDHB8|PCDHB9|PCDHB@|PCDHGA1|PCDHGA10|PCDHGA11|PCDHGA12|PCDHGA2|PCDHGA3|PCDHGA4|PCDHGA5|PCDHGA6|PCDHGA7|PCDHGA8|PCDHGA9|PCDHGB1|PCDHGB2|PCDHGB3|PCDHGB4|PCDHGB5|PCDHGB6|PCDHGB7|PCDHGC3|PCDHGC4|PCDHGC5|PCYOX1L|PDE6A|PDGFRB|PDLIM4|PDLIM7|PFDN1|PFN3|PGGT1B|PHAX|PHYKPL|PITX1|PJA2|PKD2L2|PLAC8L1|POU4F3|PPARGC1B|PPIC|PPP2CA|PPP2R2B|PRDM6|PRELID1|PRELID2|PROB1|PROP1|PRR16|PRR7|PRRC1|PSD2|PTTG1|PURA|PWWP2A|RAB24|RACK1|RAD50|RANBP17|RAPGEF6|RARS1|RASGEF1C|RBM22|RBM27|REEP2|REEP5|RELL2|RGS14|RMND5B|RNF130|RNF14|SKP1|SLC12A2|SLC22A4|SLC22A5|SLC23A1|SLC25A2|SLC25A46|SLC25A48|SLC26A2|SLC27A6|SLC34A1|SLC35A4|SLC36A1|SLC36A2|SLC36A3|SLC4A9|SLC6A7|SLIT3|SLU7|SMAD5|SMIM23|SMIM3|SNCAIP|SNCB|SNHG4|SNORA74B|SNX2|SNX24|SOWAHA|SOX30|SPARC|SPATA24|SPDL1|SPINK1|SPINK13|SPINK14|SPINK5|SPINK6|SPINK7|SPINK9|SPMIP10|SPOCK1|SPRY4|SQSTM1|SRA1|SRFBP1|SRP19|STARD4|STC2|STING1|STK10|STK32A|SYNPO|TAF7|TBC1D9B|TCERG1|TCF7|TCOF1|TENM2|TGFBI|THG1L|THOC3|TICAM2|TIFAB|TIGD6|TIMD4|TLX3|TMCO6|TMED7|TMED7-TICAM2|TMED9|TMEM232|TNFAIP8|TNIP1|TRIM36|TRIM41|TRIM52|TRIM7|TRK-CTT2-3|TRP-TGG3-1|TRPC7|TRT-TGT6-1|TRV-AAC1-4|TRV-CAC1-2|TSLP|TSPAN17|TSSK1B|TTC1|TXNDC15|UBE2B|UBE2D2|UBLCP1|UBTD2|UIMC1|UNC5A|UQCRQ|VDAC1|VTRNA1-1|VTRNA1-2|VTRNA1-3|VTRNA2-1|WDR36|WDR55|WNT8A|WWC1|YIPF5|YTHDC2|ZCCHC10|ZFP2|ZFP62|ZMAT2|ZNF300|ZNF346|ZNF354A|ZNF354B|ZNF354C|ZNF454|ZNF474|ZNF608|ZNF879		See cases	VCV000394550	5	106716357 - 180687338			394550	381443			copy number gain		Pathogenic		no assertion criteria provided							
GRCh37/hg19 5q33.2-35.1(chr5:154886174-169757448)x1	ADAM19|ADRA1B|ATP10B|C1QTNF2|C5orf52|C5orf58|CCNG1|CCNJL|CLINT1|CYFIP2|DOCK2|EBF1|FABP6|FAM200C|FNDC9|FOXI1|GABRA1|GABRA6|GABRB2|GABRG2|GARIN3|HAVCR1|HAVCR2|HMMR|IL12B|INSYN2B|ITK|LCP2|LOC100128059|LSM11|MAT2B|MED7|MIR103A1|MIR146A|NIPAL4|NUDCD2|PANK3|PTTG1|PWWP2A|RARS1|RNF145|SGCD|SLIT3|SLU7|SOX30|SPDL1|TENM2|THG1L|TIMD4|TTC1|UBLCP1|WWC1		See cases	VCV000253504	5	154886174 - 169757448			253504	247952			copy number loss		Pathogenic	Jan 20, 2016	criteria provided, single submitter							
